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 Abstract  
Background: It is well established that adverse experiences during childhood increase 
the chances of developing emotional psychopathology in adulthood, particularly during 
vulnerable times, such as pregnancy. Furthermore, research has also demonstrated an 
association between maternal depression in pregnancy and poorer offspring 
developmental outcomes. The primary aim of this thesis is to investigate the pathways 
by which maternal history of abuse during childhood interacts with depression during 
pregnancy, and how both conditions affect offspring development at six days, eight 
weeks and one year after birth. The second aim of this study is to explore the alterations 
in maternal hypothalamic-pituitary-adrenal (HPA) axis functioning during pregnancy 
among women who are depressed and/or have experienced childhood abuse, and 
whether these are related to offspring behavioural and physiological regulation as well 
as to offspring HPA axis response to stress.  
Methods: The sample comprises 125 pregnant women recruited in the area of South 
London. Women were assessed in pregnancy for maternal depression and history of 
abuse in childhood in a one-to-one clinical interviews (25 weeks gestation), and for 
maternal HPA axis (25 and 32 weeks gestation) through the collection of salivary 
samples. Infants were administered the Neonatal Behavioural Assessment Scale 
(NBAS) at six days, with an assessment of the HPA axis functioning before and after 
the NBAS. Infant HPA axis response was reassessed at eight weeks and one year before 
and after routine immunization.  
Results: Women who have been abused in their childhood were 7 times more likely to 
develop depression in pregnancy than non-abused women. Furthermore, women who 
were depressed in pregnancy and especially those with both childhood abuse and 
antenatal depression, showed an increase in the evening cortisol levels at 32 weeks 
gestation compared with the other women. Neonates of depressed women had poorer 
behavioural regulation at 6 days, with an increase in their HPA axis stress response 
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following the NBAS compared with neonates of non-depressed mothers, irrespective of 
maternal history of childhood abuse. At one year, infants of mothers with childhood 
abuse and depression exhibited greater stress following the immunization compared 
with infants of non-depressed mothers, but this difference was not seen at 8 weeks.  
Conclusions: The effects of exposure to childhood abuse and depression in pregnancy 
can be seen in the mothers’ high level of stress hormone circulating in the evening in 
the 3rd trimester of pregnancy. Moreover, the effects are also seen in the next generation 
during the first year of life, as observed in the persistent biological and behavioural 
changes in the offspring. These findings have implications for clinical practice: doctors 
and midwives in antenatal clinics should be aware of the importance of asking about 
women’s own childhood histories and their mental health during pregnancy in order to 
offer support during their transition to motherhood.  
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1 Introduction  
1.1 Overview  
Evidence of an association between childhood abuse and heightened levels of 
depression in adulthood, particularly in vulnerable periods such as pregnancy, is now 
well established (Benedict et al., 1999) (Bifulco et al., 2002), with further evidence that 
childhood abuse leads to disruptions in the neurobiology of stress in adulthood (Trickett 
et al., 2010). Furthermore, a vast body of research has shown evidence of links between 
maternal depression in pregnancy and infant outcomes. In fact, there is evidence that 
depression in pregnancy can have detrimental effects on infant development after birth 
(Field et al., 2006) (Deave et al., 2008) and on infant stress response regulation (Davis 
et al., 2011).  
It is with this in mind that this thesis aims to investigate the clinical and molecular 
mechanisms by which maternal abuse in childhood interacts with maternal depression in 
pregnancy and how both conditions impact the baby’s development after birth. This is 
the first study that explores potential pathways of this intergenerational transmission 
and the interaction between clinical and biological factors shaping this trajectory. This 
investigation will assess both mothers and infants from pregnancy to one year, using a 
combination of maternal diagnostic and infant behavioural measures, as well as 
biological measures with both mothers and their babies.  
The purpose of the introductory chapter that follows is to offer an overview of the 
literature and the work that has been conducted in this field up to now, with a focus on 
the interaction between the biological system and psychopathology in mothers 
(childhood abuse and depression in pregnancy). First, a brief overview of childhood 
abuse, its relevance to the perinatal period and its association with antenatal depression 
is provided. Next, I review the literature on the functioning of the biological systems in 
healthy adults and then in women who experienced childhood abuse and/or antenatal 
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depression and finally I discuss the biological and behavioral alterations in the 
offspring.  
1.2 Childhood abuse  
1.2.1 Phenomenology 
Childhood abuse is a term that covers a wide spectrum of phenomena. Bifulco identifies 
4 categories of abuse – physical, emotional, sexual abuse and neglect. Physical abuse is 
“defined in terms of hitting by parents or other older household members. A range of 
attacks is reflected by those rated severe are usually repeated attacks where implements 
such as belts or sticks are used, or punching or kicking occurs with the possibility of 
causing harm” ((Bifulco et al., 2005), page 567). Emotional or psychological abuse is 
caused by the failure of parents to provide a safe, caring and loving environment for 
their children. It is concerned with cruelty demonstrated by verbal and nonverbal acts, 
repeated or singular, intended or not, from a close other in a position of power or 
responsibility over the child. Such acts have the potential for damaging the social, 
cognitive, emotional, or physical development of the child and are demonstrated by 
behaviours which are humiliating or degrading, terrorising, extremely rejecting, 
depriving of basic needs or valued objects, inflicting marked distress or discomfort, 
corrupting or exploiting, cognitively disorientating, or emotionally blackmailing (Moran 
et al., 2002). Sexual abuse is defined as an act that “involves physical contact or 
approach of sexual nature by any adult to the child, but excludes willing sexual contact 
with peers. Severe sexual abuse (marked or moderate severity) includes all repeated 
sexual contact with an adult or single incidents of a serious nature, such a rape or sexual 
contact with a family member” ((Bifulco et al., 2005) page 567). Neglect has been 
defined as the “parents disinterest in material care (feeding and clothing), health, school 




Several studies in the UK report that the rate of maltreatment amongst children and 
adolescents is unacceptably high (May-Chahal and Cawson, 2005). Recent statistics 
from the Child Protection Register show that currently in the United Kingdom over 
50,000 children are under the child protection services (NSPCC, 2014). These children 
are known to have been abused or to be at high risk of abuse. The Department of 
Education (2013) has published data on the prevalence of specific types of childhood 
abuse in the UK, as shown in Table 1 (NSPCC, 2014). The data show an increase in the 
total number of reported cases of abuse particularly in the number of children 




Table 1. Prevalence of different types of abuse in the UK  

















































































Importantly, the statistics also show that one in four adults have been abused in their 
own childhood (NSPCC, 2014). The most recent data gathered by the NSPCC on the 
prevalence of child abuse and neglect among UK families are based on a large study 
published by Radford and colleagues (Radford et al., 2011). Researchers interviewed 
more than 2,000 young adults, adolescents and parents of young children. The Juvenile 
Victimization Questionnaire (Finkelhor et al., 2005) was used to gather information 
about physical violence, emotional abuse, sexual abuse and neglect by a parent or other 
adult living in the family. In this study physical violence was defined as “the act of 
being beaten, kicked, hit or physically hurt by a parent or guarding or physically 
attacked with or without a weapon but no including smacking” ((Radford et al., 2011) 
page 44).  
Emotional abuse included “being scared or made feel really bad because the caregiver 
called the child name, said mean things, or said that they did not want the child; 
breaking or ruining the child’s things and threatening him/her with violence” ((Radford 
et al., 2011) page 45), while sexual abuse included both contact and non-contact abuse 
by a caregiver. Neglect was defined as “the absence of physical care, lack of health care, 
educational neglect, poor supervision and monitoring, and a caregiver being 
unresponsive to the child’s emotional needs to such an extent that significant harm is 
likely to result” ((Radford et al., 2011) page 43). A further category of severe 
maltreatment was judged on the basis of frequency, level of injury, use of weapon, 
having different abuse experiences, whether the act would be seen as severe in criminal 
law (Radford et al., 2011).  
Table 2 reports the data regarding the lifetime rate of physical, emotional and sexual 
abuse and neglect by a parent or a guardian (Radford et al., 2011). As shown, 8.9% of 
children under the age of 11, 21.9% of adolescents aged 11 to 17 and almost a quarter of 
young adults aged 18 to 24 have experienced some form of maltreatment in their life 
(Radford et al., 2011).  
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Table 2. Lifetime rate of maltreatment by a parent or a guardian in the UK 
Maltreatment type  
 























































Interestingly, the data show neglect to be the most prevalent type of maltreatment in the 
family across all age groups. The study also found a very strong association between 
childhood abuse and poor emotional wellbeing (Radford et al., 2011).  
1.3 Childhood abuse and perinatal period  
As we have seen the prevalence of childhood abuse in the UK is high with almost a 
quarter of young adults having reported being abused in their childhood or adolescence. 
Not only does abuse in the current generation of children constitute a major social 
problem (Lang et al., 2010) but also the effects of experiencing abuse as a child may 
have long lasting effects into adulthood. For example, Bifulco and colleagues (1994) 
showed that neglect and abuse during childhood predicted depression in adulthood, 
particularly in vulnerable periods. Such effects may become particularly visible when a 
woman becomes a mother herself (Lang et al., 2010). It is now acknowledged that an 
experience of childhood abuse may lead to negative consequences on pregnancy 
outcome, childbirth, parenting and later child development (Leeners et al., 2006), both 
from a medical and psychological point of view. Moreover, there is evidence to show an 
association between a history of childhood abuse and heightened levels of postpartum 
depression (Benedict et al., 1999). For example, physical abuse has been linked to 
elevated postpartum depressive symptoms (Buist, 1998), and sexual abuse has been 
linked with heightened anxiety among postpartum women (Grimstad et al., 1999). 
However, surprisingly few studies have examined the impact of the experience of 
childhood abuse on maternal depression in pregnancy. Findings from studies that have 
addressed this question suggest an association with depressive symptomatology during 
pregnancy (Romano et al., 2006) (Rich-Edwards et al., 2011) (Chung et al., 2008). 
More recently Plant and colleagues (2013) have demonstrated in a South London 
sample that mothers who have experienced abuse in their own childhoods are 10 times 
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more likely than those who were not abused to develop clinically diagnosed depression 
in pregnancy. 
1.4 Antenatal depression 
1.4.1 Phenomenology 
Antenatal depression is a major depressive disorder (MDD) that occurs in pregnancy. 
As studies published today use DSM-IV criteria and I use these same DSM-IV criteria 
for my Thesis, I will refer to these rather than to the more recent DSM-5 criteria, which 
are in any case virtually identical. According to the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; (American Psychiatric 
Association, 2000), a diagnosis of MDD is rated if an individual has suffered from at 
least one core symptom of (i) depressed mood or (ii) diminished interest or pleasure in 
activities, and at least three of the following symptoms: (iii) significant weight change 
or change in appetite; (iv) insomnia or hypersomnia; (v) psychomotor agitation or 
retardation; (vi) fatigue or loss of energy; (vii) feelings of worthlessness or excessive or 
inappropriate guilt; (viii) diminished ability to think or concentrate or indecisiveness; 
(ix) recurrent thoughts of death, recurrent suicidal ideation or plans for committing 
suicide. These symptoms must be present for most of the day, nearly every day, for at 
least two weeks. Furthermore, the symptoms must cause significant distress or 
impairment in normal functioning, and should not be attributable to the death of a loved 
one, a general medical condition or substance use (American Psychiatric Association, 
2000). This last criteria (the so called “bereavement exclusion” is no longer valid for 
DSM-5. 
1.4.2 Epidemiology 
A meta-analysis was conducted in 2004 into the prevalence of antenatal depression 
(Bennett et al., 2004).  The meta-analysis included studies published since 1980. 
Twenty-one studies were identified, with seven based on clinical diagnoses of 
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depression rated through structured clinical interviews (Schedule for Affective 
Disorders and Schizophrenia; SADS).  The remaining studies were based on ratings of 
depression using self-report measures such as the Edinburgh Postnatal Depression Scale 
(EPDS) and the Beck Depression Inventory (BDI). The authors reported the point 
prevalence of depression by trimester, with rates of 7.4% in the first, 12.8% in the 
second and 12.0% in the third trimester. Prevalence estimated through structured 
interviews did not differ significantly from rates attained through the EPDS, but were 
significantly lower that rates attained through the BDI. 
Gavin and colleagues (2005), reviewed studies where depression during pregnancy had 
been rated only through structured clinical interviews (Gavin et al., 2005). They 
reported a period prevalence rate (conception to birth) for MDD of 12.7%. In both 
studies there were methodological flaws, such as the exclusion of women with previous 
psychiatric histories and of low socioeconomic status. Given that both of these factors 
are well-known risk factors for depression (Gotlib and Hammen, 2008), it is likely that 
these are conservative estimates. 
One of the potential mechanisms that might underlie the association between the 
experience of childhood abuse, an early-life adversity, and depression in pregnancy is 
through the long-term alteration of the neuroendocrine system. Specifically, and as 
reviewed below, childhood abuse (especially in the context of adult depression) leads to 
persistent activation of the main hormonal stress system, the hypothalamic-pituitary-
adrenal (HPA) axis. In turn, pregnancy in itself is also associated with a persistent 
activation of the HPA axis, and therefore it is plausible that this makes pregnancy a 




1.5 Hypothalamus-Pituitary-Adrenal (HPA) axis  
1.5.1 HPA axis general functioning in healthy adults 
The hypothalamic-pituitary-adrenal (HPA) axis controls reactions to stress and regulates 
many body processes, including digestion, the immune system, mood and emotions, 
sexuality and energy storage (Pruessner et al., 2003) (Heim et al., 2002). The activated 
HPA axis not only regulates body peripheral functions such metabolism and immunity 
but also has profound effects on the brain (Pariante and Lightman, 2008).  
The HPA axis is a complex set of direct influences and feedback interactions among 
three endocrine glands: the hypothalamus, the pituitary gland (located below the 
hypothalamus), and the adrenal  glands (located on top of the kidneys).  It is activated 
via the hippocampus, resulting in secretion of corticotrophin releasing hormone (CRH) 
from the hypothalamus. In turn, CRH stimulates secretion of the adrenocorticotrophic 
hormone (ACTH) from the pituitary gland, which causes secretion of cortisol from the 
adrenal glands. In addition to its actions to prepare the body to counteract the stressor, 
cortisol has an inhibitory action on secretion of CRH at the hypothalamic level via the 
glucocorticoid receptor though the activation of a negative feedback loop (Pruessner et 











1.5.2 HPA axis in depressed adults 
A number of biological mechanisms have been found to be involved in the 
pathophysiology of maternal depression (Leung and Kaplan, 2009). Specifically, one of 
the most consistent findings in the biology of depression is the alteration of the HPA 
axis and the role of cortisol (Belvederi Murri et al., 2014). Although this evidence has 
been consistently shown in studies over the last 40 years, the mechanisms that lead to 
this abnormality are still unclear (Pariante and Lightman, 2008).  
These neuroendocrine alterations have been confirmed by an analysis of studies testing 
HPA axis function (by dexamethasone suppression test) in thousands of depressed 
patients suggested evidence of an increased production of CRH in the brain and 
impaired negative feedback regulation by glucocorticoids in 44% of the sample (Arana 
et al., 1985)  (Pariante, 2003). Moreover, those depressed patients show increased levels 
of cortisol in urine, plasma (Sachar et al., 1970) and cerebrospinal fluid (Nemeroff et 
al., 1984) and increased volume of pituitary (Krishnan et al., 1991) and adrenal and 
pituitary glands  in depression (Rubin et al., 1995) (Nemeroff et al., 1992) (Pariante, 
2003).   
This biological vulnerability has been tested in a large cohort study on subjects with a 
history of major depression (Vreeburg et al., 2009). Salivary cortisol was collected at 7 
time points throughout the day. Results have shown higher cortisol awakening response 
in subjects with a current or previous diagnosis of major depression compared to 
subjects with no mental health diagnosis.  
1.5.3 HPA axis in adults abused in childhood 
 A history of child sexual abuse has been associated with HPA axis dysregulation across 
a number of studies, although the direction of its effect remains controversial, with 
studies finding in general HPA hyperactivity in the context of adult depressed subjects 
with a history of childhood abuse. (Bublitz and Stroud, 2012). Childhood sexual abuse 
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has been associated with greater cortisol awakening response in a group of patient with 
first episode of psychosis (Mondelli et al., 2010) and with a blunted cortisol response in 
a laboratory setting after an experimental stress challenge (Pierrehumbert et al., 2009). 
A Chinese study investigated the cortisol awakening response (as a measure of the HPA 
axis) in a group of 30 depressed subjects who were victims of emotional and physical 
neglect and 30 depressed patients without history of child neglect. Results showed a 
significant increase in the cortisol awakening response in patients with both depression 
and neglect compared with those who were only depressed. Interestingly, child neglect 
was found to have an effect on the HPA axis response but not on the severity of 
depression. Despite this initial evidence of an association between childhood abuse and 
HPA axis functioning, the studies cited above have a relatively small sample size and 
used different instruments to assess childhood abuse. This might further explain the lack 
of clear direction in the associations found.  
1.5.4 HPA axis in pregnancy 
The maternal HPA axis undergoes dramatic changes during pregnancy and the 
postpartum (Duthie and Reynolds, 2013). Specifically, in healthy pregnant women, 
circulating cortisol increases during pregnancy, with a peak in the third trimester (Jung 
et al., 2011). This is due to the increased oestrogen stimulation of corticosteroids and 
the higher placental secretion of CRH into maternal blood during the second and third 
trimester of pregnancy (Jung et al., 2011). Placental CRH stimulates maternal pituitary 
glands and, consequently, there is a higher production of cortisol level. As pregnancy 
progresses, this increased circulation of cortisol down regulates the hypothalamic 
production of CRH and decreases the HPA axis response (Duthie and Reynolds, 2013). 





HPA axis in depressed pregnant women 
Evidence suggests that this mechanism is altered in pregnant women who experience 
depression but the effects of this alteration remain unclear. A study by Dyane and 
colleagues shows that depression in pregnancy might heighten cortisol levels as well as 
the placental secretion of corticotrophin releasing factors (CRF), although its role 
remains unclear (Dayan et al., 2010). A different outcome was found in a longitudinal 
study of a Swedish pregnant women (Hellgren et al., 2013). Recruited in a scanning 
clinic of Uppsala, participants were invited to complete a web-based questionnaire 
regarding their mood at 17 and 32 weeks gestation. 57 women were free from mental 
health diagnosis, while 38 had depression during the current pregnancy. The women 
collected saliva samples at awakening, 15, 30 and 45 minutes post-awakening. 
Surprisingly, results showed no difference in the cortisol levels of depressed pregnant 
women and healthy pregnant controls (Hellgren et al., 2013). The author suggests that 
the physiological changes related to pregnancy that lead to higher cortisol levels, might 
suppress the higher cortisol awakening response seen in non-pregnant subjects 
(Hellgren et al., 2013) 
Two other studies have compared HPA axis measures in pregnant women with an 
operationally defined diagnosis of major depression and healthy controls. Both found 
significantly higher cortisol, measured at a single 2nd trimester time-point, in the 
depressed group (Field et al., 2009b).  By measuring both morning and evening cortisol, 
O’Keane (O'Keane et al., 2011) demonstrated cortisol hyper-secretion especially in the 
evening, a pattern frequently found also in adults with major depression outside of 
pregnancy. This study also made fuller assessments of the HPA axis and demonstrated 
significantly higher plasma CRH in depressed women in the 2nd trimester. Cortisol was 
measured in another study which assessed antenatal depression and foetal growth 
restriction; compared with the non-depressed group, depressed women had higher levels 
of cortisol (Diego et al., 2009).  
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The difference in methodology adopted by O’Keane and by Hellgren might further 
explain the difference in the results of the two studies. It is possible to speculate that 
face-to-face interview, as administered by O’Keane, is more effective in detecting 
maternal psychopathology compared with the web-based evaluations by Hellgren.  
1.5.5 HPA axis in women with a history of childhood abuse and antenatal 
depression 
A study by Bublitz and colleagues, investigated the association between childhood 
abuse and the HPA axis in a sample of pregnant women (Bublitz and Stroud, 2012). 
Specifically, the sample comprised 30 women with history of childhood sexual abuse, 
58 women with history of non-sexual abuse and 47 healthy controls with no history of 
abuse. Participants collected salivary cortisol at awakening, +30 minutes and bedtime 
for three consecutive days during the second and third trimester of their pregnancy.  
Women with history of childhood sexual abuse displayed higher cortisol levels at 
awakening compared with women in the other two groups (Bublitz and Stroud, 2012). 
A study of Canadian pregnant women, investigated the effects of depression and early 
childhood maltreatment on cortisol awakening response during pregnancy. The sample 
comprised 33 depressed women and 33 healthy women between week 25 and 33 of 
gestation. Cortisol response was measured at awakening and at +30 and +60 minutes 
thereafter. Results showed that cortisol awakening response was not different between 
women with antenatal depression and those with no diagnosis. However, those with 
history of childhood maltreatment showed an attenuated cortisol awakening response 
(Shea et al., 2007). While my Thesis will replicate some of these investigations, by 
assessing awakening and diurnal cortisol in pregnancy, it will also extend these findings 
by focusing on history of childhood abuse and by adding measurement of HPA axis in 
the baby and correlating the HPA axis results with a range of behavioural measures. 
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1.6 Interim summary  
For the research reviewed in this section, we can see that a history of physical, 
emotional, sexual abuse and neglect in childhood can have detrimental long-lasting 
effects into adulthood. These effects include a greater risk of developing 
psychopathology such as anxiety and depression later in life together with a greater 
predisposition to neuroendocrine alterations, such as the hyper activation of the 
hypothalamic-pituitary-adrenal (HPA) axis, which leads to an abnormal response to 
stress.  These changes are particularly manifested in vulnerable periods of life, such as 
when a woman is about to become a mother herself. In fact, women who experienced 
depressive symptomatology in pregnancy are seen to have a biological vulnerability and 
alteration of the stress response that, in turn, may contribute to an alteration in the 
intrauterine environment. These changes in the biological system of the foetus are one 
of the potential mechanisms that underlie the intergenerational transmission of 
vulnerability to psychopathology. 
This initial review of the literature on childhood abuse and depression shows that there 
is a strong association between childhood experience of physical, sexual and emotional 
abuse and neglect with the hyperactivity of the HPA axis, which is also considered to be 
part of the pathogenesis of depression.  
In the next section I will explore the effects of maternal childhood abuse and antenatal 
depression on the intrauterine environment (foetal programming hypothesis) and the 
infant behavioural outcomes and biological response to stress in the first year.  
1.7 The fetal programming hypothesis  
There is increasing evidence that adult vulnerability to diseases is programmed during 
foetal life and shaped by the environment in utero (Duthie and Reynolds, 2013). 
Findings from a series of studies on a British cohort that demonstrated that the lower the 
birth rate the higher the risk from dying of heart disease later in life, led Barker to 
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hypothesise that coronary heart disease, type 2 diabetes, stroke and hypertension, 
originate in developmental plasticity, in response to under nutrition during foetal life 
(Barker et al., 1993). In his pioneer work, he found that foetal exposure to under 
nutrition in utero leads to changes in the foetus metabolism and organ structure (Barker, 
1997). In fact, children of mothers with low weight during pregnancy (under nutrition, 
less than 45 kilos) were more prone to develop coronary heart disease in adult life 
compared with children of mothers without nutrition problems (Barker, 1997). Further 
human and animal studies have corroborated Barker’s original findings but the 
molecular mechanisms have not yet been clarified (Smith et al., 2011).  
Studies investigating the Dutch Hunger Famine (1944-1945), explored the effects of the 
exposure to maternal under nutrition during gestation on the offspring outcomes in later 
life, between age 50 and 60 (de Rooij et al., 2006). Seven hundred participants, half of 
whom were exposed to the famine while in utero, were invited to perform a 
computerized stress test, which comprised a colour-word conflict challenge (Stroop 
test), a mirror test and a speech test. In the mirror test, participants were asked to trace a 
star that could only be seen in the mirror; a beep sound would appear when there was a 
divergence from the circuit of the start and the line of star. In the speech test, people 
were asked to imagine a scenario where they were falsely accused of pickpocketing and 
to prepare a 3 minute speech to give in front of a camera to prove their innocence. 
During this procedure, salivary cortisol was collected at 7 time points between the 
baseline period and after the completion of the test. Despite an increase in the cortisol 
levels after the end of the test, results showed no group difference in cortisol response 
between those who were exposed to famine and those who were not exposed to such 
condition in utero. This study suggested that exposure to famine in utero does not have 
an association with an altered neuroendocrine profile in adulthood, although the stress 
test used in the study might not have been good enough to provoke an activation of the 
HPA axis.  
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Further evidence on the magnitude of big phenomena in pregnancy and its long-lasting 
effects on the offspring, such as the Dutch Famine, has been provided by a longitudinal 
study that investigates the effects of in utero exposure to a natural disaster. The ice 
storm study looks at the effects of the natural disaster occurred in Quebec in 1998 on 
later child outcome and development (King et al., 2012). More than two-hundred 
pregnant women were recruited in the study and assessed for mental health and HPA 
axis functioning and children were seen up to age 13. Results show that babies of 
women who experience high levels of stress during the exposure to natural disaster have 
slower physical growth rate at birth and impaired cognitive development and language 
at 5 ½ years, as show in lower IQ levels (Laplante et al., 2008). Furthermore, results 
from a follow-up at age 12, show that there is a great association between exposure to 
stress in utero and later immune-deficiencies in those children. In fact, children of 
mothers experienced high stress levels following the natural disaster had greater 
chances to develop asthma and chronic use of corticosteroids, but this condition was 
found only in girls (Turcotte-Tremblay and Lim, 2014). Taken together, the Quebec Ice 
Storm project supports the foetal programming hypothesis that the antenatal 
environment programs the infant outcome from a developmental but also an 
immunological prospective.    
1.7.1 HPA axis in offspring of mothers depressed in pregnancy 
More recently it has been hypothesized that maternal HPA axis alterations during 
pregnancy expose the foetus to higher levels of stress and that this might affect the 
foetal HPA axis (Duthie and Reynolds, 2013). A study by Davis and Sandman (2010) 
assessed maternal HPA axis in pregnancy by measuring plasma at 15, 19, 25, 31 and 36 
weeks gestation and maternal stress, anxiety and depression. Infants’ HPA axis was 
measured 24 hours after birth by collecting a hair sample from the baby. An evaluation 
of the behavioural response to the hair pull was also observed. They found that the 
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infant’s cortisol response to stress was associated with maternal high levels of stress and 
higher cortisol in pregnancy (Davis et al., 2011). Moreover, infants of mothers with 
high stress found it more difficult to regulate their behaviour after the hair was removed, 
compared with infants of non-stressed mothers (Davis et al., 2011). This research 
suggests that infant capacity to regulate their stress is indeed influenced by maternal 
stress response, although no causal relationship has been demonstrated.  
There is evidence to suggest that exposure to maternal stress in pregnancy goes far 
beyond the infancy period as is suggested by the foetal programming hypothesis. Indeed 
evidence from a study by Ashman et al., (2002) shows that exposure to maternal 
depression from pregnancy to the first two years of the infant’s life predicts infant 
cortisol response following a stress test at 8 years (Ashman et al., 2002). Women were 
interviewed retrospectively about their symptoms of depression during pregnancy and 
the postnatal period when their infants were 14 months old, 24 months old, 3.5 years 
old, 4.5 years old, 6.5 years old and 8 years old. Children were invited for a laboratory 
stress task, during which they were administered the fear-potentiated startle paradigm. 
This procedure allows measuring the reflexes and anxiety levels experienced by the 
child when s/he anticipates the fear related to an aversive stimulus. Specifically, the 
threatening stimulus involved an intense noise that the child would perceive as unsafe 
(Ashman et al., 2002). Infant cortisol levels were measure prior and after the 
administration of the stress test. The authors concluded that children of depressed 
mothers had a more reactive hormonal stress system compared with children of healthy 
mothers. Furthermore there is evidence showing that children of mothers who 
experienced stress during pregnancy were more likely to develop emotional or cognitive 
problems, such as attention deficit, hyperactivity, anxiety and language delay compared 
with children of mothers who were not stressed in gestation (Talge et al., 2007). It has 
been suggested that this association is accounted for by changes in the foetal 
environment seen when exposed to maternal stress (Talge et al., 2007).  
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Further work by Glover and colleagues, offers substantial evidence that maternal stress 
in pregnancy has permanent effects on the infant neurodevelopmental system (Bergman 
et al., 2007). In her work, Glover found that women with higher cortisol levels in 
pregnancy, due to maternal stress, are strongly associated with greater cortisol levels in 
the amniotic fluid, which is an indicator of the foetal exposure to maternal environment 
(Sarkar et al., 2007). More than two hundred women were recruited and assessed for 
stress and depression in pregnancy. Maternal cortisol was assessed through maternal 
blood, which was drawn immediately before the amniocentesis procedure, during which 
foetal cortisol was collected (Glover et al., 2009). Results show that there is a very 
robust association between maternal plasma cortisol and foetal amniotic fluid cortisol 
among women who experienced high stress in pregnancy, suggesting that the emotional 
state in pregnancy can not only affect women’s biological profile but also the 
functioning of the placenta, which moderates foetal exposure to maternal environment. 
This, in turn, increases the potential high risk of compromising the infant’s later 
development (Sarkar et al., 2007). Despite accumulating evidence on the mechanisms 
that allow the transmission of stress from mother to baby, little is known about which 
stresses in pregnancy are the most detrimental for the infant and when in pregnancy is 
the most critical time for the transmission of maternal stress through the placenta 
(O'Donnell et al., 2009).  
A further study showed that the maternal HPA axis during pregnancy had a strong 
effect on the newborn’s regulation of his own HPA axis (Smith et al., 2011), with 
evidence to suggest that the neonatal HPA axis was associated with maternal HPA axis 
at the time of delivery (Smith et al., 2011). Two hundred women were recruited on the 
basis of their current psychiatric diagnosis at 14 weeks gestation: of those, 67.5% met 
the criteria for depression, while 20% of women had anxiety disorders. The remaining 
10% had another diagnosis. Maternal and infant cortisol profile was obtained at birth, 
with a blood test on the mother and the umbilical cord blood for the infant. After 
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controlling for delivery methods, results show that maternal cortisol levels in pregnancy 
are predictive of infant cortisol levels at birth.  
These findings further support the foetal programming hypothesis suggesting that there 
in an intergenerational transmission of the HPA axis functioning and that offspring 
whose mothers had been stressed in pregnancy are themselves compromised in that they 
may have difficulties in regulating their own HPA axes making them vulnerable to the 
adverse consequences of stressful life experiences. Again, my Thesis will extend these 
findings by investigating how these HPA axis change may be related to maternal history 
of childhood abuse. 
1.7.2 HPA axis in offspring of mothers abused in childhood 
The majority of studies focus on the effects of childhood abuse on the adult HPA axis, 
and the effects of maternal childhood abuse on offspring physiological regulation 
remain mainly unexplored. A study by Brand et al (2010) recruited 126 women in the 
postpartum period with a history of major depression. Maternal childhood abuse was 
assessed using the Childhood Trauma Questionnaire (Bernstein et al., 1994). In order to 
examine the effects of maternal childhood abuse on the mothers’ and children’s 
physiological response, the authors measured salivary cortisol in a laboratory stress 
paradigm at 6 months postpartum (Brand et al., 2010). During the laboratory stressor 
the infant was placed in a car seat and the mother was placed behind a screen out of the 
infant’s view; the mother could see her baby on a TV monitor. The stressor was a noise 
burst and an arm restraint task experienced by the infant. Saliva samples were collected 
(1) before from mothers and infant at baseline, when they were still together in the same 
room; (2) after 20 minutes when they were separated; (3) immediately after the stressor; 
(4) 20 minutes later. Results suggest that infants of mothers abused in their own 
childhoods had lower cortisol at baseline compared with infants of healthy controls 
mothers. This might suggest an impaired baseline cortisol response in the offspring of 
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mothers who had themselves experienced trauma in their own childhoods (King et al., 
2001). However, infant cortisol response after the stressor was not associated with a 
maternal history of childhood abuse but infants whose mothers had both a history of 
childhood abuse and were depressed had a greater cortisol response after the stressor 
compared with children of mothers in the healthy group (Brand et al., 2010). Overall, 
the study suggests a biological vulnerability that exposes women with abuse in early life 
to develop depressive symptoms and this vulnerability is seen in the child’s increased 
response to stress. 
A study on parents who survived the Holocaust and their adult offspring, showed that 
those exposed to severe traumatic experiences of abuse have an increased rate of post-
traumatic stress disorder (PTSD) compared with a healthy control group (Yehuda et al., 
2001). Researchers assessed the offspring of those parents with PTSD by measuring 
their psychopathology and HPA axis functioning in adulthood. Results showed that 
offspring of parents that were abused in the Holocaust had higher urinary cortisol levels 
and a higher level of reported PTSD symptoms as adults compared with the offspring in 
the control group (Yehuda et al., 2001). The authors believe that traumas experienced in 
the parent might lead to a transmission of altered stress response in the offspring, 
resulting in a vulnerability to increased psychopathology (Yehuda et al., 2001).   
To my knowledge, our research is the first to investigate the impact of early life stresses 
in the mother’s own childhood on her mood in pregnancy and the biological correlates 
between the maternal and offspring stress response. 
1.8 Developmental and behavioral outcomes  
1.8.1 Offspring of mothers depressed in pregnancy 
The earliest studies on infants of depressed mothers focussed on mother-infant 
interaction (Field et al., 2006). Most studies show that maternal depression has long-
term effects on child’s social and emotional development and on the mother-infant 
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relationship (Tronick and Reck, 2009). Some neurobehavioral studies show that infants 
of depressed mothers have greater right frontal electroencephalogram (EEG) activation 
compared with infants of non-depressed mothers, which is associated with negative 
affect, depression and poor capacity to regulate emotions (Field et al., 2006). Moreover, 
as depression is associated with an abnormal biological profile (such as elevated cortisol 
and norepinephrine), we might expect that infants of depressed women who have been 
exposed to an abnormal prenatal environment might themselves have an abnormal 
response to stress. In fact, neonates of depressed mothers show a physiological profile 
that mimics their mother’s prenatal profile, including cortisol alterations (Field et al., 
2006). In a study by Lundy et al. (1999), cortisol was measured in depressed and non-
depressed women at the end of their pregnancy and 24 hours after delivery, together 
with infant cortisol. The findings suggest that maternal cortisol in pregnancy predicts 
infant cortisol after birth (Lundy et al., 1999).  
Newborn behaviour has been widely assessed using the Neonatal Behavioural 
Assessment Scale (NBAS) (Brazelton and Nugent, 1995). Field has extensively studied 
neonatal behaviour in relation to maternal psychopathology, especially depression in 
pregnancy. Data from a study in 2006 suggests that babies of women who experienced 
depression during pregnancy showed sub-optimal performance on the NBAS within a 
few hours of birth, compared with babies of non-depressed women. Neonates of 
depressed mothers showed higher levels of irritability, lower activity levels, were less 
robust and less mature compared with neonates of non-depressed mothers (Field et al., 
2006). A review by Field (Field et al., 2009a) reported that new-borns of depressed 
mothers were also less responsive to voices and faces, showed higher arousal levels and 
were less attentive compared with neonates of non-depressed mothers. These findings 
have been further confirmed by Hernandez (Hernandez-Reif et al., 2006), who found 
that babies of depressed mothers had more difficulties in learning facial and vocal 
expressions compared with babies of healthy women. Furthermore, the authors showed 
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that neonates of depressed mothers took twice as long as babies of healthy mothers to 
habituate to their mother’s face and voice, finding it harder to distinguish their mother’s 
face and voice from that of a stranger (Hernandez-Reif et al., 2006). Field (Field et al., 
2002) also investigated the effects of anger and depression during pregnancy on the 
baby’s behaviour. One hundred and sixty-six women were classified as experiencing 
low or high anger in pregnancy: the latter also had high levels of antenatal depression. 
Babies were assessed at 2 days after birth with the NBAS (Brazelton and Nugent, 
1995). Results showed that babies of depressed and high anger women had less optimal 
orientation, motor organization and state regulation capacities compared with babies of 
non-anger and non-depressed women. Another study by Field and colleagues compared 
neonates of depressed versus non-depressed women on the NBAS supplementary items 
(Hernandez-Reif et al., 2006). Interestingly, neonates of depressed mothers had lower 
scores in their orientation to animate visual and auditory stimuli (face and voice of the 
examiner) and were less alert than babies of non-depressed women. In addition, 
neonates of depressed mothers had lower scores in cuddliness and hand to mouth items, 
suggesting that they were less able to be soothed and to self-soothe than neonates of 
non-depressed women.  
The literature shows that the effects of exposure to maternal depression in utero extend 
further than the immediate post birth period. Indeed there is now a wealth of studies 
showing that the effects extend into adolescence. Offspring of mothers depressed in the 
antenatal period are at greater risk than those whose mothers were well in pregnancy of 
becoming depressed themselves in adolescence (Pawlby et al., 2009). The same study 
showed that exposure to maternal antenatal depression also predicts violence and 
antisocial outcomes in the offspring (Hay et al., 2010). Moreover, exposure to antenatal 
depression was also found to increase offspring maltreatment (Pawlby et al., 2011). 
More evidence on the long-term effects of the exposure to maternal depression/stress in 
pregnancy is observed in the Avon Longitudinal Study of Parents and Children 
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(ALSPAC). This study involved pregnant women, partners and their infants living in 
the area of Avon, in the UK, initially assessed in 1990 and followed-up thereafter.  
A cross-cohort study that comprises 3442 participants from the ALSPAC sample and 
2280 participants from Generation R study sample, looks at the effects of maternal 
depression in pregnancy, assessed respectively at 18 and at 20 weeks gestation, on 
infant emotional regulation at age 4 (Van Batenburg-Eddes et al., 2013). Both studies 
found a direct association between maternal depressive symptoms during pregnancy and 
child attention problems at age 4, which was independent of other psychosocial 
confounders (Van Batenburg-Eddes et al., 2013). These findings further support the 
idea of foetal programming as a potential pathway for the transmission of stress from 
mother to baby. 
Similarly, a study by O’Connor and colleagues uses the ALSPAC sample, which 
comprises more than seven thousand women, to explore the effects of maternal anxiety 
and depression during pregnancy on child outcomes at age 4 (O'Connor et al., 2002). 
Maternal mental health in pregnancy (anxiety and depression) was assessed at 18 and 32 
weeks’ gestation, and in the postnatal period at 8 weeks, 8 months, 21 months and 33 
months. Infant behavioural and emotional regulation was evaluated at 4 years, with 
specific focus on conduct problems, emotional problems and hyperactivity/inattention 
(O'Connor et al., 2002). Findings suggest that antenatal anxiety/stress late in pregnancy 
has a very strong association with hyperactivity/inattention in children at age 4, even 
when controlling for antenatal and postnatal anxiety and depression. A follow-up study 
(O'Connor et al., 2003) showed that maternal high anxiety/stress in the late stage of 
pregnancy remains associated with infant behavioural and emotional problems in 
children at 81 months, even when controlling for maternal depression and other psycho-
social factors (O'Connor et al., 2003).  
In order to cast further light on the potential trajectories that lead to the development of 
emotional problems in infants exposed to maternal depression in utero, a longitudinal 
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study by Halligan and colleagues assessed 121 pregnant women and their children up to 
age 5. Women were assessed for anxiety and depression in pregnancy at 28 and 34 
weeks gestation as well as in the postpartum period at 10 days, 4 weeks and 12 weeks 
infant age, and 12 months, 18 months and 5 years after birth. (Halligan et al., 2013). 
Infant behavioural regulation was first assessed at 10 days and 4 weeks after birth using 
the Neonatal Behavioural Assessment Scale (Brazelton and Nugent, 1995). The Bayley 
Scales of Infant Development, Second Edition (Bayley, 1993) was administered to the 
infants at 12 and 18 months, while mothers were asked to complete the Behaviour 
Screening Questionnaire (Richman and Graham, 1971) as a measure of the child 
behavioural problems. A final assessment was done when the child was five years old, 
using a novel assessment called “buzz wire”, a difficult task in which children are asked 
to move a hoop along a wire without touching it, otherwise it would buzz and a red light 
would appear as an indicator that the child would have to restart the task. The examiner, 
who would make the red light appear four times in each trial, irrespectively of the child 
performance, controlled this last part of the experiment.  This last procedure showed the 
child’s regulation strategies during the frustration period. This study found that the 
child’s behavioural regulatory capacities were stable from the neonatal period to age 5, 
when children of depressed mothers showed externalizing problems (Halligan et al., 
2013). Second, maternal psychological adversities were associated with poorer 
parenting capacities, which, in turn, led to poorer behavioural regulation for the 
offspring (Halligan et al., 2013).  
1.8.2 Children of mothers abused in childhood 
Over the last decade there have been a number of studies that have shown that children 
of mothers abused in childhood have greater emotional disturbances, overall 
psychological distress, hyperactivity and behavioural problems compared with children 
of non-abused mothers (Dubowitz et al., 2001). 
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The Avon Longitudinal Study of Parents and Children (ALSPAC) recruited 13,000 
pregnant women in the 1990s into a prospective longitudinal study of mothers and their 
children. Among many other measures women were asked about their experiences of 
childhood abuse. Findings showed that a maternal history of child abuse predicted 
offspring adjustment problems at age 4 and 7 (Collishaw et al., 2007). Specifically, a 
dose-response relationship was found, indicating that the more severe the childhood 
abuse experienced by the mothers, the more severe the adjustment problems 
experienced by the child (Collishaw et al., 2007).  
Similar findings come from a longitudinal study by Pawlby et al (2011) in South 
London. They investigated the links between the mother’s experience of childhood 
maltreatment, depression in pregnancy and offspring maltreatment (Pawlby et al., 
2011). The children were assessed at 11 and 16 years for maltreatment and 
psychopathology. Results showed that children of mothers who experienced antenatal 
depression had a greater risk of experiencing maltreatment in childhood (Pawlby et al., 
2011). Offspring of mothers who experienced both maternal childhood maltreatment 
and antenatal depression were exposed to significantly greater levels of childhood 
maltreatment and exhibited significantly higher levels of adolescent antisocial 
behaviour compared with offspring not so exposed. (Plant et al., 2013). Furthermore, 
maternal childhood maltreatment accounted for a significant proportion of the variance 
in offspring childhood maltreatment in only those offspring exposed to depression in 
utero. 
Further evidence for the intergenerational association between a maternal history of 
childhood abuse and adverse offspring outcome comes from a 23-year longitudinal 
study that shows that children of mothers who have been abused in childhood have 




A recent population-based longitudinal study of nurses taking part in the Nurses’ Health 
Study in the USA investigated the effects of maternal childhood abuse on offspring 
outcomes. There was a dose-response relationship between the severity of abuse and 10-
year-old offspring autism (Roberts et al., 2013). Findings showed that a maternal history 
of combined emotional, physical and sexual abuse was associated with greater risk for 




1.9 Aims and hypothesis  
1.9.1 Aims of the study 
The literature reviewed above has shown evidence for an association between maternal 
experience of abuse in her childhood and the development of depression during 
adulthood, particularly in vulnerable periods such as during pregnancy. However the 
majority of studies reported in the existing literature are mainly of correlational design, 
indicating the existence of associations between variables rather that a causal 
relationship.  
It is also established that depression during pregnancy leads to poor outcome for the 
offspring. However, no prospective study has yet found evidence of an association 
between maternal experience of abuse in childhood and poor behavioural and 
physiological outcome for the infant offspring, nor investigated the potential 
mechanisms involved in this transmission.  
The primary aim of the study is to investigate whether offspring exposure to antenatal 
maternal depression predicts infant behavioural and physiological regulatory response at 
6 days, 8 weeks and one year and whether a mother’s experience of childhood abuse 
cumulatively adds to this effect. 
The second aim of this study is to explore the biological associations that are linked 
with alterations in maternal HPA axis functioning during pregnancy among women who 
are depressed and/or have experienced childhood abuse. The purpose of this 
investigation is to gain a better understanding of whether dysregulation in the maternal 
stress axis accounts for changes in the offspring HPA axis, neonatal behaviour and 
infant development to one year. These investigations will help clarify the 
intergenerational transmission of stress. 
1.9.2 Hypotheses  
Maternal experience of childhood abuse and antenatal depression 
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Maternal experience of childhood abuse (birth to 17 years) is associated with depression 
in pregnancy.  
HPA axis in pregnancy  
Depressed women will have an increased cortisol response in pregnancy (25 and 32 
weeks gestation) compared with women who were not depressed.  
Depressed women exposed to abuse in childhood will have greater cortisol response (25 
and 32 weeks gestation) than depressed women who were not abused. Furthermore, 
women who were not depressed in pregnancy and were exposed to childhood abuse will 
have a blunted cortisol response (25 and 32 weeks gestation) compared with those who 
are healthy and have not been abused.  
Neonatal behavioural regulation at 6 days  
Babies of women who have been exposed to maternal depression in utero will show 
behavioural dysregulation at 6 days after birth.  
Maternal experience of abuse in her own childhood will interact with maternal antenatal 
depression and impact on the baby’s behavioural dysregulation at 6 days. 
Neonatal physiological regulation at 6 days  
Babies of women who have been exposed to maternal depression in utero will have a 
higher cortisol response to the stress of NBAS administration at 6 days 
Maternal experience of abuse in her own childhood will interact with maternal antenatal 
depression and impact on the baby’s physiological response to stress at 6 days. 
Infant physiological regulation at 8 weeks  
Babies of women who have been exposed to maternal depression in utero will have a 
higher cortisol response to the stress of vaccination at 8 weeks. 
Maternal experience of abuse in her own childhood will interact with maternal antenatal 
depression and impact on the baby’s physiological response to stress at 8 weeks. 
Infant development at one year 
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Children of women who have been exposed to maternal depression in utero will have 
lower scores on the Bayley scales of infant cognitive and socio-emotional development.  
Maternal experience of abuse in her own childhood will interact with maternal antenatal 
depression and impact on the children’s cognitive and socio-emotional developmental 
scores at one year. 
Infant physiological regulation at one year 
Children of women who have been exposed to maternal depression in utero will have a 
higher cortisol response to the stress of vaccination at one year. 
Maternal experience of abuse in her own childhood will interact with maternal antenatal 
depression and impact on the child’s physiological response to stress at one year. 
Antenatal maternal HPA axis and offspring behavioural and physiological 
functioning 
Maternal HPA axis functioning in pregnancy accounts for the differences in offspring 





2 Methods  
2.1 Design 
This thesis is part of the Psychiatry Research And Motherhood (PRAM) study, a 
prospective, longitudinal, observational study of depressed and non-depressed women 
and their offspring. The study was set up in 2007, with the purpose of assessing whether 
maternal alterations of the HPA axis in pregnancy associated with depression are 
correlated with altered HPA axis in the babies of these pregnancies throughout the first 
year of life. 
2.1.1 Contribution of work by the candidate  
I was responsible for recruiting and assessing the pregnant women. I have also 
conducted follow-up assessments of women in the postnatal period and performed the 
Neonatal Behavioural Assessment on the babies at 6 days after birth and been 
responsible for obtaining infant cortisol samples at 6 days, 8 weeks and 12 months. 
Furthermore, I was responsible for administering the Childhood Experience of Care and 
Abuse Questionnaire to the women in the study.  
 Dr Patricia Zunszain (Lecturer at the IoPPN, King’s College London) carried out all the 
salivary cortisol analyses. Dr Sarah Osborne (Visiting Research Associate, IoPPN, 
KCL) and Sue Conroy (Senior Researcher, IoPPN, KCL) have contributed to the rating 
of the psychiatric interviews. Trained research assistants helped with some of the 
interviews. I conducted the statistical analyses under the supervision of Dr Susan 
Pawlby (Secondary Supervisor, Lecturer at the IoPPN, KCL) and Professor Carmine 
Pariante (Primary Supervisor, Professor at the IoPPN, KCL).  
2.2 Sample 
Women recruited into the study were aged between 18 and 50 years, with a singleton 
pregnancy. A total of 125 women were recruited into the study. 
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Of those, 67 had a current DSM-IV diagnosis of Major Depressive Disorder of at least 
moderate severity and 58 were free from psychiatric disorders during their lifetime. 
Women with obstetric complications, chronic medical conditions (pulmonary, cardiac, 
autoimmune, endocrine), those who were taking medication (except nutritional 
supplement) at the time of recruitment, those unable to communicate in English and 
those with a psychiatric history other than affective or anxiety disorder were excluded 
from the study.  
2.3 Procedure  
Ethics  
Full Ethical approval for the study was given by King’s College Hospital Research 
Ethics committee (REC ref 07/Q0703/48).  
Participant recruitment  
Participants were identified and recruited through the Obstetric Ultrasound Department 
at the Harris Birthright Centre and the Perinatal Liaison Psychiatry Services, both at 
King’s College Hospital in London. 
1. King’s College Hospital (KCH) Ultrasound Department: Women attending for 
antenatal ultrasound at approximately 20 weeks gestation were approached by me or 
a colleague and invited to participate in the study. Names and addresses were taken 
and women were told that a researcher would contact them by telephone to tell them 
more about the study. 
2. The Perinatal Psychiatry clinical liaison team at KCH: A weekly meeting reviews 
referrals from midwives (who screen all pregnant women for past and current 
mental health problems) and general practitioners. PRAM researchers have regularly 
attended the referrals meeting and potentially suitable women were identified and 
invited to take part in the study. 
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Potential participants were then contacted by telephone and screened for past and 
current mental health as well as physical health. Researchers provided a full description 
of the study procedure and, to those who fulfilled the study criteria and who expressed 
an interest in the study, a detailed study information sheet (Appendix A) was sent to 
their home. The women were informed, in particular, of the longitudinal nature of the 
study and how, if they agreed to take part, the researchers would like to visit them twice 
in pregnancy, when the baby was born and then twice thereafter, when the baby was 8-
weeks and 12 months old. Those who were willing to take part in the study were booked 
for the baseline assessment at 25 weeks gestation.  
Before commencing the interview, women were given an informed consent form to sign 
(Appendix B), to guarantee confidentiality and data protection. All clinical interviews 
were audio-recorded and discussed with the lead clinician of the team, for the agreement 
of the final diagnosis.  
Participants received £10 for each assessment, a total of £40 by the end of the study and 
thanked for their time and commitment to it.  
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Antenatal clinical assessment: 25 and 32 weeks gestation  
The baseline assessment was carried out at 25 week gestation and comprised a 
structured clinical interview. Women were also asked about socio-demographic 
characteristics and about their own childhood experiences.  
Full data on the Childhood Experience of Care and Abuse Questionnaire were collected 
from 104 women. Specifically, retrospective questions on childhood family 
arrangements, physical abuse and sexual abuse were collected from a face-to-face 
interview from 116 women during pregnancy. The remaining 9 women refused to be 
contacted for the completion of the questionnaire. Additional questions related to 
psychological abuse and neglect during childhood were administered after the interview 
in pregnancy. All women in the sample were sent the additional questions by post and 
information was obtained from 104 participants. Specifically, 27 women were 
interviewed in person, 42 were asked the questions by phone, 27 returned the 
questionnaire by post, 8 returned it by email and 21 did not return the questionnaire. 
Among those 21, 10 women were no longer in the study, 9 were impossible to contact 
and 2 had moved out of the country.  
Eighty-two women were administered the Wechsler Test of Adult Reading (WTAR). 
Antenatal cortisol assessment: 25 and 32 weeks gestation 
At the end of the clinical interview, women were provided with two sets of six Salivette 
swabs (Sarstedt, Leicester, UK) and asked to collect saliva samples the day following 
the baseline assessment and again at 32 weeks gestation.  
Women who were living far from King’s College Hospital were provided with a 
stamped envelope and asked to return samples by post, while for those who were local 
were contacted by a team member who arranged a home sample collection. All saliva 
samples were then stored in a -20C freezer before being analysed.  
6 days after birth  
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At 6 days after birth, a researcher trained in the administration of Neonatal Behavioural 
Assessment Scale (NBAS), but unaware of the mother’s clinical diagnosis, visited the 
home to conduct the assessment. Mothers were asked where possible to have fed the 
baby before the arrival of the researcher. Mothers were informed that the assessment 
would be looking at the newborn’s abilities to interact with the examiner and how we 
would be looking at the way that the baby responded to being undressed and handled. 
The mother was asked that if the baby cried she would let the assessor allow him or her 
to cry for 15 seconds before using a graded set of responses in order to calm the baby. 
The NBAS was started only once the mother had given her verbal consent. Before 
starting the NBAS procedure, the researcher took a salivary sample from the baby. A 
further sample was taken immediately after the NBAS and then again 30 minutes later. 
If the baby fed at all during any part of the assessment, the researcher made sure that the 
salivary sample was not taken until 15 minutes had elapsed after the end of the feed, in 
order to prevent contamination of the sample by the milk. 
Obstetric and birth details were taken from the mother’s discharge summary from the 
hospital notes. 
8 week postnatal maternal assessment  
Maternal clinical assessment  
The eight weeks postnatal assessment also comprised a structured clinical interview, as 
for the antenatal assessment.  
Infant neuroendocrine assessment at 8 weeks postpartum  
Infant saliva samples were collected at the time of the routine immunisation at 8-weeks 
post-partum. The researcher arranged to accompany the mother to the clinic and 
collected one saliva sample from the baby a few minutes before the injection and 
another exactly 20 minutes after the injection. The researcher sits inside the clinic with 
the mother, the infant and the nurse to ensure that the time of the injection is properly 
recorded on the assessment sheet and to note any other important information, such as if 
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the mother was present, how long the baby cried for. Mothers were asked not to feed the 
baby after the injection and wait 20 minutes before doing so; in cases where the baby 
was fed, we waited 15 minutes after the end of the feeding before collecting the second 
sample of saliva.  
One-year postpartum assessment 
Maternal clinical assessment at 1 year post-partum 
Women were contacted by a researcher a few weeks before the baby’s first birthday in 
order to arrange the one-year visit. Babies were also sent a birthday card, as way of 
keeping participants engaged in the research study. 
At the one year assessment, women were administered the same clinical interview and 
questionnaires as for the assessment at 8 weeks postpartum.  
Infant neuroendocrine assessment at 1 year post-partum  
We measured the infant stress using the same procedure as for the 8 weeks postnatal 
assessment. A researcher accompanied the mother and her baby to the immunisation 
clinic and saliva was collected before and twenty minutes after the immunisation. 
Infant developmental assessment at 1 year post-partum  
Participants were contacted again two weeks after the immunisation by a researcher 
who was unaware of the maternal diagnosis. The researcher visited the participant’s 
home in order to assess the baby’s developmental stage. 
2.4 Measures  
2.4.1 Maternal depression  
At 25 weeks gestation, 8 weeks and 1 year postpartum, an operational diagnosis of 
depression was made using the Structured Clinical Interview for DSM-IV Axis I 
Disorders Non-patient Edition (First et al., 2002) (Appendix C), a widely used semi-
structured diagnostic interview to assess DSM-IV Axis I psychiatric disorders. The 
interview consists of standardized diagnostic questions arranged in modules 
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corresponding to each Axis I disorder. The mood disorder module of the SCID-I takes 
about 1 to 2 hours to be completed, depending on the complexity of the 
psychopathology, on the experience of the assessor and on the patient’s capacity to 
properly describe her situation.  
2.4.2 Maternal experience of childhood abuse  
Measures of maternal sexual abuse, physical abuse, emotional abuse and neglect were 
obtained using the Childhood Experience of Care and Abuse questionnaire (CECA-Q) 
(Bifulco et al., 2005) (Appendix D) and scores were based on experiences occurred in 
childhood from age 0 to 17. Scores were dichotomized according to the cut-off A points 
published by Bifulco (Bifulco et al., 2005). This cut-off had the highest reliability with 
the CECA interview.  
Maternal and paternal antipathy scores from 8 to 24 were recoded into 0 (no or minimal 
maternal/paternal antipathy), while the scores greater than 25 were recoded into 1 
(severe maternal/paternal antipathy). After the total scores for maternal and paternal 
antipathy were calculated, emotional abuse was rated if either maternal or paternal 
antipathy scored 1 (0= no or minimal emotional abuse; 1 = emotional abuse).  
Maternal neglect scores from 8 to 21 were recoded into 0 (no or minimal maternal 
neglect), while scores greater than 22 were recoded into 1 (severe maternal neglect). In 
the same way, paternal neglect scores from 8 to 23 were recoded into 0 (no or minimal 
paternal neglect), while scores greater than 24 were recoded into 1 (severe paternal 
neglect). If severe neglect was experienced from either parents, neglect was rated as 1 (0 
= no or minimal neglect; 1 = neglect).  
Physical abuse was rated as a sum of the responses to the four main questions on 
physical experience before age 17: (i) if the hitting from either parent happened on more 
than one occasion (1), only once (0); (ii) if hit with a belt or stick (1), if hit with hand or 
other (0); (iii) if ever injured, black eyes or broken limbs (1), if not (0); (iv) if the person 
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was so angry that they seemed out of control (1), if not (0). If the child experienced any 
form of physical abuse (1) from either parent the criteria for physical abuse would be 
met (0 = no or minimal physical abuse; 1 = physical abuse).  
Sexual abuse was rated on the basis of the unwanted sexual experience before age 17. A 
total score for sexual abuse was made by the sum of the answers to the items: (i) the 
abuser was someone known (1), not known (0); (ii) the abuser was a relative (1), not a 
relative (0); (iii) the abuse happened in more than one occasion (1), no (0); (iv) the 
abuser touched private parts of the body (1), no (0); (v) the abuse involved intercourse 
(1), no (0). If the child experienced any form of unwanted sexual experience (1), the 
criteria for sexual abuse would be met (0 = no or minimal sexual abuse; 1 = sexual 
abuse).  
If the child experienced any antipathy, neglect, physical abuse or sexual abuse, the 
criteria for childhood abuse would be met.  
2.4.3 Maternal cognitive assessment 
Women’s cognitive performance was assessed in pregnancy with the Wechsler Test of 
Adult Reading  (Wechsler, 1939) (WTAR), a neuropsychological assessment tool that 
provides a measure of the premorbid intelligence and intellectual functioning 
(Holdnack, 2001). Specifically, the WTAR comprises 50 irregularly spelt words and it 
takes about 10 minutes to complete. Participants were audio recorded during the 
assessment and scored to a maximum of 50 by a native English-speaker. Scorings take 
into account the participant’s age and level of education.  
2.4.4 Saliva samples analysis  
Salivary cortisol was measured through the collection of saliva samples. Participants 
were asked to collect six saliva samples during one day at 25 weeks gestation, as close 
as possible to the baseline assessment, and during another day at 32 weeks gestation, 
following a reminder from one of the researchers. Cortisol was collected at awakening 
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(ideally before 10 am), +15 minutes, +30 minutes, +60 minutes, at midday and at 8 pm 
during the same day. Women were asked not to brush their teeth, not to drink coffee or 
tea and not to eat before the sample collection within the first hour after awakening and 
at least for the 30 minute preceding the midday and 8 pm collections.  
The time of the cortisol collection varied and, following the recommendations of Dr 
Patricia Zunszain, samples were excluded when the following criteria were not met: 
interval from awakening actual time to awakening sample collection is equal to or less 
than 5 minutes; +15 sample collected between 10 and 20 minutes after awakening; +30 
sample collection between 20 and 40 minutes after awakening; +60 sample collection 
between 45 and 75 minutes after awakening. Maternal and infant saliva samples were 
analysed using a standard commercial enzyme linked immune-sorbent (ELISA; 
Salimetrics, Newmarket, UK) (appendix I) by Dr Patricia Zunszain. SoftMax Pro 4.8 
software was used to calculate the cortisol values, following a 4-parameter fit. The 
analytical sensitivity was set to 0.33 nmol/l. Inter and intra-assay co-efficients of 
variations ranged from 8% to 11% and 6% to 10%, respectively, so only results into this 
range were considered in the analysis. Cortisol results have been screened by senior 
researchers working on the project (Dr Sarah Osborne and Sue Conroy, with the 
additional help of Dr Patricia Zunszain) and cortisol data have been entered into the 
databases and double checked by two researchers.  
2.4.5 Maternal socio-demographic characteristics  
Maternal ethnicity 
Information on maternal ethnicity has been recorded during the baseline interview at 25 
week pregnant. A dichotomized variable of “white” versus “black and minorities” was 
created.   
Maternal education  
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Information on maternal education achievements have been obtained during the baseline 
interview at 25 weeks antenatal interview. A dichotomized variable of “GCSE or lower” 
versus “A level or higher” has been created.  
Maternal employment status  
Information on maternal employment status at baseline has been recorded during the 
baseline interview at 25 week pregnant. A dichotomized variable of “working outside 
the home” versus “not working outside the home” was created.   
Maternal classification of employment  
Information on maternal employment classification has been obtained during the 
baseline interview at 25 week pregnant. A dichotomized variable of “professional or 
managerial” versus “not professional or managerial” was created.   
Marital status 
Information on maternal marital status has been obtained during the baseline interview 
at 25 week pregnant. A dichotomized variable of “married or cohabiting” versus “single 
+/- partner” was created.   
2.4.6 Neonatal behaviour at 6 days after birth  
The Neonatal Behavioural Assessment Scale (NBAS), also known as the Brazelton 
Neonatal Assessment Scale (Brazelton and Nugent, 1995) , was developed in 1973 by 
paediatrician Dr. T. Berry Brazelton and his colleagues at Harvard University. Dr 
Brazelton believed that new-born babies are organized and responsive already shortly 
after birth. In fact, they are capable of responding to stimuli, of interacting with the 
environment and the caregiver, and of adapting to challenges. The NBAS was created in 
order to formulate a comprehensive profile of the baby, including infants’ individual 
differences and neonatal general functioning, between 3 days and 4 weeks after birth.  
The NBAS offers a profile that describes the baby's strengths, adaptive responses and 
possible vulnerabilities. It has been widely used both in research and in clinical setting, 
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where it has been used as a therapeutic tool to help parents to get to know their baby 
more, to develop appropriate caregiving strategies and to promote their earliest 
relationship with their child. It has also been used to evaluate babies who suffered 
intrauterine deprivation, exposure to maternal substance abuse in pregnancy, and other 
perinatal conditions and, in more general terms, to identify concerns about the baby.  
The NBAS comprises five main packages, which refer to different areas of baby’s 
functioning, and assesses the infant behavioural repertoire on 28 behavioural items, 
each scored on a 9 point scale. It also offers an assessment of the baby’s neurological 
status using 18 reflex items, each scored on a 4 point scale.  
The assessment starts with an observation of the child’s initial state. An important item 
of the NBAS is the state regulation. Babies go through six main states: state 1, fast 
asleep with slow and breathing and eyes fully closed, no spontaneous activity; state 2, 
asleep with faster and irregular respiration and some minimal eye movements observed 
under closed eyes, random body movements or startles; state 3, drowsy, with eyes at 
times open, response to sensory stimuli; state 4, the ideal state, baby is alert and 
responsive, eyes are bright open and the activity is minimum; state 5, fussy state, baby 
is not quiet but the cry is not robust, eyes are open and body movements are intense; 
state 6, baby’s cry is robust and difficult to calm down, intense body movement.  
The social-interactive cluster measures baby’s alertness and baby’s capacity to respond 
to inanimate and animate visual and auditory orientations. Specifically, alertness refers 
to how the infant is aware of the environment and brightens his eyes while looking 
around. Inanimate visual auditory stimuli refer to the infant’s capacity to follow a red 
ball and turn to the sound of a rattle during the assessment, while animate auditory and 
visual stimulation is obtained by the examiner’s face and voice eliciting a response from 
the child. This section measures how much babies can fixate their attention on an object 
(ball or rattle) or a face and to follow it horizontally or vertically with 30, 60 and 90 
degrees head and eyes movements. It also measures the quality of the infant response: 
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how alert is the child when the stimuli are presented, how much he brightens, how the 
respiration and facial expression changes, and the eyes widen.  
The motor system cluster assesses the infant’s general tone, the motor maturity, activity 
levels during the assessment, the pull-to-sit and defensive movements. Specifically, this 
section assesses the baby’s motor response, both spontaneous and elicited; if the 
movements are smooth and jerky, if the arm movements are 30, 45 or 90 degrees in the 
upper quadrant of the body, if he is able to bring his head up and the body tone (floppy 
versus tense).   
The state organization scale includes: peak of excitement, the overall amount of activity 
and arousal shown during the assessment; rapidity of build-up, at which time point 
during the examination the baby starts crying; irritability, the number of time the child 
gets upset or frustrated; lability of states, the number of state changes observed during 
the examination.  
The state regulation cluster comprises: cuddliness, the infant’s response to being hold 
while alert; consolability, the manoeuvers the examiner has to put in place in order to 
bring the child to a quite state; self-quieting, the attempts the child make to calm 
himself down; hand into mouth, the attempts the child makes to insert the hands into 
mouth.  
The autonomic system cluster items assess the central nervous system of the baby by 
counting the number of tremors and startles observed, and the lability of skin colour 
throughout the examination.  
Some other supplementary items are evaluated during the NBAS: quality of alertness, 
which is the overall quality of infant responsiveness during the assessment; cost of 
attention, how hard it is for the baby to maintain attention and be responsive; examiner 
facilitation, how hard the examiner has to work in order to elicit from the child a good 
response; general irritability, infant’s general response to mild and moderate aversive 
stimuli; robustness and endurance, the energy and strengths shown during the 
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assessment; state regulation, the ability of the infant to regulate his states, from sleeping 
to crying, and to move from one state to another without signs of disorganization; 
examiner’s emotional response, how the examiner feels about the child.  
The NBAS also assesses some basic reflexes: plantar, Babinski, ankle clonus, rooting, 
sucking, glabella, passive resist arms and legs, palmar hand grasp, placing, standing, 
walking, crawling, incurvation, tonic deviation of head and eyes, nystagmus, tonic neck 
reflex and Moro reflex.  
The Habituation package of the NBAS is administered when the infant is asleep, ideally 
in states 1 or 2, and it assesses how the infant habituates to disturbing stimuli, such as 
the sound of a bell or a rattle, as well as a light on the eyes. This package allows an 
observation of the infant’s capacity to shut out intrusive and negative stimuli.   
One key concept that examiners keep in mind while performing the NABS is that with 
the NBAS we aim to get the best performance out of the baby.  
At the end of the examination, we also record the first and second predominant state 
during the NBAS, which gives an idea of how the child has been throughout the 
examination; e.g. he spent most time being withdrawn and difficult to engage (state 2-
3), or difficult to calm (states 5-6).   
Figure 2 and 3. Neonatal Behavioural Assessment Scale administration 
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Since the items in each cluster of the NBAS were highly correlated, not all items were 
included in the analyses. Specifically, I have used baby’s alertness and animate auditory 
(social-interactive), irritability (state organization), motor maturity (motor system), 
cuddliness and consolability (state regulation), tremulousness (autonomic system), and 
all the supplementary items. I did not use baby’s reflexes as the motor maturity is 
already an indicator of the infant motor system regulation.  
At the end of the NBAS, the researcher recorded the baby’s gender, gestational age, 
birth weight, and the mother’s parity from the hospital discharge notes. 
2.4.7 Infant neuroendocrine assessment at 6 days after birth 
Infant cortisol was measured as an indicator of the infant response to stress (HPA axis 
functioning). Saliva samples were collected from babies before, immediately after and 
30 minutes after the administration of the Neonatal Behavioural Assessment Scale. The 
saliva collection was done using the Salimetric’s Children Swabs (SCS, Salimetrics 
Europe Ltd, Suffolk, UK) (Appendix G) and then stored into the Salivette tubes and 
kept at -20 degrees. The SCS were placed into the infant’s mouth for about 90 seconds, 
passing it under the tongue and in the cheeks in order to absorb as much saliva as 
possible and ensure optimal saturation. This procedure is not painful for the infant.  
Infant neuroendocrine assessment at 8 weeks  
As for 6 days, infant saliva collection was done using the Salimetric’s Children Swabs 
(SCS, Salimetrics Europe Ltd, Suffolk, UK) (Appendix H). The SCS was placed into 
the infant’s mouth for about 90 seconds, passing it under the tongue and in the cheeks in 
order to absorb as much saliva as possible and ensure optimal saturation. Once 
collected, samples were stored into -20 degrees freezers. 
2.4.8 Infant cognitive and social-emotional development at one year 
The Bayley Scales of Infant Development (Bayley, 2005) are a standard measure of 
infant social, emotional, cognitive, language and motor development. The scale 
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consists of a series of developmental play tasks and its administration takes between 
45-60 minutes. Specifically, the Cognitive, Language, Motor Scales are completed by 
the examiner, while the Social-Emotional and Adaptive Behaviour Scales are 
completed by the caregiver.  
The Social-Emotional Scale assesses the child mastery of self-regulation and interest in 
the world, his capacity to communicate and engage with others while establishing 
relationships, and to use his emotional skills in problem solving (Bayley, 2005). 
Caregivers are asked to complete questions about their child’s attention capacity, how 
easy is he to calm down and engage, how he responds to other with sounds and how he 
interacts.  
The Adaptive Behaviour Scale assesses the daily functions of a child; measuring what 
the child actually does and his potential.  
It comprises ten subscales that assess different skills: Communication, which looks at 
the child’s speech, language, listening and nonverbal skills; Community Use, his 
interest in activities outside the home environment and his capacity to recognize 
familiar places; Functional Pre-Academics, his capacity to recognize letters, to count 
and draw simple shapes; the Home Living, if the child helps adults with the house tasks 
and takes care of personal possessions; the Health and Safety; his capacity to recognize 
danger and keep safe; Leisure, the child’s capacity to play, follow rules, and engage in 
pleasurable activities at home; Self-Care skills, the child’s eating, toileting and bathing 
capacities; Self-Direction, his capacity to self-control, to follow directions and make 
choices; Social skills, the child capacity to get along with people, to use manners, to 
assist others, recognize emotions and seek friendships; Motor skills, the child 
locomotion and manipulation of the environment.  
Raw scores of successfully completed items are converted to age-correlated scale scores 
and the sum of scale scores are converted into composite scores with a standardised 
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mean of 100 and standard deviation of 15. The composite scores allow for a comparison 
of the child's performance against typically developing children of that age.  
Infant neuroendocrine assessment at 1 year   
As for 6 days and 8 weeks postnatal, infant saliva was collected using the Salimetric’s 
Children Swabs (SCS, Salimetrics Europe Ltd, Suffolk, UK) (Appendix H). The SCS 
was placed into the infant’s mouth for about 90 seconds, passing it under the tongue and 
in the cheeks in order to absorb as much saliva as possible and ensure optimal 
saturation. Once collected, samples were stored into -20 degrees freezers. 
2.5 Data analysis  
Data were analyzed using the SPSS Statistical Software, Version 20.0 (IBM Ltd, 
Portsmouth, UK). Data normality was assessed using Kolmogorov-Smirnov test and 
Levene’s test for homogeneity of variance. I have applied Log Transformation where it 
was needed to improve the normality of the data. Data that were not normally 
distributed after the Log Transformation were treated with non-parametric statistics (the 
non-transformed values were reported in the tables).  
Descriptive statistics are shown as mean, standard deviation (SD), and percentages (%). 
In the graphs, the Standard Error of the mean is also reported (SE). Within the 
univariate analysis, the independent sample T-test was used to compare the means of 
parametric continuous variables between two groups. ANOVAs were used in group 
comparisons for parametric data. Mann-Whitney test was applied to non-parametric 
continuous data (z scores are reported) and Kruskal-Wallis test was used for group 
comparisons. Pearson’s chi-square test (X2) test for independence was used to analyze 
categorical data. In situations where the cell count was less than five, Fisher’s exact test 
was applied. Correlations were used to test the association between continuous 
variables; specifically Person’s correlation was applied in parametric data, while 
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Spearman’s correlation was applied in non-parametric data. General Linear Model 
procedures were used to control for potential confounders.  
Generally, statistic values are reported with one decimal place. Exceptions are made 
when two or more decimal places would reveal important information about the data. P 
values > .05 are reported at two decimal places, while those <.05 are reported at three. 
Significant results in the tables are highlighted in bold and, in the figures, the asterisk 
(*) will indicate the significance level. In the tables, maternal depression in pregnancy is 
presented as “MDD only”, maternal childhood abuse as “CA only”, while both 
conditions of maternal depression and childhood abuse as “MDD & CA”.  
In this Thesis, I will conduct multiple statistical tests. In particular, I will use Analysis 
of Variance (ANOVA) to compare four groups of women over time (before and after 
birth) and their babies’ outcomes (also in four groups), controlling for potential 
confounders using Generalized Linear Model procedures. As the data are not normally 
distributed, Kruscal-Wallis test has been used to compare the four independent samples 
and the p values have been corrected according to the number of group comparisons 
made, in order to avoid an inflation of false positive results. When conducting multiple 
statistical tests with a modest sample size there is a greater risk of obtaining p values 
less than 0.05 purely by chance, even if the null hypotheses are really true. Using 
Bonferroni corrections (for parametric data) and pairwise comparisons (for non-
parametric data) enables to control the family wise error rate. Hence, instead of setting 
the p value to the standard 0.05, a lower critical value is used. Specifically, the most 
common way of controlling for type I errors is to divide the familywise error rate 
(usually 0.05) by the number of tests performed. Thus, when I conduct 4 statistical tests, 
the critical value for an individual test would be 0.05/4=0.0125 and only individual tests 
with a p value <=0.0125 are considered to be significant.   
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3 Results  
3.1 Part 1: Maternal depression and experience of childhood abuse   
3.1.1 Overview  
The primary aim of the first set of analyses was to investigate the hypothesis that abuse 
during childhood increases the risk of developing depression during pregnancy. The 
secondary aim was to test whether depression alters the HPA functioning of women in 
pregnancy and then whether an experience of abuse in childhood moderates this 
association. 
First, I describe the sample by presenting the socio-demographic characteristics at 25 
weeks gestation. Next, I examine the association between maternal childhood abuse and 
maternal depression in pregnancy. I then compare the impact of exposure to childhood 
abuse and of current depression on maternal salivary cortisol levels at 25 weeks and 32 
weeks gestation.  
3.1.2 Descriptive analyses 
Sample characteristics at 25 week gestation  
One hundred and twenty-five pregnant women participated in the study. Of those, 58 
(46.4%) were healthy controls, free from mental health diagnosis and 67 (53.6%) were 
cases, with a current DSM-IV diagnosis of Major Depressive Disorder (single episode, 
code 296.2x or recurrent, code 296.3x). 
Basic maternal socio-demographic characteristics at 25 weeks gestation are shown in  
Table 4.  The majority of women (65.6%) were of white ethnic origin and their mean 
age was 31.12 years. Most women (78.4%) pursued a higher education and were 
employed (62.4%). More than half of the women (65.6%) were married or cohabiting 
and the majority were primiparous (81.6%).  
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Table 4. Socio- demographic characteristics of the sample at 25 weeks gestation 
 
  
Mother’s age (years)                         
Mean (S.D.)                    
Range 
                                                    
31.1 (6.0)                                 
18-46 
Maternal ethnicity (%)                 
White                 
Black and minority 
                                                   
82 (65.6)                                 
43 (34.4) 
Maternal qualifications (%) 
GCSE or lower                          
A level or higher 
                                                         
27 (21.6)                                       
98 (78.4) 
Maternal employment status (%)                     
Working outside the home              
No working outside the home  
                                        
78 (62.4)                                      
47 (37.6) 
Marital status (%)                    
Married or cohabiting                            
Single or with a partner living out 
                                                         
82 (65.6)                                        
43 (34.4) 
Parity (%)                 
Primiparous                      
Multiparous 
                                                     




Socio-demographic characteristics at 25 week gestation: healthy and depressed 
women  
The socio-demographic characteristics across diagnostic groups are shown in Table 5. 
Women with depression were significantly more likely to have achieved lower 
education level, being unemployed, being single, being multiparous and having lower 
IQ. Indeed, there were significant differences in the educational level of women with 
and without depression in pregnancy (X2(1) = 13.8; p<.001). Specifically, 65.7% of the 
women with antenatal depression obtained A levels or higher education, compared with 
93.1% in the control group. There were also significant differences in the current 
employment status of women with and without depression in pregnancy (X2(1) = 6.4; 
p=.012). 47.8% of the women with depression were not working, compared with 25.9% 
in the control group.  Similarly, there were also significant differences in marital status 
between women with and without depression in pregnancy (X2(1) = 20.4; p<.001). 
Specifically, 52.2% of the women with antenatal depression were single, compared with 
13.8% of the control group.  Furthermore, there were significant differences between 
women with and without depression in pregnancy in their parity (X2(1) = 4.7; p=.03). 
The proportion with women who were multiparous was higher among the depressed 
group (25.5%) than the control group (10.3%). There were also differences in the IQ 
scores as measured by the WTAR (t(67.53)=2.8; p=.007), with women with depression 
having significantly lower scores (M = 109, SD = 13.1) compared with women who 














Variable Healthy                   
N=58 




Mother’s age (years)                       
Mean (S.D.)                   
Range 
                           
31.7 (4.6)                   
21-40            
                                   
30.7 (7.0)                  
18-46 
                          
t(114.61)=1.0; p=.33 
Maternal ethnicity (%)        
White                                        
Black and minority 
                                      
43 (74.1)                           
15 (25.9) 
                                  
39 (58.2)                        
28 (41.8) 
                         
X2(1)=3.5; p=.06 
Maternal qualification (%) 
GCSE or lower                          
A level or higher 
                                       
4 (6.9)                        
54 (93.1) 
                                  
23 (34.3)                 
44 (65.7) 
                         
X2(1)=13.8; p=<.001 
Maternal employment 
status (%)                    
Working outside the home                              
No working outside the home 
                                                       
 
43 (74.1)               
15 (25.9) 
                                   
 
35 (52.2)                      
32 (47.8) 
                              
 
X2(1)=6.4; p=.012 
Marital status (%)                 
Married or cohabiting      
Single or partner living out 
                                 
50 (86.2)                   
8 (13.8) 
                                            
32 (47.8)                     
35 (52.2) 
                        
X2(1)=20.4; p<.001 
Maternal parity (%)                          
Primiparous                       
Multiparous 
                               
52 (89.7)                          
6 (10.3) 
                                  
50 (74.6)                       
17 (25.4) 
                           
X2(1)=4.7; p=.031 
Maternal WTARa 










Childhood abuse  
A history of childhood abuse was obtained from 109 women (87.2%) in the sample. 
Sixteen women did not complete the Childhood Experience of Care and Abuse 
Questionnaire. Of those who completed the questionnaire 51 women (46.8%) did not 
experience childhood abuse, while 58 (53.2%) experienced some form of childhood 
abuse. Of those who had been abused, 26 (44.8%) women experienced sexual abuse, 20 
(34.5%) experienced severe physical abuse from at least one parent, 38 (65.5%) 
experienced severe neglect from at least one parent and 40 (69.0%) experienced 
antipathy from at least one parent.  
3.1.3 Antenatal depression and maternal exposure to childhood abuse  
There was a strong association between antenatal depression and childhood abuse 
(X2(1)=21.7; p<.001, OR=6.9, 95% CI [2.96, 15.98]). Among women with antenatal 
depression, 44 (71.3%) women experienced some form of sexual abuse, physical abuse, 
neglect or antipathy during childhood whereas in the control group only 14 (28.6%) 
women experienced some form of abuse (Table 6).  Compare with women who had not 
experienced abuse in childhood, women who had been abused were almost 7 times 




Table 6. Childhood abuse in healthy and depressed women  
 






Healthy (%) 35 (71.4) 14 (28.6) 49 (100) 
Depressed (%) 16 (26.7) 44 (73.3) 60 (100) 
Total (%) 51 (46.8) 58 (53.2) 109 (100) 
 






Socio demographic characteristics at 25 week gestation: healthy, depressed and 
women with childhood abuse 
Given the strong association between childhood experience of abuse and depression in 
pregnancy, further analyses compared the socio-demographic characteristics across the 
four groups: healthy women, free from mental health diagnosis and child abuse history 
(HEALTHY, N=35); women with a current diagnosis of major depressive disorder 
(MDD only, N=16); women abused in childhood but free from any mental health 
diagnosis during their lifetime (CA only, N=14); women with a current diagnosis of 
MDD and a history of childhood abuse (MDD & CA, N=44). Findings are presented in 
Table 7. Women with MDD & CA achieved lower education levels, were single, and 
had lower IQ scores. Indeed, significant differences were found between the 4 groups of 
women in the level of educational qualifications obtained by the women (X2(3)=20.3; 
p<.001) and in their marital status (X2(3)=25.2; p<.001). 59.1% of the women with 
MDD & CA had qualifications of A level or above compared with 97.1% (HEALTHY), 
87.5% (MDD only) and 92.9% (CA only).  40.9% of the women with MDD & CA were 
in a married or cohabiting relationship compared with 88.6% of the HEALTHY women, 
68.8% MDD only and 92.9% CA only. There was also a significant group difference in 
the women’s IQ scores as measured by the WTAR (F(3)=3.6; p=.018).  Tamhane post-
hoc tests shows that MDD & CA women had significantly lower IQ scores (M = 97.2, 






Table 7. Socio-demographic characteristics in women with/without depression and/or 










CA                 
N=44 
Statistic  
Mother’s age  
(years)                            
Mean (S.D.)                                
Range   
 
                   
32.5 (4.7)                   
21-40 
 
                        
32.1 (6.1)                     
19-42 
 
                        
31.1 (3.8)                     
24-37 
 
                        
30.3 (7.5)                   
18-46 
 
                    
F(3)=1.0;             
p=.42 
Maternal 
ethnicity (%)                           
White                           
Black and minority 
 




















qualification (%)            
GCSE or lower                       
A level or higher 
 





















status (%)                   
Working outside 
the home                     
Not working 
outside the home 
 
 
                                         
25 (71.4) 




     
11 (68.8) 




                            
10 (71.4) 




                            
22 (50.0) 




                    
X2(3)=4.9; 
p=.19 
Marital status(%)                                 
Married/cohabiting              
Single or with 
partner living out 
31 (88.6) 
4 (11.4) 
                                   
11 (68.8) 
5 (31.2) 
                            
13 (92.9) 
1 (7.1) 
                            
18 (40.9) 
26 (59.1) 
                
X2(3)=25.2; 
p<.001 
Parity (%)                     
Primiparous  
Multiparous                       
                                 
31 (88.6) 
4 (11.4) 
                  
15(93.8) 
1 (6.2) 
                       
13(92.9) 
1 (7.1) 
                      
32(72.7) 
12 (27.3) 
                  
X2(3)=6.5; 
p=.08 
Maternal WTARa  



















3.1.4 Maternal depression and HPA axis  
The HPA axis activity was measured at 25 weeks and 32 weeks gestation, with the aim 
of further understanding the physiological responses of women with current depression 
and women who had been abused during childhood.  
At 25 weeks gestation, valid cortisol data were obtained from 26-27 healthy women and 
46-48 depressed women. Among the participants who collected all cortisol samples at 
each time point at this stage of pregnancy, data are available for 25 healthy and 42 
depressed women. Due to a change in the study protocol, at 32 weeks gestation, a larger 
number of women have cortisol only at awakening and 8 pm (n=91), than at awakening, 
12 pm and 8 pm (n=50). 
Descriptive analyses: HPA axis at 25 weeks gestation  
The cortisol awakening response (CAR) was indexed through the measurement of the 
maternal salivary cortisol at the time of awakening (before 10 am), and at 15+, 30+ and 
60+ minutes after awakening (Figure 3). Cortisol was also collected at 12 pm and 8 pm 
in order to index the cortisol levels during the day. Table 8 illustrates the mean cortisol 
levels throughout the day in healthy and depressed women, while Table 9 illustrates the 
mean cortisol levels throughout the day in women with/without depression and/or 
childhood abuse.   
As it can be seen from Figure 3, the mean cortisol level upon awakening was 10.3 
(SD=4.4) nmol/L in healthy women and 12.2 (SD=11.9) nmol/L in depressed women. 
Cortisol levels rose during the first 15 minutes after awakening to a mean peak of 11.8 
(SD=5.0) nmol/L in healthy women and 14.6 (SD=17.4) nmol/L in depressed women. 
Cortisol continued increasing in both groups at 30 minutes post-awakening (healthy: M 
= 12.0 (SD=5.7) nmol/L; depressed: M = 13.7 (SD=13.7) nmol/L and started decreasing 
at 60 minutes after awakening, where both controls and cases reached a similar mean 
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cortisol level (healthy: M = 10.7 (SD=3.7) nmol/L; depressed: M = 10.2 (SD=6.0) 
nmol/L.  As can be seen from Figure 5, at 12 pm, cortisol levels in both groups 
continued dropping, remaining slightly lower in healthy women: M = 6.0 (SD=2.5) 
nmol/L; depressed: M = 7.7 (SD=6.2) nmol/L. As expected based on the diurnal cycle, 
at 8 pm, salivary cortisol reaches lower levels compared to that observed during the day, 
with M = 3.2 (SD=2.0) nmol/L in healthy women and M = 3.7 (SD=3.5) nmol/L in 
depressed women.  
There were no significant differences between healthy and depressed pregnant women 
in their awakening response or in the cortisol levels at midday or in the evening at 25 
weeks gestation.  
A similar pattern (no differences) was found in the awakening response, cortisol levels 
at midday and in the evening at 25 weeks gestation when comparing healthy women, 
those with MDD only, CA only women and those with MDD & CA. Mean cortisol 
levels are presented in Table 9, alongside the statistical values.   
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Table 8. Maternal depression and salivary cortisol at 25 weeks gestation 
 
 







                                    
9.9 (4.5) 
                            
11.8 (11.3) 
                          
Z=.1; p=.9 
Awakening+15 minutes  
Mean (SD) 
                                         
11.6 (5.1) 14.3 (16.7) 
                                                     







                                                    







                                                   








Z=-.4; p=.66  






























Awakening Awakening+15 Awakening+30 Awakening+60
Healthy (n=25)
Depressed (n=42)
















Figure 4. 25 weeks salivary cortisol at awakening and 8 pm in healthy 






























Figure 5. 25 weeks salivary cortisol at awakening, 12 pm and 8 pm in 











Awakening 12:00 PM 8:00 PM
Healthy (n=25)
Depressed (n=42)












Table 9. Salivary cortisol at 25 weeks gestation in women with/without antenatal 














Healthy                        
N=19-20 
MDD only                                
N=10-11 








                                 


















































































K-W(3)=.4; p=.95  
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Maternal depression and salivary cortisol 32 weeks gestation 
At 32 weeks gestation, salivary cortisol was available from 56 healthy women and from 
49 depressed women.  
As for 25 weeks gestation, the cortisol awakening response (CAR) was indexed through 
the measurement of the maternal salivary cortisol at the time of awakening (before 10 
am), and at 15+, 30+ and 60+ minutes after awakening. Cortisol was also collected at 12 
pm and 8 pm in order to index the cortisol levels during the day. The mean cortisol 
values have been calculated at each time points at 32 weeks gestation and plotted in the 
graphs below. It is of note that, because of a change in protocol after the initial period of 
recruitment, a larger number of women have cortisol only at awakening and 8 pm 
(n=105) than at awakening, 12 noon and 8 pm (n=55) or indeed throughout the 
awakening response curve (n=55). Results of these samples are presented separately in 
Figures 6, 7 and 8, but together in Table 11. 
Figure 6 illustrates the cortisol awakening response (CAR) in healthy and depressed 
women, while Figure 7 illustrates the mean cortisol levels at awakening, 12 pm and 8 
pm in healthy and depressed women in women who have all the three time points. As 
can be seen from Figure 6, the mean cortisol level upon awakening was 10.2 (SD=3.8) 
nmol/L in healthy women and 11.2 (SD=6.0) nmol/L in depressed women. Cortisol 
levels rose during the first 15 minutes after awakening to a mean of 12.0 (SD=4.6) 
nmol/L in healthy women and 13.4 (SD=13.8) nmol/L in depressed women. Cortisol 
increased up to 30 minutes post-awakening, 13.0 (SD=5.4) nmol/L in healthy women 
and 13.0 (SD=6.3) nmol/L in depressed women, and started dropping at 60 minutes 
after awakening, where cortisol in both controls and cases reach a very similar level to 
those observed upon awakening (healthy: 11.6 (SD=5.0); nmol/L; depressed: 11.7 
(SD=6.9) nmol/L) 
In Figure 7, cortisol levels decreased in both healthy and depressed women through the 
morning, reaching a mean of 7.8 (SD=2.8) nmol/L in healthy women and a mean of 8.2 
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(SD=5.6) nmol/L in depressed women at 12 pm. Cortisol levels further decreased 
through the rest of the day to a mean level of 4.5 (SD=2.8) nmol/L in healthy women, 
and a mean of 8.0 (SD=14.4) nmol/L in depressed women at 8 pm. In this smaller 
sample of women who have all the three time-points, the 8 pm cortisol levels is higher 
in depressed women, but the difference is not statistically significant.  
Figure 8 represents the awakening and 8 pm cortisol values in the larger sample (n=105) 
where there is data only at these two time points. The mean awakening and 8 pm 
cortisol values were similar in this larger sample compared with the smaller one in 
Figure 7. Specifically, at awakening, the mean cortisol level in healthy women was 9.2 
(SD=3.7) nmol/L and in depressed women 11.1 (SD=5.7) nmol/L. At 8 pm, cortisol 
levels in healthy women decreased to a mean of 3.6 (SD=3.3) nmol/L while in 
depressed women they only decreased to a mean of 7.1 (SD=11.8) nmol/L. However, 
because of the larger power, the difference in the 8 pm salivary cortisol now reached 
significance, with depressed mothers having higher cortisol levels than control mothers 
(t(54.49) =-2.0; p=.05). 
Means and statistical values of all the data (irrespective of sample size), and the 
statistics, are also presented in Table 11. 
To quantity further the cortisol indexes across groups (healthy, n=24; depressed, n=36), 
the area under the curve (AUC) has been calculated for each participant across the first 
hour after awakening, and during the day (at awakening, 12 pm and 8 pm). First, the 
total AUC was calculated on the basis of the actual time points, the ground (AUCg), and 
subsequently on the basis of the awakening cortisol levels, with respect to its increase 
(AUCi). The mean AUCg for cortisol levels across the first hour after awakening was 
715.2 (SD=264.8) nmol/L in healthy women and 746.0 (SD=428.6) nmol/L in 
depressed women. The mean for AUCi in the first hour after awakening was 107.9 
(SD=179.3) nmol/L in healthy women and 70.2 (SD=247.7) nmol/L in depressed 
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women. Overall, these results offer a further index for the CAR, which can be 
interpreted as the natural response to stress during the day across diagnostic groups.   
There was no significant difference in AUCg and AUCi between healthy and depressed 
women (respectively, t(58)= -.31; p=.76; t(58)= .64; p=.53).  
Next, the AUC was also calculated during the day. The mean cortisol secretion during 
the day among healthy women was 5372.9 (SD=1626), nmol/L while in depressed 
women it was 6588.1 (SD=5263) nmol/L. There was no significant difference between 
the two groups (t(54)=-1.1; p=.29).  
 
Socio-demographic confounders 
Earlier it was shown that at 25 weeks gestation maternal depression was significantly 
associated with maternal marital status, parity, maternal qualifications and employment 
(page 67, Table 5). However, none of these potential confounders was found to be 




Table 10. Association between maternal socio-demographics and maternal 32 weeks 
salivary cortisol at 8 pm 
Potential confounders  
 
8 pm maternal 
cortisol (nmol/L) at 
32 weeks  
Statistics  
Marital status mean (SD) 
Married/cohabiting 














Qualifications mean (SD) 
GCSE or lower 






Employment mean (SD) 
Working outside the home 










Table 11. Salivary cortisol at 32 weeks in women with and without depression 
Cortisol time collection Healthy                MDD    




                                    
9.2 (3.7) 
                                 
11.1 (5.8) 
                                
Z=-1.3; p=.2  




                                                                
12.9 (12.5) 
     
























Z=-.3; p=.8  







Z=-3.2; p=.002  
 
a
 healthy, n=56 ; depressed, n= 49 
b
 healthy, n=25 ; depressed, n= 40 
c
 healthy, n=26 ; depressed, n= 44 
d healthy, n=25 ; depressed, n= 43 
e
 healthy, n=25 ; depressed, n= 42 
f






Figure 6. 32 week awakening cortisol response in healthy and depressed 
women, with SE 
Note: Numbers represent women who collected cortisol at all times, not  

















Awakening Awakening+15 Awakening+30 Awakening+60
Healthy (n=23)
Depressed (n=32)















Figure 7. 32 weeks cortisol at awakening, 12 pm and 8 pm in healthy and 
depressed women, with SE 
Note: Numbers represent women who collected cortisol at all times, not 














Awakening 12:00 PM 8:00 PM
Healthy (n=23)
Depressed (n=32)















Figure 8. 32 weeks cortisol at awakening and 8 pm in healthy and 




























Maternal childhood abuse and antenatal depression and salivary cortisol at 32 
weeks gestation  
Maternal salivary cortisol during the day was also compared between the group of 
healthy women, MDD only women, CA only women and the group of MDD & CA 
women. Mean (and SD) cortisol levels are presented in Table 12, alongside the 
statistical values.  
As for the results described above, a larger number of women have cortisol only at 
awakening and 8 pm (n=91) than at awakening, 12 noon and 8 pm (n=50) or indeed 
throughout the awakening response curve (n=50).   
Figure 9 shows cortisol levels at awakening in the small sample of women with/without 
depression and/or childhood abuse. There is an increase in the cortisol levels within the 
first hour after awakening across all 4 groups. During the first 15 minutes post-
awakening, cortisol rose to a mean peak of 12.1 (SD=4.5), nmol/L in healthy women 
12.5 (SD=3.6) nmol/L in women with MDD only, 11.9 (SD=4.5) nmol/L in women 
with CA only, and 12.5 (SD=14.3) nmol/L in women with MDD & CA. Cortisol 
continued increasing at 30 minutes post awakening to a mean peak of 12.7 (SD=5.1) 
nmol/L in healthy women, 15.8 (SD=7.7) nmol/L in women with MDD only, 15 
(SD=5.6) nmol/L in women with CA only, and 10.5 (SD=5.8) nmol/L in women with 
MDD & CA. Similarly, at 60 minutes post-awakening, cortisol means reached 11.9 
(SD=4.2) nmol/L in healthy women, 14.1 (SD=6.8) nmol/L in women with MDD only, 
12.8 (SD=7.0) nmol/L in women with CA only, and 10.6 (SD=6.2) nmol/L in women 
with MDD & CA. However, at no time was there a difference between the four groups. 
Figure 11 represent the awakening and 8 pm cortisol values in the larger sample (n=91) 
that has only these two time points. The mean awakening and 8 pm cortisol values are 
similar in this larger sample compared with the smaller one in Figure 10. 
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Specifically, maternal cortisol at 32 weeks gestation decreases across all groups during 
the day. Mean cortisol upon awakening was 9.8 (SD=3.9) nmol/L in healthy women, 
12.8 (SD=3.6) nmol/L in women with MDD only, 9.4 (SD=2.8) nmol/L among women 
with CA only and 10.0 (SD=5.6) nmol/L among women with MDD & CA. As observed 
from the graph, at awakening, cortisol in healthy women was very similar to cortisol in 
women who had experienced childhood abuse only and both conditions of childhood 
abuse and antenatal depression, whilst depressed only women have the highest cortisol 
levels in the groups, although the difference is not statistically significant. At 8 pm, 
cortisol across all groups drops, reaching a mean of 3.7 (SD=3.4) nmol/L in healthy 
women, 6.6 (SD=6.0) nmol/L in women with MDD only, 3.8 (SD=3.9) nmol/L among 
women with CA only and 7.3 (SD=14.6) nmol/L among women with MDD & CA. 
Mann-Whitney post-hoc test with the significance level adjusted for multiple testing to 
p=.02, shows that MDD women and women with MDD & CA have significantly higher 
evening cortisol levels when compared with those of healthy women (respectively, Z=-
2.3, p=.02; Z=-2.3, p=.02).  
Means and statistical values of all the data (irrespective of sample size), and the 
statistics, are also presented in Table 12. Figure 10 illustrates cortisol at awakening, 12 
noon and 8 pm in the small sample. Cortisol levels decreased in both healthy and 
depressed women through the morning, reaching a mean of 8.1 nmol/L (SD=2.8) in 
healthy women and a mean of 6.9 nmol/L (SD=1.9) in depressed women at 12 pm. 
Cortisol levels further decreased through the rest of the day to a mean level of 4.7 
nmol/L (SD=3.2) in healthy women, and a mean of 5.9 nmol/L (SD=7.4) in depressed 
women at 8 pm. In this smaller sample of women who have all the three time-points, the 
8 pm cortisol levels is higher in the MDD & CA group and the MDD group, but the 
difference is not statistically significant.  
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a Healthy, n=33 ; MDD only, n=14 ; CA only, n=14; MDD & CA, n=30 
b Healthy, n=18 ; MDD only, n=8 ; CA only, n=4; MDD & CA, n=30 
c Healthy, n=19 ; MDD only, n=10 ; CA only, n=4; MDD & CA, n=32 
d Healthy, n=18 ; MDD only, n=10 ; CA only, n=4; MDD & CA, n=31 
e Healthy, n=19 ; MDD only, n=10 ; CA only, n=3; MDD & CA, n=30 










Figure 9. 32 weeks cortisol awakening response in women with/without 
depression and/or childhood abuse  
Note: Numbers represent women who collected cortisol at all times, not 






























Figure 10. 32 weeks cortisol at awakening, 12 pm and 8 pm in women 
with/without depression and/or childhood abuse 
Note: Numbers represent women who collected cortisol at all times, not 




























Figure 11. 32 weeks cortisol at awakening and 8 pm in women 
with/without depression and/or childhood abuse, with SE 



































3.2 Part 2: Offspring outcomes at 6 days, 8 weeks and 1 year after birth  
Overview  
The aim of this section is to investigate the neonatal behavioural and physiological 
outcomes of babies exposed to maternal depression in utero and then to explore whether 
a mother’s own childhood experiences of abuse moderate these outcomes. First, I 
evaluate neonatal outcome at birth. Next, I examine the infants’ behavioural regulation 
during the administration of the Neonatal Behavioural Assessment Scale (NBAS) and 
their stress response (cortisol) following the NBAS. Next, the infant stress response at 8 
weeks and one year following the routine immunization is explored in relation to 
maternal diagnosis and cortisol levels in pregnancy (32 weeks). Finally, infant cognitive 
and socio-emotional development at one year is examined in relation to maternal 
diagnosis in pregnancy.  
3.2.1 Descriptive analyses  
Neonatal outcomes in healthy and depression groups 
Information on neonatal outcomes was obtained from the maternal hospital discharge 
notes and is reported in Table 13. There was a statistically significant difference in 
gestational age of babies of healthy and depressed mothers (t(116)=2.1; p=.04). As 
expected, babies of depressed women had a shorter gestational age (M = 39.6 weeks, 
S.D. 2.3) compared with healthy women (M = 40.3 weeks, S.D. 1.4). There was also a 
group difference in the weight of the baby at birth (t(115)=2.7; p=.008). Specifically, 
babies of depressed mothers (M = 3.311 kg, S.D. 565 grams) were lighter than those of 




Table 13. Infant outcomes at birth in mothers with/without depression and/or childhood 
abuse  
 Healthy                MDD only    CA only             MDD & CA  Statistic 
Gestational age at 

















Birth weightb                 
Mean (S.D.) 
                       
3563.0 
(440.8) 
                     
3629.2 
(459.7) 
                     
3456.6 
(308.5) 
                      
3231.5 
(584.5) 

















Mode of deliveryd %                         
Vaginal                                   
C-section  
                         
25 (71.4)               
10 (28.6) 
                         
10 (66.7)                 
5 (33.3) 
                             
12 (85.7)                
2 (14.3) 
                              




Labour onsete %  
Spontaneous                         
Non-spontaneous  
                             
24 (70.6)               
10 (29.4) 
                     
10 (62.5)                 
6 (37.5) 
                             
10 (83.3)                  
2 (16.7) 
                         
31 (77.5)                  
9 (22.5) 
                       
X2(3)=2.1; 
p=.558 
Feeding methodf % 
Breastfeeding                
Bottle                        
Bottle and breast  
                              
32 (91.4)         
0 (0.0)                    
3 (8.6) 
                    
11 (73.3)                  
0 (0.0)                    
4 (26.7) 
                             
13 (92.9)                      
0 (0.0)                     
1 (7.1) 
                             
22 (55.0)                   





a Healthy, n=35 ; MDD only, n=15 ; CA only, n=14; MDD & CA, n=40 
b Healthy, n=35 ; MDD only, n=14 ; CA only, n=14; MDD & CA, n=40 
c Healthy, n=17 ; MDD only, n=10 ; CA only, n=4; MDD & CA, n=37 
d Healthy, n=35 ; MDD only, n=15 ; CA only, n=14; MDD & CA, n=40 
e Healthy, n=34 ; MDD only, n=16 ; CA only, n=12; MDD & CA, n=40 








There was a significant difference in the birth weight of babies of women in the 4 
groups – HEALTHY, MDD only, CA only, MDD & CA - (F(3)=3.8; p=.012). 
Bonferroni post-hoc test showed that women with who had experienced childhood 
abuse and were depressed in pregnancy had a significantly lower weight at birth 
(M=3231.5; SD=584.5) compared with babies of healthy mothers (M=3563.0; 
SD=440.8).  
Since gestational age at birth and infant birth weight are significantly different between 
groups, they have been taken into account as potential confounders. As these two 
variables were highly correlated (Pearson’s r=.6; p<.001), further analyses have 
controlled for infant birth weight only. Mode of delivery is also likely to affect 
newborns’ behavior but, as no group difference was found, this variable has no longer 





Table 14. Infant outcomes at birth in healthy and depressed mothers  
 
Healthy                     
N=24-58 
MDD               
N=48-62 
Statistic 
Gestational age at birth                        
Mean (S.D.) 
                   
40.3 (1.4) 
                                 
39.6 (2.3) 
                    
t(116)=2.1;  
p=.04 
Birth weight                 
Mean (S.D.) 
                             
3560.3 (423.6) 
                               
3311.4 (564.9) 





                                 
356.5 (13.7) 
                                  
352.0 (16.9) 
                        
t(70)=1.2;  
p=.26  
Mode of delivery % 
Vaginal                                   
C-section  
                                 
46 (79.3)                          
12 ( 20.7)     
                                   
48 (80.0)                        
12(20.0) 
                       
X2(1)=.009;  
p=1  
Labour onset%  
Spontaneous                         
Non-spontaneous  
                               
39 (72.2)                         
15 (27.8) 
                                        
46 (74.2)                          
16 (25.8) 
                   
X2(1)=.06;  
p=81 
Feeding method % 
Breastfeeding                
Bottle                           
Bottle and breast  
                                     
49 (84.5)                        
0 (0)                             
9 (15.5) 
                                   
37 (61.7)                         
5 (8.3)                             
18 (30) 






3.2.2 Neonatal Behavioural Assessment Scale at 6 days post-partum  
A first step was to explore the baby’s performance on the NBAS across the whole 
sample, which offers a general understanding of the babies, irrespective of maternal 
diagnosis. Means are presented in Table 15.  
As previously explained, because of the high correlation between the items in each 
NBAS cluster only some of the items from each NBAS cluster were selected for 
analysis. Although I have log transformed the data, I am presenting the mean values and 
the range in the tables in order to show the typical values of the data, as consistent with 
existing literature.  
Correlations between the NBAS items in Table 16 showed a strong negative correlation 
between infant alertness and irritability at 6 days after birth (Spearman’s r=-.7, p<.001). 
Similarly, irritability was also negatively correlated with motor maturity (Spearman’s 
r=-.2, p<.01) and cuddliness (Spearman’s r=-.4, p<.001). Alertness was positively 
correlated with motor maturity (Spearman’s r=.4, p<.001) and cuddliness (Spearman’s 
r=.5, p<.001). As expected, motor maturity was negative correlated with tremulousness 
(Spearman’s r=-.2, p<.05). Furthermore, both consolability (higher scores represent the 
ease with which the infant can be consoled and soothed by the examiner) and animate 
auditory were positively correlated with alertness (respectively, Spearman’s r=.41, 
p<.001; Spearman’s r=.85, p<.01) and cuddliness (respectively, Spearman’s r=.41, 
p<.01; Spearman’s r=.45, p<.01) and negatively correlated with irritability 
(respectively, Spearman’s r= -.31, p<.01; Spearman’s r= -.62, p<.01).  
Obstetric variables that were significantly different between groups have been 
considered as potential confounders for infant behavioural outcomes, hence baby’s birth 
weight has been controlled for using Generalized Linear Model, as explained later in 





 Table 15. Descriptive characteristics of the NBAS in the whole sample 
NBAS items (n=114-118)    Means (SD)               Range  
Alertness       6.60 (1.84)  2-9 
Animate auditory     7.26 (1.64)  2-9 
Irritability      4.36 (2.01)  1-8 
Motor maturity     5.67 (1.42)  2-9 
Cuddliness      6.42 (1.5)  3-9 
Consolability      5.33 (1.95)  2-9 
Tremulousness     3.96 (2.56)  1-8 
Quality of alertness     6.57 (1.81)  2-9 
Cost of attention     6.23 (1.41)  4-9 
Examiner facilitation    6.18 (1.77)  3-9 
General irritability     5.97 (2.22)  2-9 
Robustness & endurance    6.27 (1.75)  3-9 
State regulation     7.24 (1.3)  4-9 






Table 16. Spearman's correlations between items in the NBAS 
NBAS items  1 2 3 4 5 6 7 
(1)Alertness -       
(2)Irritability 
 
-.71*** -      
(3)Motor maturity 
  
.42*** -.24** -     
(4)Cuddliness 
 
.53*** -.40*** .19* -    
(5)Tremulousness 
 
-.11  .05 -.19* -.01  -   
(6) Consolability 
 
.41*** -.31** .27* .41** -.28* -  
(7) Animate 
auditory  
.85** -.62** .37** .45** -.10 .40** - 
 





Next, infant stress response was examined by taking saliva from the baby before, 
immediately after, and 30 minutes after the administration of the Neonatal Behavioural 
Assessment Scale. Figure 12 shows that before the administration of the assessment, 
infant mean cortisol level was 8.8 nmol/L (n=67, SD=11.2), whilst immediately after 
the NBAS, it reaches a peak of 10.1 nmol/L (n=69, SD=10.1). Thirty minutes post-
assessment, infant cortisol drops again, returning to a similar level observed before the 
NBAS, to a mean of 8.3 nmol/L (n=70, SD=9.3). 
Simple paired t-test between neonatal cortisol before and immediately after the NBAS 
show that there is no significant increase in the cortisol levels immediately after the 
NBAS (t(64) = -1.2; p=.241). Similarly, there is no significant increase in the neonatal 





Figure 12. Baby's cortisol before, immediately after and 30 minutes after 




















Cortisol collection time  
104 
 
Exposure to maternal depression in utero and Neonatal Behavioral Assessment at 
6 days  
The scores of the babies on the NBAS items are given for babies of healthy mothers and 
for those exposed to maternal depression in utero (Table 17). Babies of women with 
depression were more dysregulated in their behavior compared with that of babies of 
healthy women. In particular, compared with babies of healthy mothers, those of 
depressed mothers were less alert (U=1038.5; Z=-3.8; p<.001), less capable of 
responding to auditory stimuli (U=1185; Z=-3.0; p=.003) and more irritable (U=1151.5; 
Z=-2.7; p=.007). Furthermore, compared with babies of healthy mothers, those of 
depressed women showed poorer motor maturity (U=1318; Z=-2.4; p=.018), and a 
higher number of tremors during the assessment (U=1184.5; Z=-3.1; p=.002). Infant of 
depressed mothers were also more resistant to being cuddled by the examiner during the 
procedure (U=1196.5; Z=-3.0 p=.003) compared with infants of healthy women. There 
was no group difference for consolability (Healthy, N=34; MDD, N=45; U=599; Z=-
1.7; p=.09). 
Babies’ scores on the supplementary items of the NBAS were also compared. The 
scoring is unidirectional, with high score representing the baby’s best performance 
Compared with infants of healthy mothers, the quality of alertness of the infants of 
depressed mothers was poorer (U=1160; Z=-3.2; p=.001) and they were less able to 
maintain a state of attention during the assessment (U=1246.5; Z=-2.7; p=.007). 
Compared with babies of healthy mothers, those of depressed mothers were also more 
irritable (U=1338; Z=-2.2; p=.027) and were rated as being more difficult to assess by 
the examiner (U=1279.5; Z=-2.5; p=.012). Furthermore, compared with babies of 
healthy women, those of depressed women were less robust (U=1214; Z=-2.9; p=.004) 
and found it more difficult to regulate their state (U=1178.5; Z=-3.1; p=.002).  
Finally the scores given by the examiners rating their emotional response to the infant 
were lower than those given to the babies of healthy women (U=1103; Z=-3.5; p=.001).  
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The infant’s predominant state throughout the duration of the assessment was 
dichotomized into “optimal” and “non-optimal”. In the whole sample, 7 (5.6%) babies 
had a predominant state of 3 (drowsy), 74 (59.2%) infants had a predominant state of 4 
(alertness), 34 (27.2%) infants had a predominant state of 5 (fussy), and 3 (2.4%) 
infants had a predominant state of 6 (crying). Given the small number of babies in each 
of the states other than 4 (alert), the “optimal” group includes infants in state 4, while 
the “non-optimal” includes infants in states 3, 5 and 6, as they are not in the ideal 
condition to perform the assessment. Although fewer babies of depressed mothers 
compared with babies of healthy mothers were in the optimal state (55% vs. 70.7%), the 
difference in the predominant state between babies of healthy and depressed mothers 
did not reach significance.  
When controlling for baby’s birth weight, Generalized Linear Model procedures show 
that the differences in the NBAS scores (alertness and irritability) between babies of 
healthy and depressed women remained significant, independently of the baby’s weight 





Table 17. NBAS in babies of healthy and depressed mothers 
NBAS item Healthy                      
N=55-58 
MDD                           
N=59-60 
Statistic 
Alertness                         
Mean (S.D.) 
                                     
7.2 (1.6) 
                                   
6.0 (1.9) 
                                          
Z=-3.8; p<.001 








Irritability                         
Mean (S.D.) 
                                      
3.8 (2.0) 
                                    
4.9 (2.0) 
                                          
Z=-2.7; p=.007 
Motor maturity                 
Mean (S.D.) 
                                    
6.05 (1.3) 
                                    
5.3 (1.5) 
                             
Z=-2.4; p=.018 
Cuddliness                      
Mean (S.D.) 
                                     
6.9 (1.3) 
                                        
6.0 (1.6) 










Tremulousness                 
Mean (S.D.) 
                                      
3.2 (2.6) 
                                    
4.7 (2.3) 
                               
Z=-3.1 p=.002 
Quality of alertness 
Mean (S.D.) 
                                     
7.1 (1.7) 
                                    
6.1 (1.8) 
                                        
Z=-3.2 p=.001 
Cost of attention               
Mean (S.D.) 
                                       
6.6 (1.3) 
                                    
5.9 (1.4) 




                                     
6.6 (1.8) 
                                      
5.8 (1.7) 




                                     
6.4 (2.1) 
                                   
5.6 (2.3) 
                                           
Z=-2.2 p=.027 
Robustness & 
endurance                      
Mean (S.D.) 
                                     
 
6.7 (1.8) 
                                    
 
5.9 (1.6) 
                                 
 
Z=-2.9 p=.004 
State regulation               
Mean (S.D.) 
                                      
7.6 (1.3) 
                                       
6.9 (1.3) 
                                   
Z=-3.1 p=.002 
Examiner’s emotional 
response                             
Mean (S.D.) 
                                             
7.1 (1.9) 
                            
 
5.8 (2.2) 




state                      




41 (70.7)                      
17 (29.3)                    
 
 
33 (55.0)                        






Exposure to maternal depression in utero, maternal history of childhood abuse 
and Neonatal Behavioral Assessment at 6 days  
In order to explore further the effects of maternal childhood abuse and maternal 
depression in pregnancy on the infant behavioral outcomes at 6 days post-partum, 
comparisons were made between the NBAS scores of the babies of the 4 groups  - 
HEALTHY, MDD only, CA only, MDD &CA. Results are presented in Table 18.   
Kruskal-Wallis test shows that there are group differences in alertness (K-W(3)=19.4; 
p<.001) at 6 days post-partum. Mann-Whitney post-hoc test shows that MDD & CA 
babies were significantly less alert compared with babies of HEALTHY women 
(U=327; Z=-4.1; p<.001) and compared with babies of CA only women (U=136; Z=-
2.9; p=.004).  
More group differences are found for Animate Auditory (K-W(3)=15.3; p=002) at 6 
days after birth. Mann-Whitney post-hoc test shows that babies of MDD & CA women 
were significantly less responsive to the animate auditory stimuli compared with babies 
of HEALTHY women (U=400; Z=-3.8; p=.001), with babies of MDD only women 
(U=173.5; Z=-2.5; p=.014) and babies of CA only women (U=145.5; Z=-2.7; p=.006).  
Similarly, Kruskal-Wallis test shows that there are group differences in irritability (K-
W(3)=11.8; p=.008) at 6 days post-partum. Mann-Whitney post-hoc tests show that 
babies of MDD & CA women had significantly higher irritability scores compared with 
babies of HEALTHY women (U=409; Z=-2.7; p=.007) and compared with babies of 
CA only women (U=126; Z=-2.7; p=.006).  
Further groups differences are found in motor maturity (K-W(3)=6.4; p=.09) at 6 days 
post-partum. Mann-Whitney post-hoc test shows that babies of MDD & CA women had 
significantly lower motor maturity compared with babies of HEALTHY women 
(U=481; Z=-2.4; p=.02). 
Group differences were also found for infant cuddliness (K-W(3)=19.7; p<.001). Mann-
Whitney post-hoc test shows that babies of MDD & CA women were significantly less 
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cuddly compared with babies of HEALTHY women (U=343; Z=-3.9; p<.001), babies 
of MDD only women (U=176; Z=-2.4; p=.02), and babies of CA only women 
(U=116.5; Z=-3.3; p=.001). No group difference was present for consolability.  
Tremulousness is also different across groups (K-W(3)=10.9; p=.013). Mann-Whitney 
post-hoc test shows that babies of MDD & CA women had a significantly higher 
number of tremors compared with babies of HEALTHY women (U=472.5; Z=-2.5; 
p=.01), babies of CA only women (U=143; Z=-2.7; p=.006). 
Similar results were found for the NBAS supplementary items. There were group 
differences in quality of alertness (K-W(3)=17.4; p=.001), cost of attention (K-
W(3)=12.7; p=.005), examiner facilitation (K-W(3)=10.5; p=.02) general irritability (K-
W(3)=8.9; p=.03), robustness and endurance (K-W(3)=12.1; p=.007), state regulation 
(K-W(3)=12.1; p=.007) and the examiner’s emotional response to the baby (K-
W(3)=20.9; p<001). Compared with babies of HEALTHY women and babies of CA 
only women, Mann-Whitney post-hoc tests respectively showed that babies of MDD & 
CA had a lower quality of alertness (Z=-3.6; p<.001; Z=-2.9; p=.004); were less 
attentive (Z=-2.6; p=.009; Z=-2.9; p=.004); needed more help from the examiner (Z=-
2.7; p=.008; Z=-2.4; p=.02); showed more general irritability (Z=-2.3; p=.02; Z=-2.3; 
p=.02); were less robust (Z=-3.0; p=.003; Z=-2.3; p=.02) and less able to regulate their 
state  (Z=-3.1; p=.002; Z=-2.3; p=.02); examiners also found them less emotionally 
engaging (Z=-3.8; p<.001; Z=-3.3; p=.001). Furthermore, compared with babies of 
MDD only women, those of MDD & CA women were less cuddly (U=176; Z=-2.4; 
p=.02); showed lower quality of alertness (U=178.5; Z=-2.3; p=.02); and were less 
emotionally engaging by the examiner (U=166.5; Z=-2.6; p=.01).  
When controlling for baby’s birth weight, Generalized Linear Model procedures show 
that the differences in the NBAS scores (alertness and irritability) between babies of 
HEALTHY, MDD only, CA only and MDD & CA women remained significant, 
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independently of the baby’s weight (alertness: F(3)=5.4; p=.002; irritability: (F(3)=4.3; 
p=.007)).  
To summarize, infants of MDD & CA mothers show greater signs of behavioral 
dysregulation during the Neonatal Behavioral Assessment Scale at six days compared 
with infants of HEALHTY and CA only mothers. Interestingly, no difference was found 
between the behavior of babies of HEALTHY and CA only women, while only a few 






Table 18. NBAS in women with/without depression and/or childhood abuse 










Alertness                      







































                           
Motor maturity   
Mean (S.D.) 
 
                          
6.0 (1.2) 
 
                    
5.8 (1.0) 
 
                          
5.9 (1.3) 
 





Cuddliness        
Mean (S.D.) 
                            
6.9 (1.3) 
                   
6.7 (1.6) 
                          
7.1 (1.1) 


















                           
3.5 (2.7) 
                    
3.9 (2.2) 
                           
2.9 (2.4) 





alertness      
Mean (S.D.) 
 
                            
7.1 (1.4) 
 
                    
6.9 (1.6) 
 
                          
7.1 (2.0) 
 




Cost of attention             
Mean (S.D.) 
 
                           
6.4 (1.2) 
 
                         
6.3 (1.5) 
 
                                          
7.0 (1.4) 
 








                              
6.5 (1.6) 
 





















































































state                          



















19 (47.5)                      
21 (52.5) 










Exposure to maternal depression in utero and cortisol response to the 
administration of the NBAS at 6 days  
Neonatal cortisol was measured in infants before, immediately after and 30 minutes 
after the administration of the Neonatal Behavioral Assessment Scale at 6 days. As can 
be observed in Figure 13, infants of depressed mothers have generally higher cortisol 
levels at each collection time than infants of healthy women. Before the assessment, 
infants of healthy women have a mean cortisol of 7.4 (SD=5.9) nmol/L. The mean 
remains similar immediately after the NBAS (M = 7.3, SD=4.0 nmol/L) and at 30 
minutes post-NBAS (M = 6.5, SD=3.6 nmol/L). The cortisol response in babies of 
depressed mothers followed a slightly different pattern. In fact, pre-NBAS the mean 
cortisol is 9.6 (SD=13.1) nmol/L followed by an increase immediately after the NBAS 
11.6 (SD=11.9) nmol/L and a subsequent drop at 30 minutes post-NBAS, with cortisol 
mean of 9.2 (SD=11.1) nmol/L similar to that observed at pre-NBAS. Babies of 
depressed mothers have a significantly higher response to stress immediately after the 
NBAS compared with babies of healthy mothers (t(59.49) =-2.2; p=.03).  
A similar pattern can be seen when analyzing the delta cortisol response following the 




Table 19. Infant NBAS delta1 and delta2 in babies of healthy and depressed women 
 
Healthy  N=22 MDD N=43 Statistic  
Baby cortisol ∆1               
Mean (SD) 
-.2 (5.4) 2.2 (11.0) Z=-.8; p=.45 
Baby cortisol ∆2                
Mean (SD) 
-.1 (6.2) -1.5 (9.9) Z=-.2; p=.88 
 
Specifically, ∆1 represents the cortisol level immediately after the NBAS minus the 
cortisol level pre NBAS, whilst ∆2 represents the cortisol level 30 minutes after the 
NBAS minus the cortisol level pre NBAS. Mean cortisol ∆1 was -0.2 (SD=5.4) nmol/L 
in babies of healthy mothers while it rapidly increases in babies of depressed mothers, 
reaching a mean of 2.2 (SD=11.0) nmol/L, although the difference between groups is 
not significant. On the other hand, ∆2 has very similar means across babies of healthy 
and depressed mothers. In fact, ∆2 cortisol mean for babies of healthy women was -.1 






Figure 13. Baby's cortisol before, immediately after and 30 minutes after 


























Cortisol collection time  
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Exposure to maternal depression in utero and maternal history of childhood abuse 
and cortisol response to the administration of the NBAS at 6 days  
There was no significant difference in neonatal cortisol response to the administration of 
the NBAS across the 4 groups – HEALTHY, MDD only, CA only, and MDD & CA 
(pre: F(3)=.3; p=.827; post1: F(3)=1.3; p=.3; post2: F(3)=.3; p=.818).  
However it is worth commenting on the levels as presented in Figure 14. The mean 
cortisol levels immediately after the NBAS remained almost stable in the healthy 
groups (Pre: M = 8.1, SD = 6.5; post1: M = 8.1, SD = 4.3), increased in the depression 
only (Pre: M = 7.1, SD = 6.0; post1: M = 8.8, SD = 4.9), and depression with abuse 
groups (Pre: M = 10.3, SD = 14.6; post1: M = 12.5, SD = 13.4), while decreased in 
babies of women with childhood abuse only to a mean of 7.0 (SD = 4.0) nmol/L before, 




Table 20. Infant NBAS cortisol delta 1 and 2 in babies of women with/without 























































Figure 14. Neonatal cortisol before, immediately after and 30 minutes 
after the administration of the NBAS in babies of women with/without 















MDD & CA (n=34-36)












Associations between infant cortisol and Neonatal Behavioral Assessment Scale 
items  
Correlations (Table 21) are presented between the items of the NBAS at 6 days after 
birth and the infant cortisol ∆1 (immediately after the NBAS minus pre NBAS). At 6 
days, neonatal self-regulatory skills were negatively associated with salivary cortisol ∆1 
increase. Further correlations were measured in cortisol ∆1 in babies of healthy and 
depressed mothers. As can be seen from Table 23, neonatal self-regulatory skills are 
negatively associated with salivary cortisol ∆1 increase but only in babies of depressed 
mothers. 
Correlations were also examined between items of the NBAS at 6 days after birth and 
the infant cortisol ∆2 (30 minutes after minus pre NBAS). As can be observed in Table 
22, neonatal behavioral regulation at 6 days was not associated with cortisol ∆2. Further 
comparisons were made between cortisol ∆2 in babies of healthy and depressed 
mothers (Table 24). ∆2 in babies of healthy women is negatively correlated with motor 
maturity (r= -.4; p=.05) and tremulousness (r= -.5; p=.02), while in babies of depressed 
women it is negatively correlated with cuddliness (r= -.3; p=.04), cost of attention (r= -




Table 21. Spearman's correlations between NBAS items and baby's cortisol delta1 
(immediately post minus pre) 
NBAS item Spearman’s correlation  N=65 
Alertness r= -.29; p=.02 
Animate auditory r= -.18; p=.15 
Irritability r= .24; p=.06  
Motor maturity r= -.25; p=.04 
Cuddliness r= -.13; p=.30  
Consolability r= -.13; p=.40 
Tremulousness r= -.1; p=.40 
Quality of alertness  r= -.24; p=.05 
Cost of attention  r= -.32; p=.01 
Examiner facilitation r= -.27; p=.03 
General irritability r= -.21; p=.08  
Robustness and endurance  r= -.26; p=.04 
State regulation  r= -.25; p=.05 






Table 22. Correlations between NBAS items and infant delta2 (30 minutes post NBAS 
minus pre NBAS) 
NBAS item Spearman’s correlation  N=65 
Alertness r= -.13; p=.31 
Animate auditory r= -.03; p=.80 
Irritability r= .16; p=.21 
Motor maturity r= -.08; p=.53 
Cuddliness r= -.16; p=.22 
Consolability r= -.11; p=.50 
Tremulousness r= -.18; p=.15 
Quality of alertness  r= -.21; p=.09 
Cost of attention  r= -.22; p=.08 
Examiner facilitation r= -.20; p=.12 
General irritability r= -.19; p=.12 
Robustness and endurance  r= -.22; p=.08 
State regulation  r= -.15; p=.22 





Table 23. Correlations between NBAS items and delta1 (immediately after NBAS 
minus pre NBAS) in offspring of healthy and depressed women 
NBAS item Healthy N=22 MDD N=43 
Alertness r= -.08; p=.71 r=-.38; p=.01 
Animate auditory r= .03; p=.91 r= -.24; p=.12 
Irritability r= .12; p=.62 r=.31; p=.05 
Motor maturity r= -.34; p=.13 r=-.2; p=.20 
Cuddliness r= .39; p=.07 r=-.27; p=.09 
Consolability r= .31; p=.31 r= -.17; p=.33 
Tremulousness r= -.28; p=.21 r=.00; p=.98 
Quality of alertness  r= .03; p=.91 r=-.28; p=.07 
Cost of attention  r= -.04; p=.87 r=-.43; p=.004 
Examiner facilitation r= -.00; p=.99 r=-.36; p=.02 
General irritability r= .15; p=.49 r=-.30; p=.05 
Robustness and endurance  r= .00; p=.99 r=-.35; p=.02 




                                                 
r= -.00; p=.99 






Table 24. Correlations between NBAS items and cortisol NBAS delta2 in offspring of 
healthy and depressed women 
NBAS item Healthy N=22 MDD N=43 
Alertness r= -.24; p=.28 r=-.19; p=.22 
Animate auditory r=-.18; p=.41 r=-.03; p=.87 
Irritability r= .05; p=.84 r=.22; p=.15 
Motor maturity r= -.43; p=.05 r=.04; p=.78 
Cuddliness r= .21; p=.35 r=-.31; p=.04 
Consolability r=-.03; p=.93 r=-.14; p=.44 
Tremulousness r= -.49; p=.02 r=-.02; p=.90 
Quality of alertness  r= -.20; p=.37 r=-.29; p=.06 
Cost of attention  r= -.20; p=.38 r=-.3; p=.05 
Examiner facilitation r= -.20; p=.38 r=-.29; p=.06 
General irritability r= -.01; p=.98 r=-.28; p=.07 
Robustness and endurance  r= -.14; p=.53 r=-.32; p=.04 
State regulation  r= -.10; p=.66 r=-.22; p=.15 
Examiner’s emotional 
response  







Infant physiological response to the mild stressor of the NBAS administration 
In order to demonstrate visually the association between the NBAS scores and the infant 
response to the minor stressor of the NBAS administration I calculated the median for 
infant alertness (median = 7) and irritability (median = 4) as these items are 
representative of infants’ behavioural regulation and their ability to engage with the 
examiner during the administration of the NBAS. Neonates have been divided into high 
alertness (the median and above) versus low alertness (below the median) and high 
irritability (the median and above) versus low irritability (below the median). Figure 15 
and Figure 16 illustrate respectively the cortisol response before, immediately after and 
30 minutes after the administration of the NBAS in babies with high versus low 
alertness and in those with high versus low irritability.  
As can be seen from Figure 15, neonates with low alertness scores (<7) had 
significantly lower levels of cortisol than neonates with high alertness scores (>=7) 
before the assessment with the NBAS (t(50.8)=-2.75; p=.008). Their cortisol levels 
increased following the NBAS.  
Similarly, there was a significant difference between the cortisol delta (immediately 
after minus pre) in neonates with low alertness scores (M = 5.9; SD = 10.6) and in those 
with high alertness scores (M = -1.4; SD = 7.6) (t(63) = 3.3; p= .002).   
Figure 16 shows that neonates with low irritability scores (<4) had higher levels of 
cortisol than neonates in the high irritability group (>=4) before the assessment with the 
NBAS but their cortisol dropped following the NBAS while it increased for babies with 
high irritability score. However the differences in cortisol levels at the three time points 
were not significant. There was a significant difference between the cortisol delta 
(immediately after minus pre) in neonates with low irritability scores (M = -2.2; SD = 
7.4) and in those with high irritability scores (M = 3.1; SD = 10.0) (t(63) = -2.1; p= 





p=.008     
 
Figure 15. Neonatal cortisol before, immediately after and 30 minutes 


































Figure 16. Neonatal cortisol before, immediately after and 30 minutes 





























Maternal salivary cortisol at 32 weeks and infant behavioural and physiological 
regulation at 6 days  
As it can be seen from Table 25, there is no significant correlation between maternal 
evening salivary cortisol at 32 weeks gestation and the infant behavioural regulation at 6 
days after birth. In the same way, as it can be observed in Table 26, maternal cortisol 
was not associated with neonatal cortisol secretion before, immediately after and 30 




Table 25. Correlations between maternal evening cortisol at 32 weeks and NBAS items 
 
NBAS item Maternal saliva at 32 
weeks  
Alertness r= .02; p=.81 
Animate auditory r= -.03; p=.75 
Irritability r= .06; p=.54 
Motor maturity r= -.002; p=.98 
Cuddliness r= -.15; p=.14 
Consolability r= .11; p=.38 
Tremulousness r= .15; p=.13 
Quality of alertness  r= .02; p=.88 
Cost of attention  r= -.01; p=.92 
Examiner facilitation r= .01; p=.94 
General irritability r= -.004; p=.97 
Robustness and endurance  r= -.01; p=.95 
State regulation  r= -.07; p=.52 
Examiner’s emotional 
response  




Table 26. Correlations between maternal evening salivary cortisol at 32 weeks and 
infant delta1 and delta2 at NBAS 
 Baby ∆1 Baby ∆2 





3.3 Infant HPA axis at 8 weeks postpartum 
Infant cortisol response was assessed pre and 20 minutes post the 8-week immunization. 
Mean cortisol values at each time point were calculated and plotted on two separate 
graphs: Figure 17 illustrates the mean cortisol levels before and after the immunization 
across the whole sample, whilst Figure 18 shows the mean cortisol levels before and 
after the immunization in babies of healthy and depressed women. As can be seen in 
Figure 17, the mean cortisol levels before the immunization was 8.6 (SD=11.4 nmol/L), 
followed by a rapid rise 20 minutes after the immunization, reaching a mean of 14.7 
(SD=13.5) nmol/L which is significantly higher than the pre-immunization one (t(96) = 
10.7; p<.001).  
From Figure 18, it can be seen that, pre-injection, the mean cortisol in babies of healthy 
mothers was 7.6 (SD=5.2) nmol/L, whilst the mean for the babies of depressed mothers 
was 9.7 (SD=15.2) nmol/L. Twenty minutes after the immunization, cortisol levels 
increased rapidly in babies of both groups, with those of healthy mothers reaching a 
mean of 14.1 (SD=10.8) nmol/L and those of depressed women reaching a mean of 15.3 
(SD=15.8) nmol/L. There was no significant difference between the two groups.  
The difference between infant cortisol after the immunization minus pre-immunization 
was calculated as a delta. Infant cortisol delta at 8 weeks was analysed in babies of 
healthy and depressed mothers and in babies of women with/without depression and/or 
childhood abuse.  
Although babies of depressed women have higher cortisol delta than babies of healthy 
women (Table 27), the difference between the two groups is not significant.  
Turning to the cortisol levels before and after the immunization in babies of women 
with/without depression and/or childhood abuse (Figure 19), cortisol levels increased 
following the immunization in babies across all groups, with babies of healthy women 
showing the lowest levels of cortisol in the sample. Specifically, babies of HEALTHY 
women reached a mean peak of 11.4 (SD=6.7) nmol/L, those of MDD only women 
129 
 
reached a mean peak of 17.2 (SD=15.7) nmol/L, those of CA only women reached a 
mean peak of 17.9 (SD=15.0) nmol/L and those of MDD & CA women reached a mean 
of 15.3 (SD=16.8) nmol/L. There was no significant difference in cortisol levels across 
groups. Similarly, there were no differences in the deltas between the four groups 
(Table 28).  Interestingly, as for infant cortisol at 6 days, no association was observed 
between maternal evening salivary cortisol at 32 weeks and infant cortisol at 8 weeks 












































Figure 18. Infant 8-week salivary cortisol before and 20 minutes after the 



































Figure 19. Salivary cortisol at 8 weeks postpartum before and 20 minutes 
after the immunization in infants of women with/without depression 





































Table 27. Infant cortisol delta at 8 weeks postpartum in babies of healthy and depressed 
mothers 
 Healthy N=46 MDD N=46 Statistic   
Baby ∆              
Mean (SD) 
                                                 
6.8 (11.8) 
                                                 
7 (10.5) 
                    
Z=-.1; p=.91  
 
Table 28. Infant cortisol delta at 8 weeks postpartum in babies of women with/without 









Statistic   
Baby ∆            
Mean (SD) 
                       
5.4 (8.2) 
                      
10.2 (10.7) 
                        
7.6 (15.9) 
                         
6.8 (9.7) 




Table 29. Correlations between maternal evening salivary cortisol at 32 weeks and 
infant cortisol at 8 weeks postpartum 
 Spearman correlation 
with ∆ cortisol 8 weeks           
(post minus pre 
immunization) 
Spearman correlation 
with infant cortisol actual 
values – post 
immunization  
Maternal cortisol 
at 8 pm  





3.4 Infant HPA axis at 1 year postpartum 
Infant cortisol response was assessed before and 20 minutes after the 1 year 
immunization, as for the 8-week cortisol assessment. Mean cortisol values at each time 
point are presented in Table 30, which illustrates the mean infant cortisol delta (after 
minus pre immunization). Babies of depressed mothers had significantly higher cortisol 
delta at 1 year after birth compared with babies of healthy mothers (Z=-3.1; p=.002). 
The cortisol values, themselves are shown in Figure 20. Although the difference at Time 
2 was not statistically significant, infants of depressed mothers had an increase in the 
cortisol levels from a mean of 5.9 (SD = 6.4) nmol/L to a mean of 9.8 (SD = 14.1) 
nmol/L 20 minutes after the immunization compared with infants of healthy mothers 
from a mean of 6.7 (SD = 12.8) nmol/L to a mean of 6.6 (SD = 13.6) nmol/L 20 minutes 





Table 30. Infant cortisol delta at 1 year postpartum in babies of healthy and depressed 
mothers 
 Healthy N=42 MDD N=32 Statistic   










































Infant cortisol delta (after immunization minus before immunization) at 1 year 
postpartum in babies of women with/without depression and/or childhood abuse  
Results analysing the deltas show that there was significant difference in the infant 
stress response at 1 year, between babies in the four diagnostic groups, as it can be seen 
from Table 31. Kruskal-Wallis test followed by Mann-Whitney post-hoc test (adjusted 
for significance) show that babies of women with MDD  & CA had a significantly 
higher response to stress following the one-year immunization compared with babies in 
the other groups (K-W(3)=21.5;  p<.001); compared with babies of the HEALTHY 
women (U=88; Z=-3.5; p <.001), babies of MDD only women (U=29; Z=-3.0; p=.002), 
and babies of CA only women (U=21; Z=-3.8; p<.001).  
Infant salivary cortisol before and 20 minutes after the immunization in babies of 
women with/without depression and/or childhood abuse is further illustrated in Figure 
21. Most importantly, as seen in Table 32, maternal salivary cortisol at 32 weeks 
gestation was highly correlated with infant cortisol response to the immunization at one 




Table 31. Infant cortisol delta at 1 year in babies of women with/without depression 
and/or childhood abuse 







CA N=19  
Statistic   
Baby ∆            
Mean (SD) 
                                
.6 (2.9) 
               
-1.6 (5.5) 
                                   
-1.1 (2.4) 










Figure 21. Cortisol at 1 year in babies of women with/without depression 





























Table 32: Correlations between maternal evening salivary cortisol at 32 weeks and 
infant cortisol at 1 year postpartum 
 Spearman correlation 
with infant ∆ cortisol 1 




with infant cortisol actual 
values – post 
immunization  
N = 67 
Maternal cortisol 
32 weeks at 8 pm  





3.5 Infant cognitive development at 1 year after birth  
Mean composite scores of the Bayley Scale of Infant Development in infants of healthy 
and depressed women are presented in Table 33, while those of women with/without 
depression and/or childhood abuse are presented in Table 34.  Infants of healthy women 
have higher composite scores in the cognitive, language, motor and socio-emotional 
domains compared with infants of depressed mothers, but the group difference is not 
statistically significant. In the same way, when comparing the Bayley composite scores 
in infants of mothers with/without depression and/or childhood abuse, no group 
difference is observed (Table 34). 
Because maternal IQ, as measured by the WTAR, was different between the depressed 
group of mothers and control mothers (see above, Table 5) and was highly correlated 
with infant cognitive composite scores (Pearson’s r=.4; p<.001) and language composite 
scores (Pearson’s r =.3; p=.03) at one year, we repeated all the analyses while 
controlling for maternal IQ: but, again, there were no significant effect of exposure to 
maternal depression in pregnancy and/or maternal childhood abuse. 
Similarly, there was no effect of baby’s gender on the Bayley cognitive composite 





Table 33. Bayley composite scores in infants of healthy and depressed mothers 
Bayley composite 
scores 
Healthy N=38-50 MDD N=33-51 Statistic 
Cognitive 






















scores                           
Mean (SD) 
                                                
101.1 (10.9) 
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Table 34. Bayley composite scores in infants of women with/without depression and/or 
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4 Discussion  
4.1 Overview  
This thesis used a prospective longitudinal study of women and their babies in order to 
investigate the possible associations between maternal history of abuse during 
childhood and antenatal depression and the interactive effects on the baby’s outcomes in 
the first year after birth. This Discussion comprises a summary of the main findings, a 
critical appraisal of current literature, strengths and limitation of this study, and 
suggestions for future research. Potential clinical implications are also discussed.  
4.2 Maternal depression and experience of childhood abuse  
The findings from this study show that history of abuse during childhood is strongly 
associated with antenatal depression. Specifically, results suggest that women who have 
been abused in childhood (age 0-17) are 7 times more likely than those who have not 
been abused to develop depression during pregnancy. These findings not only support 
the hypothesis of an association between maternal abuse during childhood and maternal 
antenatal depression, but also are consistent with previous research demonstrating that 
experiences of abuse during childhood increase the chances of developing depression 
during adulthood, especially during vulnerable periods such as pregnancy and 
adjustment to motherhood. For example they replicate the findings of the South London 
Child Development study, which assessed a cohort of women in pregnancy in 1986 and 
followed them up for almost thirty years. This research showed that women who were 
abused during childhood were ten times more likely than those who were not abused to 
develop depression in pregnancy (Plant et al., 2013). Both studies, almost 30 years 
apart, used a prospective design to assess the association between the experience of 
childhood abuse and depression in pregnancy and we thus feel confident that the 




A study by Lang and colleagues (Lang et al., 2010) specifically investigated the effects 
of maternal childhood abuse and psychopathology on parenting capacity, mother-infant 
interaction and infant temperament at the age of one year. Results show that a maternal 
experience of childhood abuse is associated with impaired mother-infant interaction; 
furthermore, women who were emotionally abused, found it more difficult to regulate 
the distress of their infant, hence their babies showed more irritable temperament at age 
one than babies of non-abused mothers. Notably, the association between maternal 
exposure to abuse in childhood and depression in pregnancy was not explored; 
moreover, the sample size was small and maternal neglect in childhood was not 
assessed (Lang et al., 2010).  
This link between exposure to childhood abuse and the development of depression 
during pregnancy casts light on the natural development of psychopathology in 
adulthood, particularly when a woman is about to become mother.  
Notably, women have been recruited into this study on the basis of their mental state 
during pregnancy and not on the basis of their childhood experiences. Hence, the 
finding that 52% of the women had experienced abuse in childhood reflects the high 
prevalence among the general population living in South London.  
The high prevalence of childhood abuse in the control group (29%) raises the issue of 
the pathways which lead to the absence of depression during pregnancy. We know that 
exposure to abusive experiences in childhood is a major risk factor for the later 
development of mental health problems, so it could be speculated that those who do not 
develop mental health problems are highly resilient individuals. This account is in line 
with theoretical knowledge by Pariante et al, which suggests that the pathways leading 
to psychopathology have to be framed in the context of a bio-psycho-social model 
(Wertz and Pariante, 2014) and that  more than one mechanism is involved in the 
development of resilience to stress (Charney, 2004). Similarly, several factors could 
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affect the association observed between childhood abuse and increased risk of adult 
psychopathology. Genetic predisposition to abuse and psychopathology, as well as other 
potential environmental or individual factors have not been explored in this Thesis but 
might contribute to explaining this strong association. In my sample, however, there are 
significant differences in the socio-demographic characteristics of healthy and 
depressed women. Employment and a stable married or cohabiting relationship with the 
baby’s father were seen to be protective factors against the development of depression 
in pregnancy.  Similarly maternal IQ was higher in women who were not depressed 
compared to those who were depressed. Moreover primiparous mothers were less likely 
to become depressed compared with mothers who already had children. The current 
findings would suggest that being in employment, in a stable relationship, with a higher 
IQ would support a woman in being effective in the self-regulation of emotions and 
functional coping strategies when facing stress or major changes such as a pregnancy. 
One could further speculate that women who were abused as children and living in very 
abusive and frightening environments, had to become very aware of what was going on 
around them and be able to anticipate potentially life-threatening parental behaviours. 
Hence, from a very early age, these women might have had to use their intellectual 
abilities as coping strategies in order to survive in a potentially dangerous environment 
(successful adaptation). This might explain the functionality of the differences in the IQ 
levels among women with/without depression and/or history of childhood abuse.  
Even though some women who have experienced abuse as a child develop coping 
strategies, the findings presented here show that the majority of women exposed to 
abuse during childhood do develop depression in pregnancy. It is well established that 
childhood abuse predisposes women to persistent psycho-biological alterations of the 
HPA axis in adulthood, although the directions of those alterations is unclear (Bublitz 
and Stroud, 2012). Specifically, exposure to abuse in early life has been robustly 
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associated with the development of pathological changes which, in turn, increase 
vulnerability to stress and mental illness in adult life (Nemeroff, 2004). It has been 
hypothesised that individuals who are abused in childhood and develop later 
psychopathology have some pre-existent genetic vulnerability that is triggered by the 
exposure to early adversities and, in turn, increases the chances of developing mental 
illnesses later in life (Nemeroff, 2004). Hence, a more holistic approach as suggested in 
the bio-psycho-social model might offer a clearer picture of how several factors play a 
significant role in the context of childhood abuse and its association with adult 
psychopathology.  
It is known that the Central Nervous System, which is characterized by plasticity, is 
highly affected by early personal adverse experiences (Nemeroff, 2004). In fact, as the 
Central Nervous System is more plastic in young age, it might well be more affected by 
events occurring in the early stage of life. Evidence from animal studies suggests that 
when young animals are deprived of maternal care during the early postnatal period 
some major neurobiological alterations occur that predispose the animal to greater stress 
in adult life (Nemeroff, 2004).  
Hence, a persistent activation of the stress response following traumatic experiences in 
early life is thought to predispose individuals to greater stress in adulthood, such as 
anxiety and depression. The main biological system involved in the regulation of the 
stress response is the hypothalamic-pituitary-adrenal (HPA) axis, which has been 
largely studied as one possible mediator of the impact of childhood abuse on later 
mental health. A hyperactivity of the HPA axis has been found to be programmed by 
early life experiences and, in consequence, its alterations predispose an individual to 
depression in adulthood (Pariante and Lightman, 2008). In fact, hyperactivity of the 
HPA axis is one of the most consistent findings in studies on major depression overall 
the last few decades and it is considered part of the pathogenesis of depression (Pariante 
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and Lightman, 2008). Hence, in psychobiology it is believed that persistent 
dysregulation of the HPA axis functioning following the exposure to abuse in childhood 
is the main biological mechanism leading to adult depression.  
4.3 Hypothalamic-pituitary-adrenal axis in women at 25 and 32 weeks gestation 
With regards to the maternal cortisol response at 25 weeks gestation, no significant 
differences were found between healthy and depressed women, nor between women 
with/without depression and/or childhood abuse.  
We know that circulating cortisol increases during pregnancy in healthy subjects, 
reaching its peak in the third trimester (Jung et al., 2011) and so one possible reason that 
no difference was detected at 25 weeks could be that the cortisol profile of depressed 
women has not yet started differentiating from that of non-depressed women. Hence, 
findings at 25 weeks gestation suggests that maternal endocrine profile at this time of 
pregnancy is not yet affected by maternal mental state, or by her experience of 
childhood abuse.  
At 32 weeks, the findings present a different picture from that at 25 weeks gestation. 
First, when comparing cortisol levels in healthy and depressed women only, results 
show that depressed women have higher cortisol levels throughout the day and that at 8 
pm it is significantly higher than healthy women. Furthermore, when comparing women 
in the healthy with/without abuse and depressed with/without abuse groups, the cortisol 
levels at 8 pm for women with depression alone and depression plus childhood abuse 
are significantly higher than in healthy women and women with childhood abuse alone. 
These findings suggests two important points: (i) that childhood abuse alone does not 
have an effect on the cortisol response at 32 weeks; (ii) that is maternal depression in 
pregnancy, with or without the added insult of childhood abuse, that affects the HPA 
axis regulation at 32 weeks.  
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These findings are consistent with a study by O’Keane et al, demonstrating elevated 
cortisol levels in depressed women in the third trimester of pregnancy compared with 
healthy controls, with no significant group difference in the diurnal salivary cortisol 
(O'Keane et al., 2011). It is known that pregnancy in general brings major changes to 
the HPA axis regulation in healthy individuals, with greater levels at awakening, and a 
decreasing cortisol pattern during the day (Jung et al., 2011).  The additional presence 
of depression during pregnancy further contributes to a dysregulation of the stress 
response, with changes in the cortisol levels observed in depressed and healthy pregnant 
women. One reason might be that severe and persistent psychological distress, as seen 
in major depression, contributes to a further increase of the overall activity of the HPA 
axis, increasing, in turn, the cortisol levels secreted during the day. Due to an 
accumulation of stress, the HPA is no longer able to bring the cortisol levels back to 
normal in the evening due to persistent alterations.  
Literature on this topic suggests that women with depression exhibit flatter diurnal 
cortisol response compared with non-depressed subjects (Jarcho et al., 2013). 
Specifically, cortisol secretion in depressed patients is characterized by a peak at 
awakening, followed by a decrease during the day and a slight increase at night 
(Balardin et al., 2011). This pattern represents a flattening of the cortisol cycle during 
the day. 
4.4 Infant obstetric outcomes at birth 
The findings from the present study show that babies of depressed mothers have a 
significantly lower gestational age at birth (M=39.6, SD=2.3, weeks) and lower birth 
weight (M=3311.4, SD=564.9, grams) compared with babies of healthy mothers 
(respectively: M=40.3, SD=1.4, weeks; M=3560.3, SD=423.6, grams). Although the 
difference is not very great in clinical terms the findings mirror those of O’Keane et al 
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(Healthy, M=40.23, SD=1.05. weeks; Depressed: M=39.46, SD=1.7, weeks) (O'Keane 
et al., 2011).  
Adverse obstetric outcomes in depressed women are well documented in the literature 
(Diego et al., 2009) (Duthie and Reynolds, 2013), where stress in pregnancy is thought 
to be the key factor contributing to the dysregulation of the HPA axis in women which, 
in turns, leads to poorer obstetric and developmental outcomes for the child later on. 
Although the exact mechanisms underlying HPA axis alterations remain speculative, 
these initial findings confirm that the intra-uterine environment plays a key role as a 
pathway to explain the trajectory of stress in the next generation (Talge et al., 2007).  
These findings are further supported by other large studies investigating the perinatal 
outcomes among women with depression and stress in pregnancy. In a study by Hobel 
et al, 524 women were assessed at 18-20, 28-30 and 35-36 weeks gestation and at 
delivery (Hobel et al., 1999). Stress in pregnancy was assessed with the Perceived 
Stress Scale, and cortisol levels were measured at each time. Results reveal that women 
who delivered pre-term babies had higher concentration of circulating cortisol compared 
with those who delivered full term (Hobel et al., 1999). Similarly, a study by Sandman 
et al, assessed a sample of two hundred pregnant women at 15, 19, 25 and 31 weeks 
gestation and followed them up at birth (Sandman et al., 2006). At each visit, maternal 
cortisol and CRH were assessed via a blood test. Results showed that women who gave 
birth preterm (<37 weeks) had an increase in the CRH levels already at 15 weeks 
gestation, suggesting that stress stimulates greater production of cortisol and CRH 
levels which, in turn, induce preterm birth. Furthermore, this study suggests that CRH 
and cortisol levels at 31 weeks are the best predictor of gestational lengths and pre-term 
birth (Sandman et al., 2006). High levels of stress in pregnancy trigger early parturition. 
The present study’s findings are in line with those from the two prospective studies that 
investigated the effects of stress in pregnancy on gestational length.  
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A recent meta-analysis of 29 studies by Grote et al, also highlighted the role of antenatal 
depression as a factor predisposing women and their offspring to a greater risk of low 
birth weight and other obstetric adverse outcome that might affect neonatal survival 
(Grote et al., 2010). In the meta-analysis, most studies assessed major depression in 
pregnancy by using short screening tools with no structured interview. The present data 
add to these findings not only by replicating this robust association between antenatal 
depression and low birth weight but also by extending their validity as depression is 
assessed with a structured clinical interview.   
4.5 Infant behavioral and physiological outcomes at 6 days after birth 
Women’s experience of childhood abuse and depression in pregnancy has a significant 
impact on baby’s behavioural and physiological regulation at 6 days after birth. The 
findings in the current study revealed that infants exposed to both maternal history of 
childhood abuse and depression in utero were more difficult to engage in the Neonatal 
Behavioural Assessment Scale, were less responsive to stimulation, less alert and more 
irritable than neonates not exposed to such conditions.  
These findings are consistent with other studies on maternal depression in pregnancy 
and infant behavioural regulation. In a study by Lundy et al, (1999) women were 
recruited in pregnancy and assessed for their current mood, while their babies were 
assessed within one week after birth with the NBAS. Results from this study suggest 
that babies of depressed mothers have lower scores in the orientation items than babies 
of healthy mothers, indicating that they find it more difficult to engage in the 
assessment and respond to facial and auditory stimulation. Furthermore, maternal 
antenatal cortisol, which was higher in the depressed group compared with healthy 
group, was associated with neonatal abnormal reflexes (Lundy et al., 1999). The present 
study replicates Lundy’s findings showing an association between maternal depression 
in pregnancy and neonatal behavioural dysregulation at 6 days, and in addition we show 
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that depression in pregnancy is associated with the baby’s response to the stressor of the 
administration of the NBAS. However in the present study there was no direct 
association between the mother’s cortisol in pregnancy and the baby’s behavioural and 
biological response to the stressor at 6 days. 
The finding that neonatal behavioural regulation is affected by maternal depression in 
pregnancy is further confirmed in a study by Field et al, 2006. Data suggests that babies 
of women who experienced depression during pregnancy show sub-optimal 
performance on the NBAS within a few hours of birth, compared with babies of non-
depressed women. Specifically, neonates of depressed mothers showed higher levels of 
irritability, lower activity levels, were less robust and less mature compared with 
neonates of non-depressed mothers, although maternal history of childhood abuse was 
not assessed. In the present study, babies of mothers who were depressed in pregnancy 
had problems in behavioural regulation and these were exacerbated when maternal 
depression occurred with the added insult of childhood abuse.  
Our findings are also in line with those by Davies et al, 2007, who found an association 
between elevated maternal stress in pregnancy (anxiety and depression) and infant 
temperament at two months (Davis et al., 2007). More than two hundred dyads were 
assessed. Maternal cortisol in pregnancy was assessed at 18-20, 24-26, 30-32 weeks one 
hour after eating in the early afternoon and maternal psychological state was evaluated 
using the Centre for Epidemiological Studies Depression Inventory (Santor and Coyne, 
1997). Infant temperament was evaluated by the mother at 2 months using the Infant 
Behaviour Questionnaire (Gartsen and Rothbart, 2003), with a particular focus on infant 
response to fear (Davis et al., 2007). In this study, elevated maternal cortisol levels at 
30-32 weeks gestation were strongly associated with and predictive of high levels of 
infant negative reactivity. Again, this study confirms the hypothesis of the existence of a 
link between the antenatal environment and foetal programming, with adverse 
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consequences for infant development but our findings do not observe a direct 
association between maternal cortisol at 32 weeks gestation and baby’s behavioural 
regulation at 6 days.  
Finding of an association between maternal high cortisol levels in pregnancy and infant 
impaired emotional regulation, activity and adaptation scores at 7 weeks was also found 
in a study carried out in the Netherlands by de Weerth et al. where a small sample of 
pregnant women (n=17) were assessed in pregnancy and followed-up until the baby was 
20 weeks old. Maternal cortisol was evaluated in later pregnancy and infant behaviour 
was video-taped during a bath session at 1, 3, 5, 7, 18 and 20 weeks of infant age (de 
Weerth et al., 2003). Maternal cortisol was categorized as either high or low, and infant 
temperament was rated on the basis of the amount of crying, fussing and negative facial 
expression shown during the bath sessions. In line with the foetal programming 
hypothesis, babies of high-cortisol women showed more difficult behaviours at each 
time point. Interestingly, this association between maternal high stress and infant high 
numbers of crying and fussing episodes and negative facial expressions was stronger at 
1-7 weeks than at a later developmental stage (18-20 weeks) (de Weerth et al., 2003). 
This further illuminates the pathway found in my study, linking maternal stress in 
pregnancy to infant behavioural regulation shortly after birth. Together the literature 
supports the association between maternal depression in pregnancy and difficulties in 
neonatal behavioural and physiological regulation shortly after birth. The current study 
adds to the literature by providing strong evidence of an association between maternal 
cumulative stress in pregnancy, as indicated here by exposure to maternal depression in 
utero and the mother’s experience of childhood abuse, on neonatal regulatory capacity 
after birth.   
The results of my study also demonstrate that neonates of depressed mothers had 
significantly higher levels of circulating cortisol immediately after the administration of 
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the NBAS compared with babies of healthy women. Specifically, although the group 
difference was not significant, babies of women with both conditions of childhood 
abuse and antenatal depression have the greatest cortisol increase after the NBAS, 
followed by babies of women with depression only. Interestingly, neonates of mothers 
with childhood abuse alone (n=3) show a blunted cortisol response after the NBAS. 
This is consistent with research (Nemeroff, 2004) on abused individuals, neonates of 
women abused in childhood show a blunted cortisol response following the mild stress 
of the NBAS, although the group difference is not statistically significant. There is some 
evidence to suggest that maternal childhood abuse per se is associated with hypo-
activity of the neonatal HPA axis but when comorbid with antenatal depression the 
neonates’ HPA axis functioning at 6 days is hyperactive.   
Several studies have now examined the effects of childhood trauma on adult 
physiological regulation. First, it is well established that there is an association between 
childhood trauma and greater stress and psychopathology in adulthood, such as post-
traumatic stress disorder. A study by Yehuda et al, examined the cortisol response and 
the association between exposure to childhood trauma and PTSD in adults offspring of 
Holocaust survivors by analysing 24-h urine secretion among those subjects. Offspring 
of Holocaust survivors reported greater levels of emotional abuse and neglect as well as 
physical neglect and sexual abuse compared to controls. Interestingly, adults who were 
sexually abused and developed PTSD showed lower cortisol levels than those who were 
sexually abused only. Moreover, adults who were sexually abused and developed 
depression in adulthood showed greater cortisol levels than those with depression alone 
(Yehuda et al., 2001). In this sample, an increase in the cortisol secretion in sexually 
abused adults was seen only in the presence of depression. Likewise, my results show 
that women exposed to both childhood abuse and depression show greater cortisol 
155 
 
levels in pregnancy compared with women who were depressed only or exposed to 
childhood abuse only.  
Following this reasoning, these results could be interpreted as a demonstration of the 
first signs of an intergenerational transmission from mother to infant, where both 
conditions of maternal childhood abuse and antenatal depression have a detrimental 
effect on baby’s behavioural regulation at 6 days, while it is maternal depression that 
has an impact on the baby’s physiological response to stress at 6 days. According to the 
psycho-bio-social model of stress, genetic factors might have an impact of the 
transmission of stress from one generation to the next, as previously discussed, but they 
have not been explored in the studies reported above, nor in this Thesis.   
4.6 Infant HPA axis at 8 weeks postpartum 
Maternal childhood abuse and/or antenatal depression does not modulate the infant 
HPA axis functioning at 8 weeks after birth. Findings suggest that there is an increase in 
the cortisol levels in babies following the 8 weeks injection, but their stress levels are 
not associated with maternal diagnosis and/or abuse history. Although infants of 
depressed mothers have non-significantly higher cortisol levels before and 20 minutes 
after the immunization compared with those of healthy mothers, no other abnormality in 
the HPA axis function is observed while comparing the difference between the cortisol 
collected before and after the injection across groups. Furthermore, there is no 
association between maternal salivary cortisol at 32 weeks gestation and infant cortisol 
levels at 8 weeks after birth. It is interesting to note that, contrary to baby’s stress 
response at 6 days after birth, at 8 weeks we could not find a similar effect. There are 
several possible reasons for this. First, one reason could be that infant HPA axis 
changes during time. Babies at 6 days could be more sensitive to stress compared with 
infants at 8 weeks, when they are more adjusted to the new environment and to maternal 
care. At this stage of the baby’s life, protective effects such as mother-infant interaction 
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might play a key role in the regulation of the child’s biological system (Field et al., 
2006).  
My findings are not in line with other studies that found an association between 
maternal depression in pregnancy and infant HPA axis dysregulation at 8 weeks after 
birth.  Data from a study in a South India give evidence that maternal depression and 
high cortisol levels in the third trimester of pregnancy were associated with infant 
cortisol response following the immunization at two months of age (Fernandes et al., 
2014). Infant salivary cortisol was collected 10 minutes prior and 20 minutes after the 
immunization, as in the current study. Compared with the families living in the area of 
South London, the socio-economic status of rural Indian families with low income 
needs to be considered as a potential factor affecting the stress response of those 
mothers and their infants. Moreover, given the small sample size of Fernandes’ study 
(n=19), one could speculate that the association between maternal depression and infant 
cortisol response could no longer be present with a bigger sample size.  
The nature of the stressor may also account for the fact that we find differences in the 
babies’ response to the stressor at 6 days but not at 8 weeks. The Neonatal Behavioural 
Assessment can be seen as a mild stressor as it involves being handled by a stranger for 
about 20 minutes. It demands concentration from the baby and draws on their ability to 
self-regulate. This could be more stressful than an injection at 8 weeks that is quicker 
and is administered when the infant is in the caregiver’s arms. The infant’s perception 
of pain and the consequent response to stress might explain the difference in the stress 
response at 6 days and 8 weeks. Davies and colleagues give further support to the idea 
that infants respond differently to stressors depending on their age. They have 
demonstrated that the association between the sympathetic branch of the autonomic 
nervous system and the secretion of salivary alpha-amylase develops between two and 
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six months of age, suggesting that young babies (0-2 months) are less responsive to 
painful stressors (Davis and Granger, 2009). This might explain my results at this stage. 
4.7 Infant HPA axis at 1 year postpartum 
At one year of age the data in the present study shows a marked difference in the 
response to the immunisation in the babies of mothers who had been depressed and had 
experienced abuse in their childhood compared with those of healthy women, and 
women with depression or childhood abuse alone. Babies of women with both 
depression and history of childhood abuse have a significant increase in the cortisol 
levels 20 minutes after the 1 year immunization compared with those of healthy 
mothers, of mothers with depression only and of mothers with experience of childhood 
abuse only, indicating that the infants of these women are more sensitive to stress. Thus, 
these data provide support to the hypothesis that the one-year-old babies of women with 
both conditions of childhood abuse and antenatal depression are particularly vulnerable 
to stress.  
The fact that the association between maternal salivary cortisol at 32 weeks and infant 
cortisol is present at 1 year but not at 8 weeks might cast further light on the nature of 
the HPA axis regulation and development in children throughout the first year of life. In 
fact, it could be speculated that maternal depression in pregnancy might have different 
effects on the regulation of the infant HPA axis at different ages. This has been shown 
to be the case in animal studies, which have shown that the HPA axis immediately after 
birth becomes hyper-sensitive to mild stressors in offspring of anxious mothers who had 
high cortisol levels in pregnancy (Van den Hove et al., 2005). After these initial hyper 
concentrations of circulating cortisol in young babies, the HPA axis becomes 
“desensitized” and leads to a down-regulation of cortisol receptors a few weeks after 
birth (Elzinga et al., 2008). Another potential explanation is that cortisol levels are 
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associated with the stress tasks. For example, babies might find the handling during the 
administration of the Neonatal Behavioural Assessment at 6 days more stressful than an 
injection at 8 weeks. Hence, we could speculate that babies of women with depression 
in pregnancy do not respond equally in stressful situations at 6 days, 8 weeks and 1 year 
after birth.  
Other studies have explored the cortisol response in children in the first year of life 
although, to my knowledge, this is the first study using a prospective longitudinal 
design to explore cortisol at 8 weeks and 1 year in infants of mothers who were abused 
in their childhood and developed depression in pregnancy. An association between 
maternal depression in pregnancy and increased salivary cortisol in the offspring at six 
month of age has been found in a study by Brennan and colleagues. Specifically, infants 
were placed in a car seat behind an occlusion seat blocked from the mother view and 
exposed to an intense sound burst for three times in 90 seconds. Salivary cortisol was 
collected at three time point during this procedure in order to assess child stress 
response. This finding suggests that exposure to maternal depression in the antenatal 
and postnatal period increases the infant cortisol response following a stressor (Brennan 
et al., 1998). These results are also consistent with another study on infants of healthy 
women, demonstrating that infant response to stress becomes more consistent between 
two and six months after birth, showing no difference between premature and full term 
babies (Grunau et al., 2010). This study suggests that two to six months is window of 
time offers the maximal cortisol response following an immunization, which will be less 
at later ages. Overall, despite some methodological and sample differences across the 
studies, data consistently show cortisol reactivity in infants exposed to a stressor from 
the third month of life, although the literature lacks studies that specifically look at the 
stress response following the injection at one year.  
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In the present study maternal salivary cortisol at 32 weeks gestation is robustly 
associated with infant cortisol at 1 year, suggesting that there might be an 
intergenerational transmission of biological alterations from one generation to the next, 
as suggested by the foetal programming hypothesis (Duthie and Reynolds, 2013).  
Evidence of an association between maternal HPA axis in pregnancy and offspring 
HPA axis is supported by studies on clinical and non-clinical samples. A prospective 
cohort study on a Swedish population assessed the natural physiologic trajectory of hair 
cortisol in healthy pregnant women and their babies during pregnancy, at 1, 5, 8 years, 
findings a significant linear association over time between maternal and infant HPA 
(Karlen et al., 2013). This study suggests that the physiology of stress has a set point 
and raises over time, with a high heritability of the cortisol traits from mother to infant. 
While this study comprises healthy subjects only, my sample suggests that a strong 
association between maternal cortisol at 32 weeks and infant cortisol at 1 year persists 
from one generation to the next, both in the healthy mothers and in cases when there are 
alterations of the stress response due to maternal depression and childhood abuse 
history.   
4.8 Infant cognitive development at 1 year  
The finding that there was no group difference in the composite scores of the Bayley 
Scale of Infant Development do not confirm the hypothesis that infants of women with 
depression would have an impaired cognitive performance at 12 months compared with 
infants of non-depressed mothers. Similarly, no association was found between 
maternal IQ in pregnancy and infant cognitive scores at 12 months of age in babies of 
healthy and depressed women and babies of women with/without antenatal depression 
and/or childhood abuse.  
One possible reason could be that the administration of the Bayley Scale of Infant 
Development in infants at 12 months does not yet detect a difference in babies’ 
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cognitive performance. In fact, the literature suggests that several studies have used the 
Bayley Scales of Infant Development in infants who were 18 months old. A 
longitudinal study that  by Conroy et al, 2012, has examined the effects of comorbid 
maternal depression and personality disorders in the postpartum period on infant 
cognitive development at 18 months (Conroy et al., 2012). A sample of two hundred 
women was recruited in the study following the birth of their baby and was assessed for 
depression and/or personality disorders two months after delivery, including a control 
group. Maternal depression and personality disorders were diagnosed with the 
Structured Clinical Interview for DSM-IV (First et al., 2002), respectively for Axis I 
and II disorders. Infant emotional and social development was assessed at 18 months 
with the Infant-Toddles Social and Emotional assessment (Carter and Briggs-Gowan, 
2006), while infant cognitive development was evaluated with the Bayley Scales of 
Infant Development (Bayley, 2005). Findings suggest that infants of mothers who had 
depression and personality disorders in the postnatal period, had lower cognitive scores 
in the Bayley Scales of Infant Development compared with those of healthy women. 
Furthermore, infants of mothers with depression and personality disorder had a higher 
rate of externalizing and internalizing problems compared with those of healthy women 
(Conroy et al., 2012). 
Interestingly, another study by Zhu et al (Zhu et al., 2014) explored the effects of 
maternal stress during pregnancy on the offspring cognitive development at 18 months. 
In this study, women’s stressful life events were assessed at 32 weeks gestation using 
the Prenatal Life Events Checklist (Zhu et al., 2013) that assessed maternal stress 
related to negative life events happened during pregnancy. This study found that babies 
exposed to maternal stress in pregnancy had impaired cognitive performance at 18 
months compared with those of women who were not stressed in pregnancy. Hence, we 
might speculate that the baby’s age at the time of the assessment might be important in 
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detecting the difference between babies of healthy and depressed mothers. Another 
important key factor to consider in the interpretation of these results is that the timing of 
maternal depression and its effects on infant cognitive outcome is not clear (Evans et al., 
2012). A large longitudinal study of parents and infants (ALSPAC study) with more 
than five thousand dyads taking part, examined the effects of maternal depression both 
in the antenatal and postnatal period on the offspring development after birth. Results 
from this study show that maternal depression during pregnancy has detrimental effects 
on infant cognitive development at 18 months of age, while no effect has been observed 
for depression in the postnatal period (Evans et al., 2012). It is possible that, in the 
present study, the age of the baby at the time of the administration of the Bayley Scales 
and the small sample size could account for the lack of findings.  
Evidence from the South London Child Development Study showed that it was the 
effects of depression in the postnatal period and not the antenatal period that accounted 
for the cognitive deficits in children exposed to maternal depression. (Hay et al., 2001).  
4.9 Methodological considerations   
This study has a number of strengths. The prospective longitudinal design from 
pregnancy to one year allowed for the exploration of the temporal relationship between 
maternal childhood history and mental state in pregnancy on the infant outcomes at 12 
months of age. Second, the use of a community sample has increased the ecological 
validity of the findings, making them possible to generalize findings beyond clinical 
samples. Thirdly, the data was obtained in a face-to-face interview or by direct 
behavioural assessment of the baby, using validated instruments and measures of 
maternal psychopathology and child development.  
Alongside the strengths of this study, there are also some methodological limitations 
and study considerations that need to be addressed and considered when interpreting the 
findings of this thesis.  
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A first limitation is the sample size, which is relatively small, especially in each of the 
four groups. Some of the unexpected negative findings (such as the lack of a significant 
association between maternal antenatal cortisol and infant physiological response at 6 
days and 8 weeks, as well as the lack of significant difference in the cortisol levels 
between women with one condition of abuse or depression alone versus those with both 
depression and childhood abuse in the antenatal and postnatal period) could be 
explained by this limitation. Similarly, some results related to the condition of maternal 
depression alone or maternal childhood abuse alone might be due to the small sample 
size of each group.   
Women were not recruited on the basis of their childhood histories but on their mood 
during pregnancy. Hence, the recruitment of women who experienced abuse during 
childhood and did not develop depression has been difficult.  
Secondly, the fact that the majority of women in the sample were highly educated 
means that the sample is not representative of the population living in the area of South 
London. This might affect the generalizability of the findings to the general population. 
Although there were other socio-demographic differences between depressed and 
healthy women as found for employment, marital status, parity and maternal IQ, these 
did not account for the differences observed in the behavioural or physiological 
regulation of the infants.  
Thirdly, it is best practice if the Neonatal Behavioural Assessment Scale is administered 
on two consecutive days, in order to assess the child’s best performance (Brazelton and 
Nugent, 1995). In the present study, the scale was only administered once, due to time 
constraints because the assessments were conducted in the participants’ homes.  
Fourth, after the 8 weeks immunization, women’s methods of consoling their baby’s 
distress varied. Between the injection and the collection of the infant saliva sample 20 
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minutes afterwards, some women fed their baby while others gave them a pacifier, 
which could potentially bring the infant cortisol levels down. I did not control for this 
variable in the analysis. Similarly, at 12 months women used different consoling 
strategies, although at this age infants are easier to distract with a toy or are able to walk 
around.  
Last, alternative possible explanations for the results might be due to environmental 
effects, genetic and other factors that have not been explored in this work. Hence the 
associations found do not define a specific trajectory for the data but offer a view on 
what the transmission of stress across generations might involve.   
Suggestions for future research  
Taken together, there are long term detrimental effects of child maltreatment on adult 
heath, child development and the associated economic costs (May-Chahal and Cawson, 
2005). It becomes, therefore, of vital importance to investigate further the 
psychobiological and biological mechanisms linking maternal history of childhood 
abuse and perinatal outcomes. This would also allow for the targeting of risk factors for 
optimal child development (Mohler et al., 2008) and the development of clinical 
interventions to prevent later mother-child psychopathology.  
To further explore the present findings, future studies should comprise a bigger sample 
size, especially for the group of ‘abused only’ women.  
Future research will need to explore maternal sensitivity and mother-infant interaction 
as a potential mediator between maternal history of childhood abuse and antenatal 
depression on infant developmental and physiological outcomes after birth. The 
identification of patterns leading to mother-infant wellbeing would provide the 
opportunity to identify the optimal time for targeted interventions. 
Furthermore, it would be interesting to further explore the role of fathers as a protective 
factor that mediates the association between maternal experience of childhood abuse 
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and depression in pregnancy with the infant outcomes. Also, given the interesting 
finding that 29% of women had been exposed to childhood adversities and did not 
develop depression in adulthood, it would be important to understand further the 
mechanisms by which childhood experiences did not lead to mental health problems 
later in life, and look closely at the children of this group of women in a larger sample. 
Future studies should further investigate resilience processes in people who have been 
abused in childhood, in order to predict, potentially prevent, and treat stress-related 
adult psychopathology. 
Future studies also need to consider wider biological markers as indicators of 
physiological abnormal response in mothers and babies, which could potentially clarify 
further the cortisol response and the HPA axis function in these women. For example 
maternal cytokines in pregnancy might be another possible mediator between maternal 
antenatal depression and foetal outcomes. Further investigations on placenta enzymes, 
maternal cortisol in the amniotic fluid and maternal serotonin levels might offer a better 
understanding of the mechanisms underlying the transfer of maternal cortisol from 
mother to foetus.  Epigenetics is another area that is becoming more explored as it is 
involved in the mediation of the stress from mother to baby. Current environmental 
factors should also be explored as potentially being involved in the development of 
psychopathology and the alteration of neurobiological responses in an individual’s 
lifetime.  
Finally, studies should look at how the brain changes happening in women who suffered 
abusive childhood experiences and their babies affect the psychological and biological 
response both in mothers and babies. For example, future studies using neuroimaging, 
could look at the brain volume differences and brain activation of women who have 
been abused in childhood and their infants after birth, in order to discover other 
pathways of this intergenerational transmission.  
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4.10 Clinical implications  
This research has far-reaching implications in the context of identifying factors that 
affect infant development in early life and could be targeted in preventive or therapeutic 
interventions in women and their babies. Several initiatives have been launched by the 
government and by national and local charities in order to ensure support to children 
and families since the early postnatal period. One of those is Sure Start, which aimed to 
improve childcare, health and family support in specific areas in need. Furthermore, 
several programs, such as Family Nurse Partnership, supports very young parents in 
their transition into parenthood by offering home-based consultation on request. In a 
similar way, the National Childbirth Trust offers courses to families in the antenatal 
period as well as consultations after birth about breastfeeding and other issues that 
families might face in their adjustment to the new-born. With these premises, it is 
known that some of the people at great risk of depression are either in isolation, so they 
do not reach the services available, or live in deprived areas of the city, where services 
might lack or they might not be aware of the existence of these sources of support. 
Hence, professionals dealing with women in pregnancy and the postnatal period (such 
as nurses and health visitors that often see women in their homes) should all undertake 
specialist trainings that enable them to detect difficulties in mother-infant bonding 
and/or in the infant behaviour. Trainings in Neonatal Behavioural Observation would 
provide professionals with a new perspective to think about mothers and infants that 
would enable them to detect sign of difficulties in the bonding process and then refer 
those mothers to seek advice before the difficulties become pervasive.  
Furthermore, these findings cast light on the importance of the childhood histories of 
women in pregnancy.  Training of professionals involved in the care of pregnant women 
could include developing awareness of the consequences of unresolved childhood 
traumas, screening for early childhood experiences and depression in pregnancy, and 
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close monitoring of the symptomatology after birth, together with further support during 
the transition to parenthood, by offering not only prioritized access to psychological 
therapy to pregnant women with mental health problems, but also parenting and child 
assessments and follow-up after birth, to ensure the wellbeing of the mother and the 
dyad.  
My findings also demonstrate that neglect, physical, sexual and emotional abuse during 
childhood increases the chances of developing mental illness in adulthood and then 
potentially in the next generation. This is a serious health problem, with incredibly high 
costs both in terms of health care and its social implications. By intervening at a very 
early stage, even before conception (e.g. during family planning visits), and tackling the 
unresolved trauma that often follows adverse experiences, it might be possible to reduce 




4.11 Conclusions  
In conclusion, several new findings appear as a result of this thesis. Women who 
suffered physical and sexual abuse, neglect, and felt unwanted and unloved during 
childhood (0-17 years) are seven times more likely to develop depression during 
pregnancy compared to women who did not suffer such abuses. Furthermore, women 
who have been abused and developed antenatal depression have high levels of 
circulating evening cortisol in the 3rd trimester of pregnancy. Effects of exposure to 
maternal childhood abuse and depression in pregnancy can be seen in the next 
generation during the first year of life, as observed in the biological and behavioural 
changes in the offspring.  Maternal HPA axis dysregulation in pregnancy could be one 
of the pathways leading to this transmission. Overall, these findings show an association 
between a maternal childhood history of abuse and psychopathology in pregnancy and 
infant behaviour and physiological response to stress as early as 6 days that is also 
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Appendix A: Participant Information Sheet  
 
 
Participant Information Sheet  
 
Study title  
Does the maternal stress system during pregnancy modify stress responses in babies 
following birth?  
 
Invitation paragraph  
We would like to invite you to take part in a research study. Before you decide, you 
need to understand why the research is being done and what it would involve for you. 
Please take time to read the following information carefully. Talk to others about the 
study if you wish. 
Part 1 tells you the purpose of this study and what will happen to you if you take part. 
Part 2 gives you more detailed information about the conduct of the study. Please ask us 
if there is anything that is not clear or if you would like more information. Take time to 




What is the purpose of the study?  
We are studying the response to stress of babies born to mothers who have been 
depressed during pregnancy compared with babies whose mothers have not been 
depressed during pregnancy. It is commonly believed that pregnancy is a time of good 
mental health; in fact, research suggests that depression during pregnancy is relatively 
common, occurring in up to 10% of pregnant women and its occurrence may also have 
an impact on baby outcome; it is therefore an important area for further research. 
We are particularly interested in the endocrine system known as the hypothalamic-
pituitary-adrenal (HPA) axis. The HPA axis is sometimes known as the “stress system” 
because it is activated by stress; we can measure the level of hormones from this system 
in the body. Cortisol is a major hormone from this “stress system”; during normal 
pregnancy, levels of cortisol become very high and are linked to the timing of birth. Of 
particular importance is that abnormally high levels of cortisol in pregnancy may be 
associated with premature birth and lower birth-weight babies. Depression is also 
associated with high levels of cortisol. Our previous research has suggested that 
pregnant women who are also depressed tend to have higher levels of cortisol & related 
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hormones than those who are not depressed; also that their babies may have higher 
levels of cortisol and have a different hormone response to stress than the babies of 
women who have not been depressed in pregnancy. We wish to study this further, and 
look at other hormones related to this stress system and the way that genetic material 
(DNA) might influence the “stress system”. 
Why have I been invited? 
You have been invited to participate because you are pregnant and routine screening at 
your initial meeting with your midwife either has not identified you as someone who is 
suffering from depression or has identified you as someone who may be at risk of 
developing, or actually suffering from, depression. At Kings College Hospital, 
pregnancy services are linked closely with a team of specialists concerned with the 
mental health of pregnant women and new mothers. In total, we will include 204 
pregnant women; 62 with depression and 142 who are not depressed; we will also 
include their babies after they are born. 
 
Do I have to take part?  
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. You are free to withdraw at any time, without giving 
a reason; this would not affect the standard of care you receive.  
 
What will happen to me and my baby if I take part?  
Your participation will be for up to 18 months, the study will go on for 3 years in total. 
There will be up to 5 study visits, each visit lasting from 30 minutes to 4 hours: 
 
Visit 1 occurs when you are about 25 weeks pregnant. You will be seen by a clinical 
researcher who will ask you some background questions such as age, number of 
children, employment and ethnic origin, life events and childhood experiences. You will 
also complete some brief questionnaires, a cognitive assessment, and be asked about 
any symptoms of depression/anxiety. You will have a blood test to look at hormone 
levels and DNA for genetic studies (30mls blood - about 2 tablespoons). The researcher 
may also obtain background information from your medical notes. You will be asked to 
provide 6 specimens of your saliva on one day, during the week after this visit. You will 
be shown how to do this at visit 1. We are looking at cortisol (“stress hormone”) levels 
in saliva samples. 
 
When you are about 32 weeks pregnant we will ask you to repeat the saliva samples and 
complete some brief questionnaires and post them back to us. There is no need for a 
visit at this stage. 
 
Following the delivery of your baby, the midwives will take a small section of the 
umbilical cord or some blood from the umbilical cord after it has been removed from 
your baby. We will use this to look at the baby’s DNA for genetic studies. A study visit 
180 
 
is not required at this stage; the sample will be collected by the researcher at a later 
point. 
 
Visit 2 occurs 6 days after your baby is born. A clinical researcher will visit you at 
home to assess your baby’s behaviour; they will use a standardised rating scale to make 
this assessment, which takes about 30 minutes. The researcher will collect a specimen 
of your baby’s saliva shortly before and after the assessment, to look at levels of the 
stress hormone - cortisol, cotinine (a marker of exposure to tobacco) and DNA, and ask 
you to complete some brief questionnaires. 
 
 
Visit 3 occurs the day before your baby is due for routine immunizations, 8 weeks after 
birth. At this time, as for visit 1, we will evaluate any symptoms of depression/anxiety. 
We will also look at the interactions between you and your baby; to do this we will 
make a 3-5 minute video recording at your home, you will be asked to play and talk to 
your baby as you normally would. The video data will be analysed using existing, 
validated observational scales by a trained observer.  
 
We will also obtain saliva samples from your baby, to look at “stress hormone” levels, 
cotinine and DNA. The clinical researcher will meet with you and your baby when you 
attend for the baby’s routine vaccinations, and show you how to obtain the sample by 
inserting a cotton swab between your baby’s upper lip & gum prior to & 20 minutes 
after the immunization. We would then ask you to repeat this procedure twice on the 
following day, 12 hours apart and in between feeds. You will also be asked to provide 6 
of your own saliva samples on the day after your baby’s vaccination.  
 
Visit 4 occurs the day before your baby is due for routine immunizations at one year of 
age. At this time, as for visit 3, we will evaluate any symptoms of depression/anxiety 
and observe interactions between you and your baby. We will also make an assessment 
of your child’s development at that stage, using a standardised rating scale. We will 
obtain saliva samples from you and your baby as for visit 3. 
 
The study assessments are over and above those involved in standard care; normal 
treatment will not be withheld during the study and will continue as needed after this. 
All video recordings are treated as confidential, will not be used for commercial 
purposes and will be destroyed when the study is completed. 
 
Expenses and payments.  
You will be reimbursed for travel expenses you incur in attending for study visits and as 
a token of our appreciation you will receive a £20 gift voucher at the end of the study. 
 
What will I have to do?  
If you wish to take part in the study, you will be asked to sign the consent form at the 
end of this document; you will be given a copy to keep. You should be prepared to 
undertake the 4 study visits, as detailed above, either in your own home or at the 
hospital. Please also consider that in agreeing to participate, you are also providing 
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consent on behalf of the baby you are expecting. If you have recent or current 
participation in other research studies please consider whether you should also 
participate in this study. 
 
What are the possible disadvantages and risks of taking part? 
You may experience some discomfort and/or bruising from the blood test. Although it is 
not painful, your baby may experience some distress on collection of saliva samples. 
You may find the study visits/procedures inconvenient, particularly after your baby is 
born, as this is often a busy period for new mothers. 
 
During the study, it is possible that other conditions are discovered of which you were 
unaware, which may have implications for your future health, or otherwise impacts on 
your interests. If anything is identified, your GP or hospital consultant will be informed, 
with your agreement. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you of taking part in the study; however the knowledge 
gained from this study may be of help to other people in the future. 
 
 
What if there is a problem?  
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed; detailed information on this is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 




If the information in Part 1 has interested you and you are considering 






What if there is a problem?  
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (tel. 020 7848 5009). If you 
remain unhappy & wish to complain formally, you can do this through the NHS 
Complaints Procedure; details can be obtained from the hospital. 
 
In the event that something does go wrong & you are harmed during the research and 
this is due to someone’s negligence then you may have grounds for a legal action for 
compensation against King’s College Hospital Foundation NHS Trust or the study 
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sponsor, King’s College London, but you may have to pay your legal costs. The normal 
National Health Service complaints mechanisms will still be available to you.  
 
Will my taking part in this study be kept confidential? 
Yes, your confidentiality will be safeguarded during and after the study, which is 
conducted in accordance with the Data Protection Act 1998. 
An identification code will be allocated to you and later to your baby. The information 
we collect will be recorded and put into electronic databases using this code rather than 
your name. Paper and electronic records are stored securely at the Institute of 
Psychiatry; the custodian of all study materials is Dr Carmine Pariante (Chief 
Investigator). 
The researcher will have access to your clinical notes, and those of your baby, and by 
signing the consent from you will be giving consent for the researcher to examine your 
notes and those of your baby. 
Study data will be analysed and results will be submitted for publication; your identity 
will not be revealed. Study data will be retained and may be used in future studies, if 
this happens, further Research Ethics Committee approval will be sought. 
Authorised persons such as researchers, sponsors, regulatory authorities and Research 
and Development audit will have access to view identifiable data, for monitoring of the 
quality of the research. 
Study data will be retained for 10 years after completion of the study; and will be 
disposed of securely. 
You have the right to check the accuracy of data held about you and correct any errors 
according to local law and procedures. 
 
Involvement of the General Practitioner/Family doctor (GP) 
If you consent, we will write to your GP to inform them of your participation, and 
provide a brief study outline. 
 
What will happen to any samples I give? 
All samples from you and your baby will be processed then stored prior to analysis 
using the identification code already described. The researchers and laboratory scientists 
will have access to the samples; the researcher will be able to link your other study data 
to data from the analysis of your sample by the identification code. All samples will be 
destroyed once the study is completed. 
 
Will any genetic tests be done?  
Yes, we will look at genetic material (DNA) which might be relevant to the 
development of stress and depression.  
 
What will happen to the results of the research study? 
The data and results from this study may be published in medical journals or used in 
scientific reports and may be communicated to the regulatory authorities. You will not 
be identified by name. Once the study has been completed, a report of the findings will 




Who is organising and funding the research?  
The Chief Investigator, Dr Carmine M. Pariante is organising the research, which is 
sponsored by the Institute of Psychiatry, King’s College London. Funding is being 
sought from medical research charities. 
 
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing & dignity. This study has 
been reviewed & given favourable opinion by The Kings College Hospital Research 
Ethics Committee.  
 
Further information and contact details. 
Chief Investigator: 
 
Dr Carmine M, Pariante  
Head of the Joint Sections of Perinatal Psychiatry & Stress, Psychiatry and 
Immunology Institute of Psychiatry 
Reader, MRC Clinician Scientist Fellow 
Division of Psychological Medicine and Psychiatry 
Centre for the Cellular Basis of Behaviour, 
Room 2-055 
The James Black Centre 
125 Coldharbour Lane 
London SE5 9NU 
 
 Tel. 020 7848 5009 
 
You will receive a copy of the information leaflet and signed consent form to keep. 
 
 








Title: Does the maternal stress system during pregnancy modify stress responses in 
 babies following birth? 
 
 







I confirm that I have read & understood the participant information sheet dated 
03.10.11 (version 4.1) for the above study. I have had the opportunity to consider the 




I understand that my participation is voluntary & that I am free to withdraw at any 





I understand that relevant sections of my medical notes & data collected during the 
study may be looked at by individuals from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. I give permission for 








I agree that my GP or hospital consultant will be informed if, during the study, other 




I agree to give samples of blood, saliva or hair for the above study. I understand 








research rather than clinical purposes, and that these results will have no 
implications for me personally. 
 
 
I agree that I may be contacted in the future regarding the study, should the 
research be extended, but I am under no obligation to participate. I understand that 
information held by the NHS and records maintained by the General Register 








Name of Participant:_______________________________ 
Signature of Participant: ________________________________ Date: ______ 
Name of Investigator:  _______________________________ 
Signature of Investigator: ________________________________ Date: ______ 









Appendix C: Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician 
Version – Mood Disorder section 
 
Raters initials: 
Date:     
             
 




I’m going to be asking you about problems or difficulties you may have had, and 
I’ll be making some notes as we go along.  Do you have any questions before we 
begin? 
OCCUPATIONAL HISTORY 
IF CURRENTLY WORKING: How long have 
you been in your current job? 
 
  IF < 6 MONTHS: Why did you leave your 
last job? 
 
Have you always done that kind of work? 
 
IF NOT CURRENTLY WORKING:  What 
kind of work have you done before? 
 
 How are you supporting yourself now? 
 
 
IF UNKNOWN:  Has there ever been a period 
of time when you were unable to work or go to 
school/ college? 
 
 IF YES:  When?  Why was that? 
 
 
STATUS OF CURRENT TREATMENT (PATIENTS ONLY) 
IF UNKNOWN:  Have you been in any kind 





Treatment setting: (Circle one) 
 
1 - Current inpatient (including residential 
treatment) 
2 - Current outpatient 
3 - Other (e.g. psychotherapy) 




IF INPATIENT:  When did you come into 
hospital? 
IF OUTPATIENT:  When did you start 




CHIEF COMPLAINT AND DESCRIPTION OF PROBLEM (PATIENTS ONLY) 
What led to your going there (this time)?  
(What is the major problem you are 
having trouble with?) 
 
IF DOES NOT GIVE DETAILS OF 
PRESENTING PROBLEM:     Tell me 
more about that.   




ONSET OF PRESENT ILLNESS OR EXACERBATION (PATIENTS ONLY) 
When did this begin?  (When did you 
first notice that something was wrong?) 
 







NEW SYMPTOMS OR RECURRENCE (PATIENTS ONLY) 
Is this something new or a return of 
something you had before? 
 







ENVIRONMENTAL CONTEXT AND POSSIBLE PRECIPITANTS (PATIENTS 
ONLY) 
(USE FOR REPORTING AXIS IV.) 
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Did anything happen or change just 
before this all started?   
(Do you think this had anything to do 
with your [PRESENT ILLNESS]?) 
What other kinds of problems were you 






COURSE OF PRESENT ILLNESS OR EXACERBATION (PATIENTS) 
After it started, what happened next?  





Since this began, when have you felt the 
worst? 
   IF MORE THAN A YEAR AGO:   






PATIENTS:  When was the first time 
you saw someone for emotional or 
psychiatric problems?  (What was that 
for?  What treatment(s) did you get?  
What medications?) 
 
NON-PATIENTS: Have you ever seen 
anybody for emotional or psychiatric 
problems? 
 
   IF YES:  What was that for?  (What 
treatment(s) did you get?  Any 
medications?) 
 
   IF NO:  Was there ever a time when 
you, or  
someone else, thought you should see 
someone because of the way you were 






What about treatment for drugs or 
alcohol? 
 
(THE LIFE CHART ON NEXT PAGE  
MAY BE USED TO DOCUMENT A 




Have you ever been a patient in a 
psychiatric hospital? 
 
    IF YES:  What was that for?  (How 
many times?) 
 
   IF GIVES AN INADEQUATE 
ANSWER, CHALLENGE GENTLY: e.g.  
Wasn’t there something else? People 
don’t usually go to psychiatric hospitals 
just because they are  
  (TIRED / NERVOUS / OWN WORDS) 
 
 
Have you ever been a patient in a hospital 
for treatment of a medical problem? 
 




OTHER CURRENT PROBLEMS 
PATIENTS: Have you had any other 
problems in the past month? 
 
NON-PATIENTS: How have things 









How has your physical health been?  






CURRENT SOCIAL FUNCTIONING 
How have you been spending your free 
time? 
















MOST LIKELY CURRENT DIAGNOSIS:   ____________________________________________ 
 
 
                                                                     LIFE CHART 
Age (or date)                     Description (symptoms, triggering events)                                       Treatment 
 
_________            ________________________________________________             _______________ 
 
_________            ________________________________________________             _______________ 
 




A. MOOD EPISODES 
 
CURRENT MAJOR DEPRESSIVE EPISODE CRITERIA 
 
Now I am going to ask 
you some more 
questions about your 
mood. 
(A)  Five (or more) of the following symptoms have been present 
during the same 2-week period and represent a change from 
previous functioning; at least one of the symptoms is either (1) 
depressed mood or (2) loss of interest or pleasure. 
 
A1    In the past month . 
. has there been a period 
of time when you were 
feeling depressed or 
down most of the day 
nearly every day?   
(What was that like?) 
 
IF YES: How long did 
it last? (As long as 2 
weeks?) 
 
(1) depressed mood most of the day, nearly every day as 
indicated by either subjective report (e.g., feels sad or 




?  -   + 
A2   . . . what about 
losing interest or 
pleasure in things you 
usually enjoyed? 
 
IF YES: Was it nearly 
every day? How long 






(2) markedly diminished interest or pleasure in all, or 
almost all, activities most of the day, nearly every day (as 
indicated by either subjective account or observation 

























FOR THE FOLLOWING QUESTIONS, FOCUS ON THE WORST TWO 
WEEKS OF THE LAST MONTH (OR PAST  
TWO WEEKS IF EQUALLY DEPRESSED FOR THE ENTIRE MONTH)  
 
During [2-WEEK PERIOD] …    From: …../…../……  To: …./…../…...  (insert 
dates) 
 
A3  . . .did you lose or 
gain any weight? (How 
much? Were you trying 
to lose weight?) 
 
IF NO: How was your 
appetite? (What about 
compared with your 
usual appetite?) Did you 
have to force yourself to 
eat? Eat [less/more] than 
usual?  Was that nearly 
every day?)  
 
(3) significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in a 










?  -   + 
 
 
A4  . . how were you 
sleeping?  (Trouble 
falling, waking 
frequently, trouble 
staying asleep, waking 
too early, OR sleeping 
too much?  How many 
hours a night compared 
with usual?  Was that 
nearly every night?) 
 












A5  . . were you so 
fidgety or restless that 
you were unable to sit 
still?  (Was it so bad that 
other people noticed it? 
What did they notice? 
Was that nearly every 
day?) 
 
IF NO: What about the 
opposite - talking or 
moving more slowly 
than is normal for you?  
(Was it so bad that other 
people noticed it? What 
did they notice? Was 
that nearly every day?) 
 
(5) psychomotor agitation or retardation nearly every day 
(observable by others, not merely subjective feelings of 
restlessness or being slowed down) 
 
NOTE: ALSO CONSIDER BEHAVIOUR DURING 
THE INTERVIEW 
A5 
?  -   + 
A6 . . what was your 
energy like? (Tired all 






(6) fatigue or loss of energy nearly every day A6 
?  -   + 
A7  . . how did you feel 
about yourself?  
(Worthless? Nearly 
every day?)  
 
IF NO:  What about 
feeling guilty about 
things you had done or 
not done?  (Nearly every 
day?) 
(7) feelings of worthlessness or excessive or inappropriate 
guilt  (which may be delusional) nearly every day (not 
merely self-reproach or guilt about being sick) 
 





?  -   + 
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A8 . . did you have 
trouble thinking or 
concentrating?  (What 
kinds of things did it 
interfere with? Nearly 
every day?) 
 
IF NO: Was it hard to 
make decisions about 
everyday things?   
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by subjective 




?  -   + 
A9 . . were things so bad 
that you were thinking a 
lot about death or that 
you would be better off 
dead?  What about 
thinking of hurting 
yourself? 
 
IF YES: Did you do 
anything to hurt 
yourself? 
 
(9) recurrent thoughts of death (not just fear of dying), 
recurrent suicidal ideation without a specific plan, or a 
suicide attempt or a specific plan for committing  suicide 
A9 
?  -   + 
 
A10   
AT LEAST FIVE  OF A1 TO A9 ARE “+” AND AT LEAST ONE OF THESE 
IS ITEM A1 OR A2 
A10 








A12  Just before this began, 
were you physically ill? 
  
Just before this began, were 
you taking any medications? 
 
D. The symptoms are not due to the direct effects 
of a substance (e.g. a drug of abuse, medication) 
or to a general medical condition. 
 
Etiological general medical conditions include: 
degenerative neurological illnesses (e.g., 
A12 
?  -   + 
 
 
A11  IF UNCLEAR: Has (the 
depression/OWN WORDS) made it 
hard for you to do your work, take 
care of things at home, or get along 
with other people? 
 
C. The symptoms cause clinically significant 
distress or impairment in social, occupational, 





?  -   + 
 
If A11 above is “-” (i.e. symptoms do not cause clinically significant distress or impairment) go to A1.a     
If A10 above is “-“ (i.e. fewer than five are “+”) go to A1.a  
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IF YES: Any change in the 
amount you were taking? 
 
Just before this began, were 











Parkinson’s disease), cerebrovascular disease 
(e.g., stroke), metabolic conditions (e.g., Vitamin 
B-12 deficiency), endocrine conditions (e.g., 
hyper- and hypothyroidism, hyper- and 
hypoadreno-corticism); viral or other infections 
(e.g., hepatitis, mononucleosis, HIV), and certain 
cancers (e.g., carcinoma of the pancreas). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, inhalants, 
opioids, phencyclidine, sedatives, hypnotics, 
anxiolytics.  Medications include 
antihypertensives, oral contraceptives, 
corticosteroids, anabolic steroids, anticancer 








A13  IF UNKNOWN: Did this begin 
soon after someone close to you 
died? 
E. The symptoms are not better accounted for by 
Bereavement, i.e., after the loss [death] of a loved 
one, the symptoms persist for longer than 2 
months or are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
 
A13 




















If there is any indication that the depression may be secondary (i.e., a direct physiological consequence of a general 
medical condition or substance), go to A61 and return here to make a rating of “-” or “+” 
If A13 above is “-“ (i.e. the depressed mood is better accounted for by Bereavement), go to A1.a  
If A12 above is “-“ (i.e. mood is due to substance or general medical condition), is “-” go to A1.a  
 
Go to A1.b (Past Major Depressive Episode Before This Pregnancy) 
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PAST MAJOR DEPRESSIVE EPISODE IN THIS PREGNANCY CRITERIA 
 
A1.a   During this 
pregnancy, has there  
    
..  been a period of time 
when you were feeling 
depressed or down most of 
the day nearly every day?  
(What was that like?) 
 
IF YES: How long did it 
last? (As long as 2 weeks?) 
 
1) depressed mood most of the day, nearly every 
day as indicated by either subjective report (e.g., 
feels sad or empty) or observation made by others 
(e.g. appears tearful). 
AI.a 
?  -  + 
 
past 
- in this 
pregnancy 
 
A2.a   . . . what about losing 
interest or pleasure in things 
youusually enjoyed? 
 
IF YES: Was it nearly every 
day? How long did it last? 
(As long as 2 weeks?) 
(2) markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, nearly 
every day (as indicated by either subjective 







?  -  + 
 
past 




A3.a  . . .did you lose 
or gain any weight? 
(How much? Were you 
trying to lose weight?) 
 
IF NO: How was your 
appetite? (What about 
compared with your 
usual appetite?) Did 
you have to force 
yourself to eat? Eat 
[less/more] than usual?  
Was that nearly every 
day?)  
 
(3) significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month), or decrease or increase in appetite nearly 









?  -   + 
 
past 









staying asleep, waking 
too early, OR sleeping 
too much?  How many 
hours a night compared 
with usual?  Was that 
nearly every night?) 
 






?  -   + 
 
past 




A5.a  . . were you so 
fidgety or restless that 
you were unable to sit 
still?  (Was it so bad 
that other people 
noticed it? What did 
they notice? Was that 
nearly every day?) 
 
IF NO: What about the 
opposite - talking or 
moving more slowly 
than is normal for you?  
(Was it so bad that 
other people noticed it? 
What did they notice? 
Was that nearly every 
day?) 
 
(5) psychomotor agitation or retardation nearly every 
day (observable by others, not merely subjective 




?  -   + 
 
past 
- in this 
pregnancy 
 
A6.a . . what was your 
energy like? (Tired all 






(6) fatigue or loss of energy nearly every day A6.a 
?  -   + 
past 








FOR THE FOLLOWING QUESTIONS, FOCUS ON THE WORST TWO WEEKS 
OF THE PAST MAJOR DEPRESSIVE IN THIS PREGNANCY  
 
During [2-WEEK PERIOD] …    From: …../…../……  To: …./…../…..  (insert 
dates) 
 
A10.a   
AT LEAST FIVE  OF A1 TO A9 ARE “+” AND AT LEAST ONE OF THESE 
IS ITEM A1 OR A2 
A10.a 
?  -   + 
past - this 
pregnanc
A7.a  . . how did you 
feel about yourself?  
(Worthless? Nearly 
every day?)  
 
IF NO:  What about 
feeling guilty about 
things you had done or 
not done?  (Nearly 
every day?) 
(7) feelings of worthlessness or excessive or 
inappropriate guilt  (which may be delusional) nearly 
every day (not merely self-reproach or guilt about 
being sick) 
 





?  -   + 
past 
- in this 
pregnancy 
 
A8.a . . did you have 
trouble thinking or 
concentrating?  (What 
kinds of things did it 
interfere with? Nearly 
every day?) 
 
IF NO: Was it hard to 
make decisions about 
everyday things?   
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by subjective 




?  -   + 
past 
- in this 
pregnancy 
 
A9.a . . were things so 
bad that you were 
thinking a lot about 
death or that you would 
be better off dead?  
What about thinking of 
hurting yourself? 
 
IF YES: Did you do 
anything to hurt 
yourself? 
 
(9) recurrent thoughts of death (not just fear of dying), 
recurrent suicidal ideation without a specific plan, or a 
suicide attempt or a specific plan for committing  
suicide 
A9.a 
?  -   + 
past 









A11.a  IF UNCLEAR: Did (the 
depression/OWN WORDS) made it 
hard for you to do your work, take 
care of things at home, or get along 
with other people? 
C. The symptoms cause clinically significant 
distress or impairment in social, occupational, 




?  -   + 










A12.a  Just before this began, 
were you physically ill? 
  
Just before this began, were you 
taking any medications? 
 
IF YES: Any change in the 
amount you were taking? 
 
Just before this began, were you 











D. The symptoms are not due to the direct 
effects of a substance (e.g. a drug of abuse, 
medication) or to a general medical 
condition. 
 
Etiological general medical conditions 
include: degenerative neurological 
illnesses (e.g., Parkinson’s disease), 
cerebrovascular disease (e.g., stroke), 
metabolic conditions (e.g., Vitamin B-12 
deficiency), endocrine conditions (e.g., 
hyper- and hypothyroidism, hyper- and 
hypoadreno-corticism); viral or other 
infections (e.g., hepatitis, mononucleosis, 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, 
inhalants, opioids, phencyclidine, 
sedatives, hypnotics, anxiolytics.  
Medications include antihypertensives, 
oral contraceptives, corticosteroids, 
anabolic steroids, anticancer agents, 














If there is any indication that the 
depression may be secondary (i.e., a 
direct physiological consequence of a 
general medical condition or 
substance), go to A61 and return here 
to make a rating of “-” or “+” 
If A11.a above is “-“ (i.e. symptoms not clinically significant) go to A1.b   
If A12.a above is “-“ (i.e. mood is due to substance or general medical condition), go to A1.b   
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A13.a  IF 
UNKNOWN: Did this 
begin soon after 
someone close to you 
died? 
E. The symptoms are not better accounted for by 
Bereavement, i.e., after the loss [death] of a loved 
one, the symptoms persist for longer than 2 months 
or are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
A13.a 
?  -   + 
 








CRITERIA  A, C, D & E ARE “+”                              




?  -   + 
 
 





FOR THE FOLLOWING QUESTIONS, FOCUS ON THE WORST TWO WEEKS 
OF THE PAST MAJOR DEPRESSIVE EPISODE  
 
A1.b   Has there ever   ...     
 
..  been a period of time when 
you were feeling depressed or 
down most of the day nearly 
every day?  (What was that 
like?) 
 
IF YES: How long did it last? 
(As long as 2 weeks?) 
 
1) depressed mood most of the day, nearly 
every day as indicated by either subjective 
report (e.g., feels sad or empty) or 
observation made by others (e.g. appears 
tearful). 
AI.b 





A2.b   . . . what about losing 
interest or pleasure in things 
you usually enjoyed? 
 
IF YES: Was it nearly every 
day? How long did it last? (As 
long as 2 weeks?) 
 
(2) markedly diminished interest or pleasure 
in all, or almost all, activities most of the 
day, nearly every day (as indicated by either 














IF AT LEAST ONE PAST DEPRESSED PERIOD:  Have you had more than one time like that? Which 
one was the worst? 
 
If A13.a above is “-“ (i.e. depressed mood is better accounted for by Bereavement), go to A1.b   
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During [2-WEEK PERIOD] …    From: …../…../……  To: …./…../…..  (insert 
dates) 
 
A3.b  . . .did you lose or gain 
any weight? (How much? 
Were you trying to lose 
weight?) 
 
IF NO: How was your 
appetite? (What about 
compared with your usual 
appetite?) Did you have to 
force yourself to eat? Eat 
[less/more] than usual?  Was 
that nearly every day?)  
(3) significant weight loss when not dieting or 
weight gain (e.g. a change of more than 5% of 
body weight in a month), or decrease or increase 












A4.b  . . how were you 
sleeping?  (Trouble falling, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too 
much?  How many hours a 
night compared with usual?  
Was that nearly every 
night?) 
 













A5.b  . . were you so fidgety 
or restless that you were 
unable to sit still?  (Was it so 
bad that other people noticed 
it? What did they notice? 
Was that nearly every day?) 
 
IF NO: What about the 
opposite - talking or moving 
more slowly than is normal 
for you?  (Was it so bad that 
other people noticed it? 
What did they notice? Was 
that nearly every day?) 
 
(5) psychomotor agitation or retardation nearly 
every day (observable by others, not merely 














A6.b . . what was your 
energy like? (Tired all the 





(6) fatigue or loss of energy nearly every day A6.b 






A7.b  . . how did you feel 
about yourself?  (Worthless? 
Nearly every day?)  
 
IF NO:  What about feeling 
guilty about things you had 
done or not done?  (Nearly 
every day?) 
(7) feelings of worthlessness or excessive or 
inappropriate guilt  (which may be delusional) 
nearly every day (not merely self-reproach or guilt 
about being sick) 
 











A8.b . . did you have trouble 
thinking or concentrating?  
(What kinds of things did it 
interfere with? Nearly every 
day?) 
 
IF NO: Was it hard to make 
decisions about everyday 
things?   
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 










A9.b . . were things so bad 
that you were thinking a lot 
about death or that you 
would be better off dead?  
What about thinking of 
hurting yourself? 
 
IF YES: Did you do 
anything to hurt yourself? 
 
(9) recurrent thoughts of death (not just fear of 
dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific 
plan for committing  suicide 
A9.b 






A10.b   
AT LEAST FIVE  OF A1 TO A9 ARE “+” AND AT LEAST ONE OF 
THESE IS ITEM A1 OR A2 
A10.b 







A11.b  IF UNCLEAR: Did 
(the depression/OWN 
C. The symptoms caused clinically significant 
distress or impairment in social, occupational, 
A11.b 
?  -   + 
IF “-” go to A16 (Manic Episode) 
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WORDS) made it hard for you 
to do your work, take care of 
things at home, or get along 
with other people? 
or other important areas of functioning. 
 
 






A12.b  Just before this began, 
were you physically ill? 
  
Just before this began, were 
you taking any medications? 
 
IF YES: Any change in the 
amount you were taking? 
 
Just before this began, were 











D. The symptoms are not due to the direct 
effects of a substance (e.g. a drug of abuse, 
medication) or to a general medical condition. 
 
Etiological general medical conditions include: 
degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular disease 
(e.g., stroke), metabolic conditions (e.g., 
Vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and hypothyroidism, 
hyper- and hypoadreno-corticism); viral or 
other infections (e.g., hepatitis, mononucleosis, 
HIV), and certain cancers (e.g., carcinoma of 
the pancreas). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, 
inhalants, opioids, phencyclidine, sedatives, 
hypnotics, anxiolytics.  Medications include 
antihypertensives, oral contraceptives, 
corticosteroids, anabolic steroids, anticancer 




?  -   + 
 





A13.b  IF UNKNOWN: 
Did this begin soon 
after someone close to 
you died? 
E. The symptoms are not better accounted for 
by Bereavement, i.e., after the loss [death] of a 
loved one, the symptoms persist for longer than 
2 months or are characterized by marked 
functional impairment, morbid preoccupation 
with worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
 
A13.b 
?  -   + 
 







If there is any indication that the 
depression may be secondary (i.e., a 
direct physiological consequence of a 
general medical condition or 
IF “-” go to A16 (Manic Episode) 
If “-” go to A16 (Manic Episode) 




CRITERIA  A, C, D & E ARE “+”     
                          




?  -   + 
How many separate times have 
you been (depressed/ OWN 
WORDS) nearly every day for 
at least 2 weeks and had 
several of the symptoms that 
you described, such as 
(SYMPTOMS)? 
 
Total number of Major Depressive Episodes 
including current. (CODE 99 if too numerous or 
indistinct to count).                                                                                                 







Appendix D: Childhood History of Care and Abuse Questionnaire  
CECA-Q 
 
I’m going to ask you some questions about your childhood experiences.  If you prefer not 
to answer any of the questions, that’s fine – just say you’d rather not answer. 
 
Who brought you up before age 17? 
 
Instructions to researcher: Write below the PARENT FIGURES who brought participant up 
in childhood. List each family arrangement with different types of parent figures which lasted 
a year or longer. Consider natural parents, step parents (including parents’ live in partners), 
aunts, friends of the family, adoptive parents, foster parents, etc. 
 
If participant has only lived in one arrangement, then fill in the first family arrangement and 
leave the other boxes blank. For example, if this was with their biological parents, tick 
‘natural mother’ and ‘natural father’ and write in age ‘0’. 
 
If they have lived in other arrangements that lasted a year or longer, such as with mother 
alone or mother and step-father, then list them a second/third etc family arrangement 
together with age they were when the arrangement began. 
 
a) First Family Arrangement (all) 
 
i) Mother figure: 
 1 = Natural mother    
 2 = Step-mother/ father’s live-in partner   
 3 = Other relative e.g. aunt, grandmother 
 4 = Other non-relative e.g. foster/adoptive/godmother    
 5 = Other 
 6 = No mother figure    
 
ii) Father figure: 
 1 = Natural father  
 2 = Step-father/ mother’s live-in partner  
 3 = Other relative e.g. uncle, grandfather  
 4 = Other non-relative e.g. foster/adoptive/godfather     
 5 = Other    
 6 = No father figure    
 




b) Second Family Arrangement (if applicable) 
 
 i) Mother figure: 
 1 = Natural mother    
 2 = Step-mother/ father’s live-in partner   
 3 = Other relative e.g. aunt, grandmother 
 4 = Other non-relative e.g. foster/adoptive/godmother    
 5 = Other 
 6 = No mother figure    
 
   
 
 ii) Father figure: 
 1 = Natural father  
 2 = Step-father/ mother’s live-in partner  
 3 = Other relative e.g. uncle, grandfather  
 4 = Other non-relative e.g. foster/adoptive/godfather     
 5 = Other    
  6 = No father figure 
 iii) Your age at start: _________  years  iv) Your age at finish: _________  years 
 
c) Third Family Arrangement (if applicable) 
 i) Mother figure: 
 1 = Natural mother    
 2 = Step-mother/ father’s live-in partner   
 3 = Other relative e.g. aunt, grandmother 
 4 = Other non-relative e.g. foster/adoptive/godmother    
 5 = Other 
 6 = No mother figure     
 ii) Father figure: 
 1 = Natural father  
 2 = Step-father/ mother’s live-in partner  
 3 = Other relative e.g. uncle, grandfather  
 4 = Other non-relative e.g. foster/adoptive/godfather     
 5 = Other    
  6 = No father figure 
 
iii) Your age at start: . _________  years iv) Your age at finish: _________  years 
d) Fourth Family Arrangement (if applicable) 
i) Mother figure: 
 1 = Natural mother    
 2 = Step-mother/ father’s live-in partner   
 3 = Other relative e.g. aunt, grandmother 
 4 = Other non-relative e.g. foster/adoptive/godmother    
 5 = Other 




ii) Father figure: 
 1 = Natural father  
 2 = Step-father/ mother’s live-in partner  
 3 = Other relative e.g. uncle, grandfather  
 4 = Other non-relative e.g. foster/adoptive/godfather     
 5 = Other    
  6 = No father figure 
   
iii) Your age at start: _________  years iv) Your age at finish: _________  years 
 
e) Fifth Family Arrangement (if applicable) 
 
i) Mother figure: 
 1 = Natural mother    
 2 = Step-mother/ father’s live-in partner   
 3 = Other relative e.g. aunt, grandmother 
 4 = Other non-relative e.g. foster/adoptive/godmother    
 5 = Other 
 6 = No mother figure  
 
ii) Father figure: 
 1 = Natural father  
 2 = Step-father/ mother’s live-in partner  
 3 = Other relative e.g. uncle, grandfather  
 4 = Other non-relative e.g. foster/adoptive/godfather     
 5 = Other    
  6 = No father figure 
     3 = Other relative e.g. uncle, grandfather  6 = No father figure 
 
iii) Your age at start: _________  years iv) Your age at finish: _________  years 
 
g) Were you ever in a children’s home or institution prior to age 17? 
 
i)  0 = No     1 =  Yes  
 
ii) If YES, type of institution: 
 
1 = Local authority care  i) Age entered: _________ years  ii) Age left: _________   
 
2 = Hospital    ii) Age entered: _________ years  ii) Age left: _________   
 
3 = Boarding school   iii) Age entered: _________ years  ii) Age left: _________   
 




5 = Unknown    vi) Age entered: _________ years  ii) Age left: _________   
 
Parental Loss and Separation 
 
a) Did either parent die before you were aged 17? 
 
i) Mother:    0 = No       1 = Yes 
 
ii) If YES, your age: _________ years 
 
iii) Father:    0 = No       1 = Yes 
 
iv) If YES, your age: _________ years 
 
b) Have you ever been separated from either parent for 6 months or more before 17? 
 
1) Mother:    0 = No       1 = Yes 
 
ii) If YES, your age at first separation: _________ years 
 
iii) Number of years of separation: _________ years _________ months 
 
iv) Reason for separation from mother: 
 
1 = Parental illness     
2 = Parental divorce, separation     
3 = Abandoned by parent or never knew parent    
4 = Other (please specify below)   
   






2) Father:    0 = No       1 = Yes 
 
i) If YES, your age at first separation: _________ years 
 
ii) Number of years of separation: _________ years _________ months 
 
iii) Reason for separation from father: 
 
1 = Parental illness     
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2 = Parental divorce, separation     
3 = Abandoned by parent or never knew parent   
4 = Other (please specify below)     
 




3.  Parent figures 
 
Please circle the appropriate numbers to describe your Mother Figure, as you remember 
her in your first 17 years.   If you had more than one, choose the one you were with the 
longest, or the one you found most difficult to live with. 
 
3a. Which mother figure are you describing below? 
  
 1. Natural mother  
 2. Step-mother/father's live-in partner        
 3. Other relative e.g. aunt, grandmother 
 4. Other non-relative e.g. foster mother, godmother 





 Unsure  No, 
not at 
all 
3b She was very difficult  to please 
 
1 2 3 4 5 
3c She was concerned about my worries 
 
1 2 3 4 5 
3d She was interested in how I did at  
     school 
1 2 3 4 5 
3e She made me feel unwanted 
 
1 2 3 4 5 
3f  She tried to make me feel better  
     when I was upset 
1 2 3 4 5 
3g She was very critical of me 
 
1 2 3 4 5 
3h She would leave me unsupervised 
     before I was 10 years old 
1 2 3 4 5 
3i  She would usually have time to talk 
     to me 
1 2 3 4 5 
3j She would hit me 
 
1 2 3 4 5 
3k At times she made me feel I was a 1 2 3 4 5 
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     nuisance 
3l  She often picked on me unfairly 
 
1 2 3 4 5 
3m She was there if I needed her 
 
1 2 3 4 5 
3n She was interested in who my 
      friends were 
1 2 3 4 5 
3o She was concerned about my 
     whereabouts 
1 2 3 4 5 
3p She cared for me when I was ill 
 
1 2 3 4 5 
3q She neglected my basic needs (e.g. 
      food and clothes) 
1 2 3 4 5 
3r  She did not like me as much as my 
     brothers and sisters (leave blank if no 
     siblings) 
1 2 3 4 5 
 
3s. Do you want to add anything about your mother?………………………………….. 
4.  Please circle the appropriate numbers to describe your Father Figure, as you 
remember him in your first 17 years.   If you had more than one, choose the one you 
were with the longest, or the one you found most difficult to live with. 
 
4a.  Which father figure are you describing below? 
 1. Natural father  
 2. Step-father/mother's live-in partner        
 3. Other relative e.g uncle, grandfather 
 4. Other non-relative e.g. foster father, adoptive father 




 Unsure  No, not 
at all 
4b He was very difficult  to please 
 
1 2 3 4 5 
4c He was concerned about my 
worries 
 
1 2 3 4 5 
4d He was interested in how I did 
at  school 
1 2 3 4 5 
4e He made me feel unwanted 
 
1 2 3 4 5 
4f  He tried to make me feel better  
     when I was upset 
1 2 3 4 5 
4g He was very critical of me 
 
1 2 3 4 5 
4h He would leave me 1 2 3 4 5 
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unsupervised before I was 10 
years old 
4i  He would usually have time to 
talk  to me 
1 2 3 4 5 
4j  He would hit me 
 
1 2 3 4 5 
4k At times he made me feel I 
was a  nuisance 
1 2 3 4 5 
4l  He often picked on me 
unfairly 
 
1 2 3 4 5 
4m He was there if I needed him 
 
1 2 3 4 5 
4n He was interested in who my 
      friends were 
1 2 3 4 5 
4o He was concerned about my 
     whereabouts 
1 2 3 4 5 
4p He cared for me when I was ill 
 
1 2 3 4 5 
4q He neglected my basic needs 
(e.g. food and clothes) 
1 2 3 4 5 
4r  He did not like me as much as 
my brothers and sisters (leave 
blank if no siblings) 
1 2 3 4 5 
 





5. CLOSE RELATIONSHIPS IN CHILDHOOD 
   
(Please circle as appropriate – if you circle NO to any question, SKIP the rest of that 
section and go on to the next one) 
 
5a  When you were a child or teenager, were there any ADULTS you could go to with 
your problems or to discuss your feelings?           
        0 = No     1 =  Yes  
 
5b  If YES: Who was that?  (circle more than one if relevant) 
      
 1.  mother / mother figure 
 2.  father / father figure 
 3.  other relative 
 4.  family friend 
 5.  teacher, vicar etc 
 6.  other (describe) ………………………………. 
 
5d  Do you want to note anything about the relationship(s)? ………………………… 
 
 
5e Were there other CHILDREN OR TEENAGERS of your age that you could discuss  
      your problems and feelings with?    0 = No     1 =  Yes  
 
5f  If YES: Who was that?        (circle more than one if relevant) 
 
 1.  sister 
 2.  brother 
 3.  other relative 
 4.  close friend 
 5. other less close friend(s) 
 6. other person (describe)……………………………….. 
 
5h  Do you want to note anything about the relationship(s)?……………………… 
5i  Who would you describe as the TWO CLOSEST people to you as a  child or 
teenager?         
(circle up to two) 
 
 1.  mother / mother figure 
 2.  father / father figure 
 3.  sister or brother 
 4.  other relative 
 5.  family friend (adult) 
 6.  friend your age 




5k  Do you want to note anything about the relationship(s)?………………………… 
Physical Punishment Before the Age of 17 by a Parent Figure or Other Household 
Member 
 
a) When you were a child or a teenager were you ever hit repeatedly with an implement (such 
as a belt or stick) or punched, kicked or burnt by someone in the household? 
 
  0 = No 1 = Yes 
 
b) How old were you when it began? 
 
i) Mother figure - your age: _________ years 
 
ii) Father figure - your age: _________ years 
 
c) Did the hitting happen on more than one occasion? 
 
i) Mother figure  0 = No 1 = Yes 
 
ii) Father figure  0 = No 1 = Yes 
 
d) How were you hit by your mother? 
  
1 = Belt or stick   2 = Punched or kicked No 3 = Hit with hand 4 = Other  
     
e) How were you hit by your father? 
 
1 = Belt or stick   2 = Punched or kicked No 3 = Hit with hand 4 = Other  
  
f) Were you ever injured, e.g. bruises, black eyes, broken limbs? 
 
i) Mother figure  0 = No 1 = Yes 
 
ii) Father figure  0 = No 1 = Yes 
g) Was this person ever so angry they seemed out of control? 
 
i) Mother figure  0 = No 1 = Yes 
 
ii) Father figure  0 = No 1 = Yes 
 







h) Did you experience this from anyone else in the household? 
 
Sibling  0 = No    1 = Yes 
  
Grandparent  0 = No      1 = Yes 
 
Uncle/aunt 0 = No     1 = Yes 
 
Other  0 = No     1 = Yes  
 





Unwanted Sexual Experiences Before Age 17 
 
a) When you were a child or teenager did you ever have any unwanted sexual 
experiences? 
 
0 = No  1 = Yes  
  
        
b) Did anyone force you or persuade you to have sexual intercourse against your wishes 
before age 17? 
 
 0 = No 1 = Yes  
  
c) Can you think of any upsetting sexual experiences before age 17 with a related adult or 
someone in authority, e.g. teacher? 
 
 0 = No    1 = Yes  
  
(If YES or UNSURE to any of the above then continue) 
d) 1st Experience: 
 
i.) How old were you when it began? Age: _________ years 
 
ii)  Was the other person someone you knew?   0 = No    1 = Yes 
   
iii)  Was the other person a relative?    0 = No    1 = Yes 
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iv)  Did this person do it on more than one occasion?  0 = No    1 = Yes 
   
v)  Did it involve touching private parts of your body?  0 = No    1 = Yes
  
 
vi)  Did it involve sexual intercourse?    0 = No    1 = Yes
  







e.) 2nd Experience:  
 
ii.) How old were you when it began? Age: _________ years 
 
ii)  Was the other person someone you knew?   0 = No    1 = Yes 
   
iii)  Was the other person a relative?    0 = No    1 = Yes 
   
iv)  Did this person do it on more than one occasion?  0 = No    1 = Yes 
   
v)  Did it involve touching private parts of your body?  0 = No    1 = Yes
  
 
vi)  Did it involve sexual intercourse?    0 = No    1 = Yes
  
 








   
Appendix E: Neonatal Behavioural Assessment Scale  
NBAS Scoring Form 
Baby’s first (given) name...................................... 
Sex....... dob................. Gestational age........... Birth weight.......... Height............HC....... 
Mode of delivery............... Length of Labour..............Apgar scores....................... 
...Parity...................Type of feeding................. 
Is this information collected from the hospital discharge record (Y/N) 
 
Infant Behavioural Assessment  
Social-Interactive 9 8 7 6 5 4 3 2 1                    Comments 
Animate visual           
Animate visual & 
auditory 
          
Inanimate visual           
Inanimate visual & 
auditory 
          
Inanimate auditory           
Animate auditory           
Alertness           
 
Motor System 9 8 7 6 5 4 3 2 1                    Comments 
General tone           
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Motor maturity           
Pull- to-sit           
Defensive           
Activity level           
 
State Organisation 9 8 7 6 5 4 3 2 1                    Comments 
Peak of excitement           
Rapidity of build- up           
Irritability           
Lability of states           
 
State Regulation 9 8 7 6 5 4 3 2 1                    Comments 
Cuddliness           
Consolability           
Self-quieting           
Hand-to-mouth           
 
Autonomic System 9 8 7 6 5 4 3 2 1                    Comments 
Tremulousness           
Startles           
















Supplementary Items 9 8 7 6 5 4 3 2 1                    Comments 
Quality of alertness           
Cost of attention           
Examiner facilitation           
General irritability           
Robustness & 
endurance 
          
State regulation           
E’s emotional response           
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Reflexes 0 1 2 3 Asym                     Comments 
Plantar          
Babinski          
Ankle clonus          
Rooting          
Sucking          
Glabella          
Passive resist - legs          
Passive resist - arms          
Palmar (hand grasp)          
Placing          
Standing          
Walking          
Crawling          
Incurvation          
Tonic dev. – head & 
eyes 
         
Nystagmus          
TNR          
Moro          
 
1st Predominant state: ________ 
2nd Predominant state: ________ 
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Predominant state between “Post 1” and “Post 2” saliva samples: _______ 
SUMMARY : INFANT  SUMMARY : PARENT(S) 
Strengths Concerns  Strengths Concerns 






   





Appendix F: Maternal saliva sampling collection record 
and instructions  




Subject ID (no.-initials)      -    
 
        
Researcher’s Initials         
 
 





DATE OF COLLECTION 
(DD-MM-YY) 




• Please do not eat, drink, smoke or brush your teeth between samples at 0, 15, 30 
and 60 minutes.   
• Please do not eat, drink, smoke or brush your teeth 30 minutes before samples at 
Midday and 8 pm. 
• You may drink water if you need to, but only immediately after you have taken 
a sample. 
• Collect the saliva as on the instruction diagram. Place the swab under your 
tongue and leave it there for 1-2 minutes, then place it as shown in the correct 
tube. Then close the tube firmly and store in the fridge in the bag supplied. 
• Please use the timer provided to ensure accurate timing. 
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• Try to sit down and relax for the next hour after waking up. 
 
If you have any questions about the process, please call the research team on 020 7848 
5009. 
 
Complete  When? Record the Time: 
BOX 1 (Tube 0) When you wake up  
BOX 2 (Tube 15) 15 minutes after you wake up  
BOX 3 (Tube 30) 30 minutes after you wake up  
BOX 4 (Tube 60) 60 minutes after you wake up  
BOX 5                     
(Tube 12pm) 
Midday (12:00)  
BOX 6                    
(Tube 8pm) 
8 o’clock pm (20:00pm)  
 
 
BOX 1: When you wake up                                                                   USE TUBE 0  
                                                                                                               
• What time is it now? 
_______________________________________________________________ 
• Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the time: 
_______________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of 




BOX 2:  15 minutes after waking up                                                     USE TUBE 15 
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• What time is it now? 
_______________________________________________________________ 
• What were you doing before giving the sample? 
_______________________________________________________________ 
• Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the time: 
_______________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of 




BOX 3: 30 minutes after waking up                                                         USE TUBE 30 
                                          
• What time is it now? 
_______________________________________________________________ 
• What were you doing before giving the sample? 
_______________________________________________________________ 
• Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the time: 
_______________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of 




BOX 4: 60 minutes after waking up                                                          USE TUBE 60 
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• What time is it now? 
_______________________________________________________________ 
• What were you doing before giving the sample? 
_______________________________________________________________ 
• Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the 
time____________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of 




*****YOU CAN NOW EAT, DRINK, SMOKE AND BRUSH YOUR TEETH! 
***** 
Please do not eat, drink, smoke or brush your teeth for 30 minutes before collecting 
the sample at Midday 
 
BOX 5: Midday (12:00pm) before lunch                                            USE TUBE 12pm 
• What time is it now? 
_______________________________________________________________ 
• What were you doing before giving the sample? 
_______________________________________________________________ 
  
• Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the time: 
_______________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of 






*****YOU CAN NOW EAT, DRINK, SMOKE AND BRUSH YOUR TEETH 
AGAIN! ***** 
 
Please do not eat, drink, smoke or brush your teeth for 30 minutes before collecting 
the sample at 8 o’clock pm 
BOX 6: At 8 o’clock pm  (20:00pm)                                                     USE TUBE 8pm 
• What time is it now? 
_________________________________________________________________ 
• What were you doing before giving the sample? 
_________________________________________________________________ 
  
Did you accidentally brush your teeth, smoke or have anything to eat or drink before 
taking the sample? If yes, please describe it here and record the time:     
__________________________________________________________________ 
• Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain 




Please note the name and time of any medication you have taken today (including the 
contraceptive pill): 
___________________________________________________________________ 





*****THANK YOU FOR COMPLETING THIS SALIVA COLLECTION***** 
Returning the samples: 
Your researcher will tell you if they will collect your samples from you or if you should 
post them. Please remember to place all your samples in the fridge. 
Posting: Please post your samples back to us the following Monday or Tuesday, and 
leave your samples in your fridge until posting. 
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Place all the samples in the plastic bag provided and seal it carefully. Place the bag and 
the collection record into the stamped addressed envelope provided. Please remember to 
make a note of the date you will post the specimens on the record form before sealing 
the envelope. 
Date posted: __ / __ / __ 
Office use only: 













Salivette with swab 
 
Inner tube 
 Outer tube 
 
Take care to find the salivette tube 
marked with the appropriate time. 
 
 
Carefully remove the lid (the part on 
the end with ridges on). 
 
 
Tip the swab into the lid and use this to 
place the swab under the front of your 




Keep the swab in place for 1-2 minutes 







Take the swab out of your mouth with 
the help of the lid (so you are not 
touching the swab with your fingers). 
 
 
Carefully tip the swab into the salivette 





Replace the lid firmly. 
 








Swab with saliva 
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Appendix G: Neonatal Behavioral Assessment form and infant saliva – 6 days 
postpartum 
ORDER OF ASSESSMENTS: 
1. Collect 1st saliva sample (“PRE”) with SCS/Salivette before starting NBAS 
2. NBAS 
3. Collect 2nd saliva sample (“POST 1”) with Sorbette/Salivette immediately on 
completion of NBAS 
4. Ask the participant to complete “PRAM 6 day postnatal (NBAS) self-report 
booklet” 
5. Collect 3rd saliva sample (“POST 2”) with Sorbette/Salivette 30 minutes after 
completion of NBAS 
6. Collect saliva sample with Oragene DNA kit 
7. Measure neonate head circumference 
N.B. Feeding should be avoided during the visit if possible. 
____________________________________________________ 
Saliva Oragene DNA sample: 
Record the following: 
Was the baby fed in the 30 minutes before taking the sample (Y/N) 
If yes, when and for how long: Start: ____ Finish: ____ Sample time: _______ 
How many sponges were used: ________ 
 
Neonate head circumference measured on the day of NBAS: ____ mm 
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BABY SALIVA SAMPLE COLLECTION RECORD FOR NBAS  
N.B. Ideally the samples should not be taken within the 15 minutes after a feed; 
please inform the mother of this before starting the NBAS. 
What time was the baby’s most recent nap? Start: ______Finish: ________ 
What time was the baby’s most recent feed?  Start: ________Finish: ________ 
Before the baby’s NBAS assessment collect the baby’s saliva as on the instruction 
diagram in the instructions document. Take the tube marked “PRE.” Place the SCS 
under the baby’s tongue and leave them there for a total of 60-90 seconds (the SCS can 
be placed under the tongue for 15 to 30 seconds at a time and reintroduced as needed), 
then place it in the tube, cut to length, close the tube firmly and store in the bag 
supplied. 
EXACT TIME OF SAMPLING: ________________________ 
 
TIME OF NBAS ASSESSMENT:  Start ___________ Finish ___________ 
Immediately after the NBAS assessment collect the baby’s saliva in the tube marked 
“POST-1” as for the 1st sample. Then close the tube firmly and store in the bag 
supplied. 
• What time is it now? 
_______________________________________________________________ 
• Was the baby fed? If yes, when and for how long: Start: _____ Finish: ______ 
• Did the baby sleep? If yes, when and for how long: Start: ____Finish: ______ 
 
30 minutes after the end of the NBAS assessment collect the baby’s saliva in the tube 
marked “POST-2” as for the 1st sample. Then close the tube firmly and store in the bag 
supplied. 
• What time is it now? 
_______________________________________________________________ 
• Was the baby fed? If yes, when and for how long: Start: _____Finish: _______ 
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• Did the baby sleep? If yes, when and for how long: Start: _____ Finish: ______ 
 
Please note the name and time of any medication the baby is taking 
___________________________________________________________________ 




Appendix H: Infant saliva sampling collection record and instruction at the time of 
the 8 weeks and 12 months immunization   
BABY SALIVA SAMPLE COLLECTION RECORD 
Subject ID (no.-
initials) 
b      -    
 
         
Researcher’s Initials          
 
8 weeks postnatal 1 year postnatal (please delete) 
DAY 1 (to be completed by researcher and brought back to the IOP with the saliva 
samples) 
DATE OF COLLECTION 
(DD-MM-YY) 
   -    -   
 
N.B. Ideally the samples should not be taken for at least 15 minutes after a feed.  
 
What time was baby’s most recent nap?  Start: ________ Finish: ________ 
What time was baby’s most recent feed?  Start: ________ Finish: ________ 
 
Before the immunization collect baby’s saliva with the help of the researcher (as on 
the instructions for the researcher). Take the tube marked “PRE.” Place the 
Salimetrics children’s swab under child’s tongue and leave it there for 60 to 90 seconds 
(the swab can be placed under the tongue for a few seconds at a time and reintroduced 
as needed), then place the wet end in the salivette tube, the researcher will fold the swab 
and close the tube firmly. 
EXACT TIME OF SAMPLING: ________________________ 
 
TIME OF Immunization: ___________ 
Comments e.g.  Was mother present?   Did baby cry much? 
 
Exactly 20 minutes after the immunization collect baby’s saliva in the tube marked 
“POST” as for the 1st sample. Then close the tube firmly and store in the bag supplied. 
• What time is it now? 
_______________________________________________________________ 
• Was baby fed? (Y/N) If yes, when and for how long:  Start: ____Finish:______ 




Please note the name and time of any medication baby is taking 
___________________________________________________________________ 
 
Does baby have any medical problems? If so, please list them here  
 
Office use only:  [Date of sample receipt: __ / __ / __   
Date of sample storage: __ / __ / __  
 
 
Appendix I: Assay procedure for salivary cortisol  
On arrival to the laboratory, the samples were frozen at -20°C. After thawing, saliva 
samples were centrifuged at 3000 rev/min for 15 minutes at room temperature, which 
resulted in a clear supernatant of low viscosity. Determination of cortisol levels was 
done using the High Sensitivity Salivary Cortisol ELISA KIT from Salimetrics, 
following the recommended procedure. Briefly, 25 µl of saliva and standards were 
assayed in duplicates, by incubation on a microtitre plate coated with monoclonal 
antibodies against cortisol. Cortisol linked to horseradish peroxidase was then added, to 
compete with cortisol in the standards and unknowns for the antibody binding sites. 
After incubation, unbound components were washed away and bound cortisol 
peroxidase measured by reaction of the peroxidase enzyme on the substrate 
tetramethylbenzidine. The amount of cortisol peroxidase detected, as measured by the 
intensity of colour developed, is inversely proportional to the amount of cortisol 
present. Optical density was read at 450 nm with correction at 620 nm, using a 
Beckman Coulter DTX 880 plate reader, with Multimode Detection Software 2.0.0.12. 
Values of cortisol were calculated using SoftMax Pro 4.8 software, following a 4-
parameter fit. 
 
 
